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Abstract 
The flood of RNA-related research in recent decades has revealed RNA to be a structurally and 
functionally diverse class of molecule, one that generates an intricate network of regulation that has 
been pivotal to the evolution of complex lifeforms. In order to elucidate how RNA achieves biological 
function through the formation of ribonucleoprotein complexes, characterisation of RNA recognition 
by RNA-binding proteins is an essential step. The rules governing the interaction of RNA and RNA-
binding proteins have proved difficult to define, and in many instances, it is not understood how 
specificity is achieved. Knowledge of these rules is crucial to our understanding of RNA-related 
functions and their role in disease, and requires further in-depth characterisation of a wide variety of 
ribonucleoprotein complexes. 
The research in this Thesis details the RNA-binding behaviour of two reported RNA-binding proteins. 
Firstly, the RNA-binding behaviour of the Drosophila transcription factor bicoid is investigated. For 
many years it has been believed that the bicoid homeodomain binds the 3′-UTR of the caudal mRNA 
transcript, yet no binding site or specificity determinants have been reported. The work reported here 
attempts to characterise this interaction. Further, other domains in the protein are examined with a view 
to understanding how biological specificity might be achieved. Secondly, characterisation of the RNA-
binding behaviour of the heterodimeric pair of transcription elongation factors, Spt4 and Spt5, is 
reported. This heterodimer is known to be an important player in transcription and yet surprisingly little 
is known about its function. In the present work, the AA-repeat RNA-binding properties of these 
proteins are investigated, and complex binding behaviour is reported. Overall, it is shown that the 
elucidation of RNA-binding activity by proteins is often not straightforward, requiring the application 
of multiple and increasingly sophisticated techniques if we are to grasp the underlying biology.  
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Chapter 1: Introduction 
1.1 Background 
The work detailed in this Thesis investigates the RNA-binding capacity of two different proteins. RNA 
has immense structural and functional diversity, the breadth of which our current knowledge is just 
beginning to uncover. This makes the study of RNA one of the most challenging yet potentially 
rewarding fields in modern biochemistry. 
1.1.1 The complexity of the eukaryotic transcriptome 
The biological processes that yield complex lifeforms from chemical information are extremely 
intricate. We now appreciate that the majority of DNA within eukaryotic genomes is transcribed into 
RNA [1-3], and that the vast majority of this is non-coding RNA (ncRNA); that is, it is not translated 
into a protein. Whilst there have been claims that such pervasive transcription is largely transcriptional 
noise [4, 5], evidence that conservation can be found outside the sequence level continues to grow [6, 
7]. Moreover, the observation that the non-coding portion of transcriptomes correlates consistently with 
biological complexity has led to suggestions that the proliferation of non-coding RNA has been pivotal 
to the evolution of developmentally complex lifeforms [8]. 
RNA function has been increasingly shown to be of a regulatory nature [9], extending far beyond the 
canonical protein coding messengers, ribosomal components and transfer RNAs. The 1990s saw the 
first hints of this change in our understanding, starting what would later become burgeoning fields of 
research: antisense RNA gene silencing was demonstrated [10] and the first long non-coding RNAs 
(lncRNAs) [11, 12],  microRNAs (miRNAs) [13, 14] and small nuclear RNAs (snRNAs) [15] were 
discovered.  
The extent of RNA involvement in gene regulation, and the sophisticated nature of these regulatory 
pathways, however, has only become apparent this century. Notably, small interfering RNAs (siRNA) 
and miRNAs, both short RNAs ~21–25 nucleotides (nt) in length, have now been well characterised as 
part of the RNA interference (RNAi) system, whereby genes are silenced post-transcriptionally through 
the pairing of sense:antisense RNA [16]. Additionally, miRNAs have been shown to: be implicated in 
gene silencing at the transcriptional, as well as post-transcriptional, level [17]; in certain instances 
promote translation [18]; and to be regulated dynamically to yield different post-transcriptional 
modifications [19] and diverse isomers across tissues and developmental phases [20].  
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Numerous other small RNAs are involved in gene regulation. Two examples of such small RNAs are 
1) PIWI-interacting RNAs (piRNAs) that regulate gene expression at multiple levels; although these 
were originally discovered in gametogenesis [21], roles for piRNAs in somatic cells continue to be 
unearthed [22, 23]; and 2) small nucleolar RNAs (snoRNAs) that act as guides for RNA modifications 
[24]. More small RNAs have been discovered in recent years; for instance, transcription initiation 
RNAs (tiRNAs) and 3′ splice site RNAs (spliRNAs) are small RNAs of ~18-nt that are derived from 
these regions and play regulatory functions [25]. Promoter associated RNAs (PASRs) are double-
stranded RNAs involved in gene activation and silencing through binding promoter elements of 
relevant genes [26]. The complexity of eukaryotic transcription along with some of the diverse RNA 
species transcribed are depicted in Figure 1.1. 
At the larger end of the spectrum, lncRNAs, broadly classified as ncRNAs greater than 200-nt, have 
been a hot topic of research. lncRNAs are abundant in mammals, with tens of thousands described in 
humans [27, 28], and they display tissue-specific differential expression [29, 30]. Although the majority 
of lncRNAs await characterisation, the emerging picture is that lncRNAs are important in both nuclear 
and cytoplasmic gene regulation, with predominant roles in cell differentiation and development [31]. 
A recent high-throughput study found that 89% of lncRNAs that modified cell growth acted in a cell-
 
 
 
 
 
Figure 1.1. The variety of RNA in the eukaryotic transcriptome.  
Eukaryotic DNA is pervasively transcribed in both directions in to many different types of RNA species, some 
of which are represented here. Abbreviations: tiRNAs, transcription initiation RNAs; spliRNAs, splice site RNAs; 
snoRNAs, small nuceleolar RNAs; miRNAs, microRNAs; rRNAs, ribosomal RNAs; tRNAs, transfer RNAs; 
snRNAs, small nuclear RNAs; piRNAs, PIWI-interacting RNAs. Protein coding genes encode messenger RNA 
(mRNA) and non-protein coding genes encode lncRNAs. Splice sites are indicated by dotted lines. This diagram 
is adapted from Morris and Mattick (2014) [9]. 
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type specific manner [32]. Further, multiple studies have shown that lncRNA expression is more 
specific to cell type than protein expression [29, 33], supporting the idea that lncRNAs act as cell fate 
regulators against a backdrop of (relatively) more generic protein composition [9].  
Recent data even suggest that mRNAs can have functions beyond their canonical protein coding role. 
For example, mRNA can act as a competitive binder to sequester miRNAs [34]. Indeed, mRNA 
regulatory function has proven even more sophisticated than expected. 3′ untranslated regions (UTRs) 
have been shown, in certain instances, to be translated in isolation from their associated ‘parent’ 
transcripts, possibly acting as regulatory molecules in trans [35]. Further, protein coding sequences 
have been shown to contain information apart from codon specification. As illustrations of this 
multiplicity: an alternatively spliced mRNA molecule has been shown to upregulate translation of its 
own gene [36], coding sequences can act as enhancers in a tissue-specific manner [37] and human 
codons have been shown to be often occupied by transcription factors in vivo [38]. 
What emerges is a picture of RNA as a multifarious class of molecules, one that generates an intricate 
network of regulation that has been pivotal to the evolution of life. Such discoveries highlight both how 
far we have come in our knowledge of RNA functionality since the central dogma was proposed, and 
also how much we still have to learn.  
1.1.2 RNA-binding proteins 
Overwhelmingly, RNA associates with RNA-binding proteins (RBPs) in order to achieve biological 
function, forming ribonucleoprotein (RNP) complexes. RBPs are often modular, composed of multiple 
RNA-binding domains (RBDs) as well as a wide variety of effector and other domains. RBDs recognise 
sequence and/or structural features of RNA and are usually deeply conserved across phyla. Individual 
RBDs typically bind RNA with insufficient affinity and specificity to stipulate in vivo binding sites, but 
gains in both affinity and specificity are achieved through the use of multiple RBDs [39]. Most RBDs 
characterised to date are canonical RBDs: discrete, globular domains with well characterised RNA-
binding activity. However, an increasing number of non-canonical and dual function domains are being 
reported as having RNA-binding activity. 
1.1.2.1 Canonical RBDs 
RNA-recognition motifs (RRMs) constitute the most common RBD in higher vertebrates and exist in 
all phyla [40]. The RRM family comprises many subclasses due to the diversity seen in their sequence 
and structural features, with sequence conservation generally only ~30% between RRM subclasses [41]. 
The typical RRM fold consists of around 90 amino acids with two α-helices packed against a β-sheet 
made up of four β-strands, connected by loops. Within this core fold, the lengths of the interconnecting 
loops can all vary, and numbers of both α-helices and β-strands can differ [40]. The most prevalent 
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feature is the presence of two consensus sequences in specific β-strands roughly thirty residues apart, 
RNP-1 and RNP-2. These degenerate motifs are characterised by a high proportion of hydrophobic 
residues that make stacking interactions with RNA bases. The single RRM of Fox1 is a typical example, 
utilising its β-sheet as the RNA-binding interface, with three conserved aromatic residues forming 
stacking interactions with bases, and specificity conferred by hydrogen bonds from residues located in 
the loops [42] (Figure 1.2(A)). In some cases, the β-sheet is not used as the binding surface. For 
example, YxiN utilises the opposite face of its RRM to recognise RNA, with both loop and α-helical 
residues forming bonding interactions with the RNA bases [43], as shown in Figure 1.2(B). In even 
more divergent cases, pseudo-RRMs have a conserved heptapeptide in the α1 helix that provides most 
of the RNA-binding residues [44, 45], and quasi-RRMs use loop regions to contact the RNA target [46]. 
In RRMs that employ RNP-1 and RNP-2 motifs for RNA binding, these motifs usually do not account 
for the biological specificities of particular RRMs; target recognition is often supplemented by flanking 
sequences, as well as loops and additional β-strands that extend the β-sheet [40]. 
hnRNP K homology (KH) domains  (~70 residues) also adopt a two layer α/β sandwich fold similar to 
that of RRMs and generally recognise 4-nt of single-stranded DNA (ssDNA) or single-stranded RNA 
(ssRNA) [47]. Interactions with RNA are provided by a binding cleft containing a G-X-X-G motif 
located between two α-helices. Despite this conserved binding surface, characterised KH domains bind 
a variety of sequences. Stacking interactions are notably absent; specificity is usually provided by the 
binding cleft through hydrogen bonding, and lysine residues often contact the sugar-phosphate 
backbone via electrostatic interactions. The Nova-2 KH domain bound to ssRNA in Figure 1.2(F) 
illustrates these features, with the binding cleft shown as a small helical portion [48].  
Zinc fingers (ZFs) are small domains (~20-60 residues), named after their common feature of 
coordinating at least one zinc atom that stabilises their compact fold, with different subtypes sometimes 
identified according to their folds and to the complement of cysteines and histidines coordinating the 
zinc atom. The classical (C2H2) ZF is most well-known for its DNA-binding role in transcription 
factors (TFs), but in certain instances can bind RNA as well (the renowned RNA-binding properties of 
the classical ZFs of TFIIIA are outlined in the upcoming Section 1.2.1). The RanBP2-type ZF, primarily 
a protein:protein interaction domain, has been shown to bind RNA with a core GGU motif [49]. The 
most well-characterised RNA-binding ZF domain is the CCCH-type ZF; multiple CCCH-type ZFs have 
been reported to bind RNA [50-52] and there are three structures of this domain bound to RNA 
published to date. Like many RBDs, CCCH-type ZF containing RBPs often have multiple copies of the 
domain with sequence specific recognition achieved through concerted binding. The structure of 
tandem CCCH-type ZFs from the mRNA-binding protein (mRBP) Tis11d demonstrates sequence 
specific RNA recognition provided by hydrogen bonds from the protein backbone, stabilised by 
stacking interactions from aromatic residues, with each ZF recognising four bases in a modular fashion 
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(Figure 1.2(C)) [53]. In contrast, the three ZFs of Unkempt recognise only four RNA bases in total, 
facilitated by side and main chain hydrogen bonds (Figure 1.2(D)) [54]. These two structures indicate 
that there is substantial diversity both in the folds of the domain and their recognition mechanisms.  
 
 
 
Figure 1.2. RNA recognition by canonical RNA-binding domains.  
(A) RRM of Fox-1 bound to ssRNA (PDB: 2ERR). (B) RRM of YxiN bound to ssRNA (PDB: 3MOJ). (C) ZF1 
and ZF2 of TIS11d bound to AU-rich element mRNA (PDB: 1RGO). (D) ZF4-6 of Unkempt bound to UAG RNA 
(PDB: 5ELK). (E) Pumilio-1 bound to RNA target with one base flipped out (PDB: 3BSX). (F) Nova-2 KH3 
domain bound to ssRNA (PDB: 1EC6). (G) dsRBM2 of Xlrbpa-2 bound to A-form RNA (PDB: 1DI2). 
Schematics were made in Pymol. Protein is indicated in pale blue, with side chains shown for RNA-binding 
residues (blue indicates nitrogen, red indicates oxygen). Coordinated zinc atoms in zinc fingers are shown as 
green spheres. 
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A number of helical repeat proteins act as ssRNA-binding domains and are distinctive in their large 
size. PUF and PPR domains fall into this class. PUF domains are typified by a repeating three α-helical 
unit (~30-40 residues), each of which generally recognises one base [55]. One residue from each repeat 
stacks between successive RNA bases, with another two creating hydrogen bonds or van der Waals 
contacts with a single base, creating an overall-characteristic crescent shaped structure. Bases have been 
observed to tilt away from the binding interface [56], resulting in some flexibility in RNA recognition. 
These features are demonstrated by the PUF domain of Pum1 bound to ssRNA shown in Figure 1.2(E).  
The dsRNA-binding motif (dsRBM), similar to RRMs and KH domains, contains a β-sheet backed by 
α-helices, named for its role as the best recognised dsRNA-binding protein. RNA-binding is achieved 
primarily by structural recognition of RNA helices on one side of the helix, however sequence specific 
contacts in dsRBMs have been reported [57]. Notably, the RNA is not distorted on binding, but there 
are many examples of dsRBMs that can accommodate bulges, loops or other structural features [58]. 
Recognition of dsRNA is illustrated by the dsRBM of Xlrbpa-2 in Figure 1.2(G). The domain interacts 
with 16-bp of RNA; an α-helix and loop region contact successive parts of the minor groove, with 
another α-helix contacting the enclosed major groove. The helical conformation of the RNA is 
recognised by side and main chain mediated hydrogen bonds to 2′-OH groups and bases as well as to 
the phosphodiester part of the backbone [59].  
The picture that emerges from currently available RBP structural information is that there is a large 
degree of variability in binding interfaces, bonding interactions, domain folds and RNA sequences 
recognised within individual RBD categories which has made the classification of RNA-binding rules 
difficult, even for canonical RBDs.  
1.1.2.2 Non-canonical RBDs 
Non-canonical RBDs generally constitute novel domains or sequences that can bind RNA but are 
somewhat unorthodox in their features compared with the better-defined classical RBDs. The existence 
of domains that bind RNA that do not fit the conventional categories of canonical RBDs has been known 
for some time. Early examples include the spliceosomal Sm and Sm-like domains that oligomerise to 
form ring-like structures and composite RNA-binding sites capable of binding purine-rich RNA [60], 
and the iron regulatory protein 1 (IRP1) that acts as an aconitase enzyme when iron is plentiful, but also 
mediates post-transcriptional regulation of iron responsive genes by contacting a specific stem-loop in 
target mRNA when iron is scarce [61] (Figure 1.3(E&D)). Another example is the YTH domain that 
recognises N6-methyladenoise (m6A) modified mRNA through accommodation of the chemical 
modification in a deep, hydrophobic binding pocket [62] (Figure 1.3(A)).  
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Disordered regions, as opposed to globular domains, have also been implicated in RNA-binding. There 
have been at least several reports of inter-domain linkers mediating RNA-binding interactions directly 
[63]. One structurally characterised example is the linker between RRM3 and RRM4 of polypyrimidine 
tract-binding protein 1 (PTBP1) that contributes to a hydrophobic core connecting the two domains as 
well as mediating RNA-binding [64] (Figure 1.3(C)). Similarly, low-complexity motifs (composed of 
repeats of a single or small number of amino acids, compared with the broader use of amino acids that 
constitute folded domains) can have RNA-binding activity. One prominent example is that of RGG-
 
 
 
Figure 1.3. Non-canonical RNA-binding domains. 
(A) YTH domain of rat YT521-B bound to N6-methyladenoise RNA (PDB: 2MTV). (B) RGG motif of FMRP 
bound to G-quadruplex RNA (PDB: 5DE5). (C) RRM3 (light blue), RRM4 (blue) and connecting linker (green, 
with selected sidechains involved in RNA-interaction and hydrophobic core indicated in stick representation) of 
PTBP1 bound to two CU-rich RNAs (PDB: 2ADC). (D) IRP1 in complex with ferritin H iron responsive element 
(PDB: 3SNP). (E) Hexamer of Sm-like domains from bacterial protein Hfq bound to A/U-rich RNA (PDB: 
1KQ2), alternating proteins indicated by shading). Protein indicated in different shades of blue with selected RNA-
binding residues indicated in stick representation, and RNA indicated in black. 
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boxes, which consist of repeats of arginines and glycines, with the number of repeats and their spacing 
varying widely [65]. Few structures have been published of such intrinsically disordered low-
complexity motifs bound to RNA; one is the RGG motif of Fragile X Mental Retardation Protein 
(FMRP). This peptide recognises G-quadruplex RNA through base-specific hydrogen bonds from 
protein backbone atoms and several arginine sidechains (Figure 1.3(B)) [66].  
The prevalence of non-canonical RNA-binding domains has only become clear very recently, facilitated 
by high-throughput interrogations of the mRNA-bound proteome via cellular crosslinking, oligo(dT) 
purifications and mass spectrometry. These studies not only confirmed the existence of known non-
canonical domains and intrinsically disordered regions (IDRs) in RBPs, but ~10–30% of RBPs 
identified in these studies were found to harbour neither a known RNA-binding domain (RBD) nor an 
RNA-related annotation [67-70]. Instead, these proteins have a wide range of roles, including actin 
binding, phosphorylation, ubiquitination and central carbon metabolism. Surprisingly, a significant 
number of metabolic enzymes were identified as RNA-binders. In particular, one study in human cells 
predicted ~1500 human RBPs with ~600 structurally distinct RBDs (many with only a single member) 
[71]. Taken together, these studies indicate that RBPs are much more diverse than the picture that 
current structural data paints, and there is clearly much to be learned in this area. 
Presently, there are 2250 RNA-protein complex structures deposited in the Protein Data Bank (PDB). 
Despite this significant amount of data, it is still a small minority of RBPs that have been studied in 
detail. The rules that govern specificity of RBP:RNA interactions are only understood for a small 
fraction of RBPs and are proving hard to define, in part due to the huge structural diversity seen in both 
RNA and RBPs, and the flexibility in their binding interfaces. Understanding the rules that dictate 
specificity is crucial to our understanding of RNA and RBP function and their role in disease. Reaching 
of this goal will require in-depth investigation of a wide variety of complexes, particularly newly 
classified RBPs, which constitute a largely unexplored space.  
1.1.3 RNA structure 
Like proteins, the structure of RNA is intimately linked to its function. However, RNA is not as 
chemically diverse as proteins, being made up of only four bases compared to ~20 standard amino acids. 
As a result, the secondary (base pairing) and tertiary (three dimensional) structures of RNA is used to 
regulate biological interactions.  
RNA rarely consists of sequences that are compatible with long double-helical segments, however short 
stretches of sequence are often complementary. Therefore, RNA forms much more intricate structures 
than DNA, folding back on itself to allow base pairing between complementary regions that can be 
quite distant from each other in the sequence.  
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One of the most common RNA secondary structural elements is the hairpin loop, consisting of a helical 
stem section that leads to a terminal loop of unpaired bases as shown in Figure 1.4(A). Both 
conformational and sequence variation is found in both the terminal loops and base paired helices. The 
terminal loops of hairpins may be dynamic and sample different conformations. Alternatively, they may 
form more stable structures such as tetra-loops, consisting of conserved four base motifs that often 
provide thermodynamic stability and hydrogen bonding potential [72]. Resulting helices can be fully 
base paired, or exhibit mismatches that manifest as internal loops (Figure 1.4(B)) or bulges (Figure 
1.4(C)). Multiloops are formed by the intersection of three or more double helices (Figure 1.4(D)), and 
pseudoknots consist of interactions between at least two hairpin loops and their stems (Figure 1.4(E)) 
[73].  
At the primary sequence level, DNA is as chemically diverse as RNA, however DNA has a propensity 
to adopt a B-type double helix, and this has been a major factor cementing its role as the genetic 
information repository [74]. DNA does display some structural variability, also pertinent to its 
biological functions, forming structures such as cruciforms [75], triplexes [76] and bubbles [77], 
however, the canonical right-handed double B-type helix overwhelming predominates in the cell. 
Moreover, the cellular conformation that DNA adopts is usually dictated by the structural constraints 
 
 
Figure 1.4. RNA structural elements.  
(A) Hairpin loops consist of a helical stem section leading to a terminal hairpin loop. (B) Internal loops involve 
unpaired nucleotides with flanking helical segments. (C) Bulges consist of unpaired nucleotides on one strand. 
(D) Multiloops are formed when three or more helical segments intersect. (E) Pseudoknots contain hydrogen 
bonding between at least two stem loops. 
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of double, triple or quadruple helices. Conversely, RNA is not limited by such restrictions, typically 
forming intricate three-dimensional structures that allow more diverse functions. 
In contrast to the conformational flexibility of ssRNA, double helical RNA (usually A-form) is 
relatively rigid [78]. The major and minor groove of A-form RNA helices are characterised by a 
difference in depth to the bases within the helix as opposed to a difference in the width of the helix, as 
seen in B-form helices. In A-form helices the minor groove is shallow with exposed bases, whilst the 
major groove is deep with bases buried in the helix (Figure 1.5). In contrast, both the major and minor 
grooves in DNA B-form helices are deep, but the major groove is wider than the minor groove which 
allows more access to major groove bases. Additionally, the bases in RNA A-form helices are not 
perpendicular to the helix axis, unlike DNA B-form helices. These differences create a unique pattern 
of hydrogen bonding potential for each helix type.   
 
 
 
 
 
 
 
 
 
 
 
 
 
RNA molecules sample a variety of energetically favourable conformations, with the complex three-
dimensional structures formed used to regulate target binding. The ability of RNA secondary structure 
to preclude binding by RBPs has been demonstrated through mutations that disrupted predicted RNA 
secondary structure, making RBP motifs more accessible, and subsequently these mutated sequences 
were enriched in pulldowns [79]. Conversely, RBP binding can induce RNA conformational changes 
[80]. 
 
 
 
 
 
Figure 1.5. DNA and RNA adopt different helical geometries.  
RNA canonical A-form helix (left, PDB: 5IEM) and DNA canonical B-form helix (right, PDB: 1ZQ3). Helical 
RNA is normally A-form, characterised by a wide minor groove with exposed bases. The B-form helix is more 
tightly packed than the A-form helix, with little space between the bases in the core of the helix. The major groove 
is wider and shallower than the A-form helix, giving rise to a different pattern of hydrogen bonding potential. 
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Currently the PDB contains 3556 structures that include RNA, out of 131205 total entries, which is less 
than 3% of entries. This is a statistic that is out of kilter with biology as there are many more different 
RNA species in the cell than proteins [81]. Our knowledge of the different types of non-coding RNA in 
cells is growing considerably, yet our ability to structurally characterise these RNAs is limited at present 
[82].  
The structural versatility of RNA also presents many challenges to the study of RBP:RNA interactions. 
Considerable effort has been put into the complex task of predicting RNA secondary and tertiary 
structure in order to assist in experimental design. Programs such as RNAfold [83] and Mfold [84] are 
well-established RNA-secondary structure prediction programs, and progress is slowly being made in 
the more complex task of tertiary structure prediction [85]. 
 
1.2    RNA-binding properties of the transcription factor Bicoid 
Bicoid is a TF that is a master regulator of development in Drosophila. It regulates more than ten genes 
at the transcriptional level, using its homeodomain to bind promoter elements of target genes [86]. 
Bicoid is also implicated in the post-transcriptional downregulation of one gene, caudal (cad). 
Interestingly, the homeodomain of bicoid is reported to bind directly and specifically to the cad 3′-UTR 
[87], which to date is the only report of an RNA-binding homeodomain. Explaining how such a small 
domain can specifically recognise both DNA and RNA is of interest from both a structural and an 
evolutionary perspective; for instance, how do such dual functions evolve and how common is this 
behaviour likely to be? Moreover, elucidating the molecular mechanisms of dual function domains will 
help to unravel the networks of cross-talk that can potentially take place between different regulatory 
pathways, which is now appreciated to be key to understanding biological specificity in eukaryotes [88].  
1.2.1 Transcription factors that bind RNA 
There are numerous accounts of TFs that bind RNA, often coupling transcriptional with post-
transcriptional gene regulation. Functionally, some examples are well characterised. For example, Smad 
proteins are cytoplasmic signalling molecules with TF and RBP roles. When phosphorylated, receptor-
specific Smads (R-Smads) translocate to the nucleus to regulate target genes [89], including miRNA 
genes [90, 91]. Interestingly, they are also able to specifically recognise a dsRNA sequence within pri-
miRNAs that is similar to its target DNA sequence, and this interaction has been implicated in 
facilitating processing of the pri-mRNA by the Drosha enzymeto pre-miRNA [92]. Similarly, human 
glucocorticoid receptor (GR) is a TF that, upon binding the glucocorticoid hormone, moves from the 
cytoplasm to the nucleus to bind to promoter regions of target genes to drive a range of transcriptional 
responses. GR also has been shown to bind hundreds of mRNA transcripts [93]; the presence of 
12 
 
glucocorticoid effects recruitment of accessory factors to induce decapping and degradation of the 
bound mRNA [94].  
Other examples include (i) NF-90, which both regulates transcription of IL-2 and stabilises the IL-2 
mRNA through direct binding [95], (ii) alternatively spliced isoforms of Wilms tumour protein (WT1) 
that dictate transcriptional or translational regulatory behaviour [96], and (iii) hnRNPs that can bind 
RNA motifs similar to their promoter DNA targets [97, 98]. TFs have also been shown to bind lncRNAs, 
for instance SOX2 in complex with lncRNA RMST activates genes involved in neuronal differentiation, 
whereas SOX2 without RMST activates genes that maintain neural stem cell status [99]. Lastly, a 
surprising recent study suggested that YY1 promoter occupancy at activated genes is increased through 
its direct association with RNAs transcribed from promoter and enhancer regions [100]. These examples 
paint a picture of a considerably intertwined regulatory network.  
However, it is interesting to note that the RBP high-throughput studies mentioned in Section 1.1.2 
detected only a few percent of the ~1400 TFs encoded in the human genome as having mRNA-binding 
capacity [67-70]. It may be that RNA-binding behaviour of TFs is relatively rare, or that the 
experimental conditions in the mRBPome studies were not optimal for detecting TF:RNA interactions. 
The only RNA-binding TF for which there is structural data for both DNA and RNA complexes is the 
ZF protein TFIIIA. In Xenopus laevis oocytes, TFIIIA both activates transcription of 5S RNA by 
binding to an internal control region within the gene, and binds the nascent RNA transcript as it is 
transported to the cytoplasm, and is therefore sequestered from initiating more transcription of the gene 
in a negative feedback loop [101].  
TFIIIA contains nine classical ZFs. The crystal structure of ZF1-6 bound to 5S DNA indicates that ZFs 
1, 2, 3 and 5 insert in to the major groove, dominating the DNA-binding interaction (Figure 1.6(A)) 
[102].  ZFs 4 and 6 are set back from adjacent minor grooves, with K175 of ZF6 and Q121 and Y135 
of ZF4 making contacts with the phosphate backbone. ZF5 makes typical classical ZF interactions with 
the major groove, with additional interactions provided by L148 to a DNA base, and S150 and K153 
contact backbone phosphates. These interactions specify a recognition sequence of NNNAT for the 
coding strand and GGNNN for the non-coding strand.  
In contrast, ZF4-6 constitute the minimal 5S RNA-binding domains [103]; the structure of these fingers 
bound to 5S RNA is shown in Figure 1.6(B) [104]. ZF4 and the target loop region of 5S RNA are both 
structurally primed for interaction via sequence specific hydrogen bonds which bear high similarity to 
typical ZF:DNA interactions. ZF6 binds another loop region of 5S RNA but the induced fit mechanism 
is more reminiscent of RNA:protein interactions.  ZF5 makes no contact with 5S RNA bases, but 
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structurally primed for interaction via sequence specific hydrogen bonds which bear high similarity to 
 
 
 
 
Figure 1.6. ZFs of TFIIIA bind DNA and RNA via different mechanisms. 
(A) ZF1-6 of TFIIIA bound to DNA (5S ribosomal RNA gene internal control region) (PDB: 1TF6). ZF1-3 are 
shown in grey, ZF4-6 are highlighted in purple for comparison with RNA-bound form in (B). DNA-binding 
residues from ZF4-6 are labelled and are shown in stick form (yellow for carbon, blue for nitrogen and red for 
oxygen). Coordinated zinc atoms are shown as green spheres. (B) ZF4-6 of TFIIIA bound to 5S rRNA (PDB: 
2HGH). RNA-binding residues are labelled and are shown in stick form (light blue for carbon, blue for nitrogen 
and red for oxygen). Coordinated zinc atoms are shown as green spheres. 
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follows the RNA backbone with K157, R151 and R154, and is in position to make electrostatic 
interactions with sugar and phosphate groups. R151 and R154 appear to be the only common nucleic 
acid binding residues for both DNA and RNA. In DNA-binding, however, these arginines make base 
specific major-groove contacts.  
Given that there are ~800 classical ZF proteins in the human genome, an outstanding question is how 
many of these proteins take part in similar dual RNA/DNA-binding activities. 
Based on the structural data presented here, it can be concluded that there is considerable plasticity in 
the ZFs of TFIIIA, recognising DNA and RNA via different molecular mechanisms. 
1.2.2 Bicoid – a transcription and translation factor 
The Drosophila melanogaster protein bicoid is pivotal in establishing the embryonic anterior-posterior 
axis during early development, by regulating both transcriptional [86] and post-transcriptional gene 
expression [87, 105] along this axis. Bicoid mRNA is anchored to the anterior pole of the oocyte. When 
translated (around the time of egg fertilisation), bicoid protein is transported through the embryo, 
 
 
Figure 1.7. Bicoid target gene expression in Drosophila embryos.  
(A) Schematics of developing Drosophila embryos. Localisation of mRNAs and proteins are indicated by shading, 
with cyan indicating high concentration and white indicating absence. Examples of DNA target gene products are 
shown. Embryos are shown anterior to posterior from left to right. (B) Known functional domains of bicoid 
indicated roughly to scale.  
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forming a concentration gradient that is high at the anterior pole and is detectable to around two thirds 
of the embryo length [106]. At the DNA level, bicoid directly binds to more than ten genes to activate 
or repress transcription. The only known RNA target of bicoid is cad, an important developmental gene 
required for tail formation. Bicoid binds to cad mRNA and represses its translation, forming a 
concentration gradient of cad inverse to that of bicoid. The developmental gene regulatory function of 
bicoid is depicted in Figure 1.7(A).  
Bicoid is a 54.5 kDa protein with several identified functional domains, represented in Figure 1.7(B). 
Domains known to be important for transcriptional activation are the acidic region and the Q-rich region 
[107]. The A-rich region and the self-inhibitory domain (SID) are involved in transcriptional repression: 
the A-rich region downregulates Q-rich activation [107], whereas the SID recruits the corepressor Sin-
3 [108]. The homeodomain is the DNA-interaction domain, introduced in Section 1.2.3.  
Domains known to be required for cad repression are the homeodomain and PEST domain. The 
homeodomain is thought to be the RNA-binding domain. PEST domains are known to carry proteolytic 
signals [109], however this region has also been shown to be required for cad repression, but not for 
transcriptional regulation [110]. The eIF4E binding domain, whilst not required for cad repression 
[111], contributes to repression in splice isoforms that contain this domain by recruiting the eIF4E-
related cap-binding protein 4EHP [112]. 
Bicoid is the product of a gene duplication of the homeobox gene Hox3 that occurred during the 
evolution of a particular clade of flies, the Cyclorrhapha (higher dipterans), and as such is only present 
in these flies [113]. The duplication event allowed bicoid to evolve new functionality compared to the 
ancestral gene, including regulation of cad expression (and presumably RNA-binding capacity) and a 
change in its DNA-binding specificity [114]. Within higher dipterans, the function of bicoid is thought 
to be largely conserved, despite some co-evolution with TFs [114].  
1.2.3 Bicoid homeodomain 
The homeodomain is a common DNA, and sometimes protein, interaction domain in eukaryotes, and 
is well conserved at the sequence and structural level. Over 1600 homeodomains from 32 different 
organisms have been identified [115], with ~300 in human [116]. The conserved fold of a homeodomain 
is a 60-amino-acid three helix bundle, with a characteristic helix-turn-helix motif and flexible N-
terminal arm (Figure 1.8). On binding DNA, the third ‘recognition’ helix slots in to the major groove, 
making multiple hydrogen bonds and hydrophobic interactions, and the N-terminal arm becomes more 
ordered through contacts with bases in the minor groove. Homeodomains typically recognise short 
adenine and thymine rich sequences (often 5′-TAAT-3′), however sequence discriminating capacity is 
poor [117], possibly due the high flexibility seen in homeodomain DNA-binding interfaces [118]. HD-
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containing TFs are involved in a diverse range of processes, including developmental patterning as in 
the case of bicoid, cell-type specification and/or differentiation [119], tumorigenesis [120] and redox 
regulation [121]. Due to important roles in development and growth, there are almost 200 known 
instances of human diseases linked to homeodomain proteins, including prostate cancer, autism and 
diabetes [115]. 
The structure of the bicoid homeodomain (BHD) bound to target site TAATCC has been solved [122] 
(Figure 1.8). Whilst displaying the overall topology characteristic of homeodomains, this homeodomain 
has some unique characteristics. It is the only homeodomain reported to bind RNA, and the only known 
homeodomain with a K50 and R54 combination. These residue positions are located in the recognition 
helix and play key roles in distinguishing DNA sequences. The importance of this combination to the 
distinctive ability of the bicoid homeodomain to bind RNA is demonstrated by a study that showed that 
K50A mutation abrogates both DNA and RNA target recognition, while R54A just affects RNA target 
recognition [123].  
1.2.4 Evidence that the bicoid homeodomain binds cad 3′-UTR directly 
Bicoid is involved in silencing cad mRNA and this has been well established over decades of research 
into pattern formation in Drosophila development. Maternal effect, segmentation and homeotic genes 
in Drosophila determine axis formation, body plan and the growth of specific body structures. Bicoid 
is an intensely studied maternal effect gene, with many reports implicating bicoid in cad silencing; 
multiple studies have shown bcd mutants fail to form a cad gradient [87, 112, 124, 125]. The 
contribution of the homeodomain to this phenotype was established through mutations to homeodomain 
residues that disrupted translational repression of cad [87, 105]. Early cross-linking [87] and reporter 
 
Figure 1.8. Bicoid homeodomain bound to DNA target. 
The structure of bicoid homeodomain (grey) bound to its DNA target containing consensus site TAATCC 
(black) (PDB: 1ZQ3). DNA-binding residues are shown as yellow sticks; the picture on the right is rotated 45 ° 
along the Y axis with DNA removed and DNA-binding residues labelled. 
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construct [105] experiments indicated that binding of bicoid to the cad 3′-UTR was dependent on the 
homeodomain, although the exact region of cad bound by bicoid varied between studies. Subsequently, 
an electrophoretic mobility shift assay (EMSA) revealed direct and specific binding of GST-tagged 
bicoid homeodomain to a 343-nt region of the cad 3′-UTR, named the bicoid recognition element (BRE) 
[126] (Figure 1.9(A)).  
More recently, a region of the cad 3′-UTR involved in bicoid-mediated regulation was localised to a 
63-nt sequence in the BRE (BRE_257-319); this region contains a hairpin loop that constitutes the most 
conserved sequence in the cad 3′-UTR in drosopholids [111]. This study incorporated GFP reporter 
 
Figure 1.9. The bicoid homeodomain regulates cad 3′-UTR at the Bicoid Recognition Element. 
(A) Radiolabelled BRE or Tubα1 3′-UTRs were incubated with different amounts of GST tagged bicoid 
homeodomain, with or without cold competitor RNAs as indicated, demonstrating that the bicoid homeodomain 
binds the BRE but not a fragment of Tubα1 3′-UTR. The highest quantity of 80 ng equates to ~ 200 nM GST-
tagged bicoid homeodomain. This data is taken from Chan and Struhl (1997). (B) BRE and SV40 (control) 3′-
UTR sequences were tested for bicoid mediated repression by incorporation of these sequences into the GFP 
reporter gene as indicated and bicoid was expressed using a nanos-GAL4 system in embryos. The BRE exhibited 
a drop in relative fluorescence from 1 to 0.4 in the presence of nanos-GAL4 expressed bicoid, whereas 
SV40+BRE_257-319 exhibited a drop in relative fluorescence from 0.6 to 0.4, indicating that this region partially 
restores bicoid mediated repression. (C) EMSAs indicating that the bicoid homeodomain binds BRE_257-319; 
the highest quantity of 20 pmole is ~ 2 µM bicoid homeodomain. Binding is also seen to negative control 
sequences CU58mer and shSV40, albeit weaker. Figures from (B-C) are taken from Rodel et al. (2013). 
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constructs at a set location in the Drosophila genome, with BRE sequences contained in the 3′-UTR of 
the sensor (Figure 1.9(B)). Bicoid was expressed under the nanos-GAL4 system. In early fly embryos, 
the control reporter, consisting of the SV40 early polyadenylation signal, was unresponsive to bicoid. 
In contrast, the reporter containing BRE demonstrated a reduction in fluorescence with bicoid 
expression from 1 to 0.4, whereas the SV40+BRE_257-319 reporter demonstrated a reduction from 0.6 
to 0.4, indicating that this region of the BRE partially restores bicoid mediated repression. Further, 
BRE_257-319 is capable of binding the bicoid homeodomain (Figure 1.9(C)). Control sequences 
consisting of a 58-nt CU sequence (CU58mer), and part of the SV40 3′-UTR (shSV40) were also bound 
by the bicoid homeodomain, although a higher concentration of protein was required. 
Together, these data show that bicoid likely mediates cad repression via direct binding of the 
homeodomain to the BRE, with indications that there may be redundant mechanisms at play within this 
region.  
1.2.5 Bicoid-mediated repression of cad translation 
The canonical eukaryotic translation initiation process requires binding of the 5′ 7-methyl guanosine 
(m7G) cap of an mRNA by an initiation complex containing initiation factor eIF4E; this binding event 
causes circularisation of mRNA and recruitment of the ribosome. As described in Figure 1.7(B), bicoid 
contains an eIF4E binding motif that is involved in bicoid-mediated translation silencing of cad. An 
early model of translational repression by bicoid demonstrated that this motif is likely bound by 4EHP, 
an eIF4E-related cap binding protein. This study demonstrated that 4EHP likely bridges bicoid and the 
mRNA 5′ m7G cap as shown in Figure 1.10(A), preventing the translation initiation complex binding 
the cap. This in turn blocks mRNA circularisation and therefore prevents translation [112].  
 
 
Figure 1.10. Proposed models for bicoid-mediated cad translational repression. 
(A) This model proposed by Cho et al. (2005) involves 4EHP binding both the 5′ cap of cad mRNA and bicoid, 
preventing the eIF4E initiation complex from binding. (B) A more recent model involving bicoid mediated 
recruitment of Bin3 which methylates 7SK RNA and subsequently effects formation of a repressive complex 
that includes Ago2, Larp1 and PABP. Abbreviations: 4E: eIF4E, 4G: eIF4G, 4A: eIF4A. 
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It has since been shown that bicoid isoforms lacking the 4EHP/eIF4E-binding domain are still capable 
of repressing cad, which indicates that there are multiple repression mechanisms utilised by bicoid 
[111]. The involvement of miRNAs was postulated by the same authors, after noticing that the BRE 
contains a putative miR-2 family binding site within the highly conserved hairpin loop sequence of 
BRE_257-319. Mutations to this region in the BRE that disrupted miRNA binding but preserved the 
predicted secondary structure of cad mRNA stopped bicoid-mediated repression of cad 3′-UTR sensor 
constructs [111]. Moreover, in the same study, compensatory mutations to the miRNA (that re-
established complementarity with the mutated BRE) partially restored bicoid-mediated repression, 
suggesting that miRNAs play a role in bicoid-mediated repression of cad.  
A recent report proposes a more complex mechanism of inhibition, involving bicoid-interacting protein 
3 (Bin3), and 7SK RNA. Bin3 was initially discovered to interact with bicoid via a yeast-two hybrid 
screen [127], and has been suggested to be a probable RNA-methyltransferase based on homology to 
the human protein BCDIN3 which methylates the 5′ γ-phosphate of 7SK RNA [128]. 7SK RNA is a 
snRNA that is primarily known for its transcriptional role of inhibiting the positive transcription 
elongation factor (P-TEFb) [129]. Bin3 was found to bind and stabilise 7SK RNA, and both were 
present in bicoid-immunoprecipitated complexes [130]. Further, in the same study, Bin3 was shown to 
be required for cad translational repression, and genetic interactions were found between bin3 and the 
genes for the following translation regulatory proteins: Argonaute-2 (Ago2), poly-A binding protein 
(PABP), Larp1 and eIF4E. Overall, the data from this study are consistent with a model whereby Bin3 
is recruited to cad mRNA by bicoid; subsequently Bin3 methylates and stabilises7SK RNA, which 
serves as a scaffold for the formation of a repressive complex involving the RNA-binding proteins 
Ago2, poly-A binding protein and Larp (Figure 1.10(B)). Translational repression of cad is then thought 
to occur through preventing binding of essential translation factors such as eIF4G to eIF4E.  
At this stage it seems likely that the 4EHP and Bin3 repressive complexes act in a redundant fashion, 
but further work is needed to clarify the relationships of these pathways. The genetic interaction found 
between Bin3 and Ago2 may provide a possible mechanism for the miRNA mediated repression 
proposed discussed above [111]. 
The current view is that bicoid mediates cad repression via direct and specific binding of the 
homeodomain to regulatory elements within the cad 3′-UTR, and that there are redundant mechanisms 
at play. However, binding motifs within the cad 3′-UTR have not been determined, and therefore very 
little is known about the molecular details of this interaction.  
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1.3 RNA-binding properties of the transcription elongation factors 
Spt4&5  
Spt4 and Spt5 (Spt4/5) are accessory factors in gene transcription. During transcriptional initiation, 
RNA polymerases (RNAPs), the enzymes that catalyse transcription, form the transcription initiation 
complex (TIC) along with general transcription factors (TFIIA, B, D, E, F, H), and this complex 
identifies and binds promoter DNA and begins transcription [131]. Following the initiation of 
transcription, the general transcription factors dissociate from the elongating RNAP, and a variety of 
elongation factors (e.g. Spt4/5, Spt6, FACT, Swi/Snf, TFIIS, Elf1, and Paf1 and TREX complexes) are 
recruited to form the transcription elongation complex (TEC) along with the double stranded DNA 
template and the nascent RNA [132]. As well as carrying out transcription elongation, this complex is 
responsible for initiating co-transcriptional events such as chromatin remodelling [133] and pre-mRNA 
processing [134] via the recruitment of accessory factors. 
The catalytic cores of RNAPs are highly conserved across evolution but their accessory factors that 
bind during the elongation process are much more divergent. Intriguingly, Spt5 is the only accessory 
factor that displays the same level of conservation as RNAPs. Further, we know that the Spt5 gene is 
essential for cell viability in yeast [135]. Whilst Spt4 is non-essential in yeast [136], yeast cells that lack 
Spt4 demonstrate markedly reduced RNAPII transcription elongation processivity [137]. In Drosophila 
cells, however, loss of either Spt4 or Spt5 is lethal [138]. Taken together, it appears that Spt4 and Spt5 
carry out unique and fundamental functions. The details of these functions are still only partially 
understood, however. 
1.3.1 Eukaryotic Spt4 and Spt5 dimerise to carry out transcription related processes 
Eukaryotic Spt5 (Figure 1.11) is a ~62 kDa protein that contains a NusG N-terminal domain (NGN, 
named after the bacterial homolog, NusG) and five Kyprides, Ouzounis, Woese (KOW) domains, 
flanked by disordered regions on both sides; an N-terminal acidic region and a C-terminal repeat (CTR) 
region. The NGN domain along with the first KOW domain constitutes the core of Spt5 that is 
conserved across phyla. Spt4 is an ~11.2 kDa zinc finger containing protein that, in Eukaryotes and 
Archaea (named RPoE′′ in Archaea), dimerises with the NGN domain of Spt5, however bacteria lack 
an Spt4 homolog. The domain arrangements for Spt4/5 in Eukaryotes, Archaea and Bacteria are shown 
in Figure 1.11(A). 
The NGN domain of Spt5 has a fold that resembles RRM (see Section 1.1.2.1), displaying a βαββαβα 
topology. The structure of yeast Spt5NGN in complex with Spt4 demonstrates that these proteins align 
via their β-sheets, with E338 of Spt5 making an acid-dipole interaction with the helix dipole of α-helix 
4 of Spt4 (Figure 1.11(B)) [139].  
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The conserved core of the heterodimer has been implicated in transcription elongation and RNAP 
processivity [140, 141], that is, the addition of nucleotides to the nascent transcript as the TEC 
progresses through the template strand. The NGN domain is thought to mediate associations with 
RNAPs in all phyla [142]. This interaction has been structurally characterised in Archaea; these data 
show that Spt5 bridges the RNAP central nucleic acid cleft, which probably enhances the processivity 
of the transcription elongation complex (TEC) by stabilising it [143, 144]. No structures of eukaryotic 
Spt4/5 with RNAPs had been published prior to the time of writing, but a model based on both 
 
 
Figure 1.11. Spt4 and Spt5 form a heterodimer.  
(A) Schematics illustrating the domain arrangement of Spt4/5 (and homologous proteins) in Eukaryotes, Archaea 
and Bacteria. Eukaryotes: known functional domains of Spt5 indicated roughly to scale with the full length 
representing the 62 kDa protein; the 11.2 kDa Spt4 is shown bound to the NGN domain of Spt5. Archaea: Spt5 
consists of just the NGN domain and first KOW domain, and the Spt4 homolog RpoE′′ dimerises with the NGN 
domain of Spt5. Bacteria: The bacterial homolog of Spt5 is NusG, consisting of the NGN domain and KOW1. 
Abbreviations: NGN, NusG; K1-5, KOW domains 1 to 5; CTR, C-terminal repeat region; ZF, zinc finger. (B) 
Structure of yeast Spt4 (light cyan with yellow Zn2+ sphere) and Spt5NGN (light blue) (PDB: 2EXU). E338 of 
Spt5NGN, shown in stick form, makes an acid dipole interaction with the adjacent Spt4 α-helix. 
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crosslinking-coupled mass spectrometry and negative staining electron microscopy indicates that Spt4 
and the NGN domain of Spt5 (Spt4/5NGN) binds in a similar position to the Archaeal proteins [145].  
A sizeable body of work indicates that eukaryotic Spt5 makes extensive use of its large, multi-domain 
assembly to associate with many accessory partners and execute transcription related processes 
(reviewed in [146]). The five KOW domains and connecting linkers are certainly important to biological 
function; the deletion of two or more KOW domains is lethal in yeast and results in reduced affinity of 
Spt4/5 for RNAPs in vitro [142]. Specifically, crosslinking data have demonstrated that KOW domains 
4 and 5 contact RNAPII [147]. Moreover, interactions between the KOW domains and connecting 
linkers with nucleic acid (discussed in the next Section) are also thought to be crucial to the role of 
Spt4/5 in transcriptional processing. Additionally, the disordered terminal regions provide extra 
interaction potential. The CTR, for example, is essential for the ability of Spt4/5 to modulate 
transcriptional processing [148]. This region is phosphorylated to stimulate transcription elongation 
[149], effecting the recruitment of a variety of accessory factors [134, 150]. No role has yet been 
ascribed to the N-terminal acidic region. 
1.3.2 Nucleic acid binding of Spt4/5 
As well as interacting with RNAPs and accessory factors, Spt4/5 is known to interact with nucleic acids 
as part of its role in transcription. There are multiple reports that suggest Spt5NGN can interact with the 
non-template DNA strand [151, 152]; this interaction is thought to be required, not for association of 
Spt4/5 with the TEC, but rather for stopping TEC arrest. The nascent RNA transcript has been shown 
to be required for optimal binding of Spt4/5 to the TEC [151, 153]. Consistent with this, Spt5 has been 
shown to bind directly to a 35S rRNA oligonucleotide which constitutes an RNAPI transcript [142]. 
The first KOW domain in conjunction with the adjacent C-terminal linker has also been shown to be 
able to bind a variety of DNA and RNA species [154], and there have been two recent reports of KOW5 
crosslinking to the nascent RNA transcript [142, 155]. The exact nature of nucleic acid binding, 
however, and its relevance to the biological role of Spt4/5 remains to be clarified. 
With the ultimate aim of better understanding Spt4/5 function at the biochemical level, our collaborators 
demonstrated that the NGN and KOW domains of Spt5, along with Spt4, preferentially bind RNA over 
DNA; specifically, single-stranded RNA containing an AA-repeat motif [156]. SELEX (Systematic 
Evolution of Ligands by Exponential enrichment – a technique whereby a protein is incubated with a 
random library of RNA oligonucleotides and the tightest binding sequences are identified) was 
performed on Spt4/51K, Spt4/52K and Spt4/55K (domain arrangements are illustrated in Figure 1.12(A)) 
proteins with a random 24-nt library. The motif with the most significant increase in abundance in all 
cases was the 14-nt sequence AANAANAANAANAA, where N is any nucleotide.  
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Figure 1.12. Spt4/5 binds AA repeat RNA. 
(A) Schematic illustrating domain arrangement for constructs used in this work. (B)  EMSAs demonstrating that 
Spt4/55K binds AArich but not AArichmut and GGrich RNA. Increasing concentrations of Spt4/55K were incubated with 
fluorescently labelled RNA then resolved on a 6% polyacrylamide gel. (C) MST assays indicating that Spt4/55K 
binds AArich but not AArichmut or GGrich RNA. Symbols indicate the average of three independent measurements, 
fitted to a simple 1:1 binding isotherm for AArich yielding a Kd of 0.65 ± 0.2 µM. (D) EMSAs demonstrating that 
Spt4/5NGN is sufficient for RNA-binding. Increasing concentrations of Spt4, Spt5, Spt4/5NGN, Spt4/51K, Spt4/52K 
and Spt4/55K were incubated with fluorescently labelled RNA then resolved on a 6% polyacrylamide gel. Data from 
(B-D) are taken from Blythe et al. (2016). (E) Unpublished data performed by Amanda Blythe: MST assays of 
Spt4/5NGN binding to RNA with varying numbers of AA repeats. Increasing concentrations of Spt4/5NGN were 
incubated with fluorescently labelled RNA then resolved on a 6% polyacrylamide gel. Binding isotherms were 
fitted using the Hill method. (F) Sequences of RNAs tested.  
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The rate of enrichment was higher for proteins containing a larger number of KOW domains; significant 
enrichment was seen for Spt4/55K in two rounds, Spt4/52K in four rounds and Spt4/51K in seven rounds. 
Specificity of binding to a 24-nt sequence with five AA repeats (AArich, one of the sequences selected 
from SELEX) was confirmed by EMSA and Microscale Thermophoresis (MST), whereas no binding 
was observed to the control oligonucleotides GGrich (the same sequence in which the five AA repeats 
were mutated to GG repeats) and AArichmut (five AA repeats mutated to an assortment of non-AA 
nucleotides) (Figure 1.12(B-C)). Further, Spt4/5NGN was shown to be the minimal RNA-binding region; 
this polypeptide bound AArich with an affinity comparable to that of Spt4/55K (Kd ~2 µM) (Figure 
1.12(D)). 
MST assays were also performed on shorter RNA oligonucleotides containing one, two and four AA 
repeats (Figure 1.12(E)). These data indicate that Spt4/5NGN is able to bind RNA with as little as one 
AA-repeat with a Kd of 16 µM, with each extra AA repeat approximately halving the dissociation 
constant.  
Sequence specific RNA-binding by Spt4/5 is an intriguing possibility; however neither the biological 
relevance of this interaction nor the molecular basis for it have been established. The demonstrated AA-
repeat RNA-binding of Spt4/5 requires further characterisation, to ultimately instruct experiments 
aimed at determining how this interaction contributes to the transcriptional processing roles of the 
Spt4/5 heterodimer.  
 
1.4 Aims of this study 
The aims of this Thesis are to characterise the RNA-binding properties of what can be considered two 
non-canonical RNA-binding protein domains, with the ultimate goal of illuminating the molecular 
underpinnings of the poorly understood RNA-binding behaviour of multifunctional protein domains. 
Chapters 2 through 4 report on the RNA-binding capacity of bicoid. Firstly, Chapter 2 focuses on 
determining the RNA-binding specificity of the bicoid homeodomain and cad 3′-UTR interaction, 
which is followed by an examination of the molecular details of this interaction in Chapter 3. Finally, 
Chapter 4 addresses the features of the full length bicoid protein with a view to illuminating how 
biological specificity might be achieved. Chapter 5 moves on to investigating and characterising the 
AA-repeat RNA-binding by Spt4/5NGN.  
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Chapter 2: Investigation of the RNA-binding properties of the 
transcription factor Bicoid 
2.1 Introduction 
As discussed in Chapter 1, the bicoid homeodomain has been reported to bind to the bicoid recognition 
element (BRE) within the 3′-UTR of cad mRNA; no specific binding motif within this RNA has 
however been identified [111, 126]. The primary aim of this Chapter is to identify the sequence or 
structural element(s) within the BRE that are required for homeodomain binding.  
 
2.2 Techniques used in this Chapter 
2.2.1  Electrophoretic mobility shift assay 
The electrophoretic mobility shift assay (EMSA) is a commonly used technique to detect interactions 
between proteins and nucleic acids. Nucleic acid probes are typically labelled either with a fluorophore 
or with 32P. A small, constant amount of nucleic acid probe is incubated with increasing amounts of 
protein, creating a titration series. Samples are equilibrated and then run on a non-denaturing (in order 
to maintain structures of macromolecules and preserve interactions) polyacrylamide gel. An interaction 
between the two species is typically indicated by an upward shift of the labelled nucleic acid probe due 
to the increased size of the complex compared to the unbound nucleic acid probe.  
RNA EMSAs are complicated by the structural versatility and electronegative properties of RNA. To 
help ensure RNA sequences are correctly folded, RNA samples are typically snap cooled before being 
incubated with protein, and gels are often run at 4 °C in the presence of magnesium to help preserve 
secondary structure. To assist in reducing non-specific binding, a competitive binder such as heparin is 
usually included. Heparin is negatively charged and so can compete with RNA for binding to positively 
charged proteins.  
All EMSAs were repeated two to three times in each case; gels shown in this Thesis are representative. 
2.2.2 Microscale thermophoresis 
Microscale thermophoresis is a recently developed technique that exploits the thermophoretic 
movement of molecules to quantify biomolecular interactions [157]. When molecules (and other 
particles) are subjected to a temperature gradient, they move according to a thermophoretic force. The 
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properties of the molecule and of the solution will dictate whether thermophoresis is positive 
(movement from hot to cold areas of the solution) or negative (movement from cold to hot). 
At thermophoretic equilibrium, thermodiffusion is offset by mass balance effects. The ratio of the 
concentration of molecules in the hot region (CHOT) to the cold region (CCOLD) is dictated by difference 
in temperature (ΔT) and the Soret coefficient (ST), which is defined as the ratio of the thermal diffusion 
coefficient to the normal diffusion coefficient: 
                                                 
                                                                                                                                        Equation 2.1 
                                                                                                                                     
 
As can be seen in Equation 2.1, the thermophoresis of molecules yields information about their size, 
charge and hydration shell, which are all potentially perturbed by a binding event. The instrument 
manufactured by Nanotemper requires that one binding partner be fluorescent (either labelled or 
intrinsic) in order to quantify thermophoretic movement in the bound and unbound state. A serial 
dilution of the unlabelled binding partner is executed with the labelled binding partner at a constant, 
low (typically tens of nanomolar) concentration. Each titration point is loaded into a capillary, and a 
heat gradient is established by an infrared laser (IR) which heats each sample locally by two to six 
Kelvin. Fluorescence is detected at the same point in the capillary that was heated by the IR laser. 
Fluorescence at or near equilibrium is normalised to initial fluorescence to give Fnorm (Figure 2.1(A)) 
and affinity is quantified by fitting Fnorm to a binding model as a function of concentration of the binding 
partner (Figure 2.1(B)).                                                       
Conditions generally need to be optimised to achieve smooth fluorescence curves with good signal to 
noise ratios. Pertinent parameters include (i) IR power, which establishes the magnitude of the heat 
gradient, (ii) LED power, which dictates fluorescence excitation, (iii) the buffer composition and 
(iv) the types of capillaries used, which have varying properties to prevent adsorption by different types 
of molecules. The sticking of samples to the capillaries is indicated by shoulders in fluorescence peaks 
before the heat gradient is established, and aggregation can be detected by fluctuations in fluorescence 
curves due to aggregates moving back to hotter areas by convection flow. The MST curves presented 
in Figure 2.1 are representative of high quality data. 
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2.2.3 NMR spectroscopy 
Nuclear magnetic resonance (NMR) spectroscopy is founded in the propensity of magnetic nuclei 
(isotopes that contain an odd number of protons and/or neutrons) to absorb electromagnetic radiation at 
discrete and characteristic frequencies when they are subjected to a magnetic field. Valuable structural 
information about molecules is obtained, primarily because radiation absorbed by each nuclei is 
dependent on their local chemical environment. 
The number of dimensions in NMR experiments reflects the complexity of the information being 
sought. One dimensional (1D) experiments involving biological molecules such as proteins are 
convenient as 1H is naturally abundant in biological molecules and so no isotopic labelling procedure 
is required. Further, 1H spectra are quick to acquire due to the high sensitivity of 1H to the NMR 
 
 
Figure 2.1. Good quality MST data. 
(A) Raw fluorescence data from MST. The initial fluorescence F0 drops when the IR laser is turned on (known as 
the temperature jump); the magnitude of the drop reflects the temperature sensitivity of the fluorophore. This is 
followed by diffusion limited thermophoresis, before a steady state of thermophoresis is reached in which 
diffusion due to thermophoresis is offset by mass balance effects. When the IR laser is turned off, there is an 
inverse temperature jump and then back diffusion occurs, driven by pure mass diffusion. (B) Normalised 
fluorescence curves. The affinity of an interaction is quantified by normalising the fluorescence after 
thermodiffusion (area indicated between two red lines) to the initial fluorescence before the heat gradient 
establishment (area indicated between two blue lines)  	      =
  
  
 	and analysing the change in normalised 
fluorescence as a function of the concentration of titrated binding partner. 
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phenomena (about 400 times more sensitive than 13C, one of the other most commonly examined 
nuclei). 
A 1D 1H spectrum allows one to readily assess the folded state of a protein. A well-ordered protein is 
characterised by sharp and well-dispersed peaks, indicating that individual protons are experiencing 
somewhat unique chemical environments (a characteristic of a folded protein). With increasing protein 
size, signal overlap and increases in linewidth reduce the utility of the 1H NMR spectrum somewhat, 
although it can typically still be used to assess whether a protein is folded or not. 
 
2.3 The search for RNA-binding specificity in the bicoid homeodomain  
2.3.1 Cloning, expression and purification of the bicoid homeodomain 
Analysis of the RNA-binding specificity of the bicoid homeodomain first required recombinant 
production and purification of the protein. The homeodomain was cloned into pGEX-6P using full 
length bicoid, provided by Dr Michalis Averof in the vector pET18b, as a template. The desired 
sequence (Figure 2.2) was amplified by PCR using primers incorporating BamHI and EcoRI restriction 
sites.  
This bicoid homeodomain construct, named BHD, would be expressed as a GST fusion, which can be 
cleaved by HRV-3C to yield a 68 amino acid protein containing the characteristic 60-residue 
homeodomain with an extra N-terminal glycine remaining from HRV-3C cleavage and seven extra C-
terminal residues for solubility [122].  
 
 
 
 
Figure 2.2. Amino acid sequence of the bicoid homeodomain produced to determine bicoid RNA-binding 
specificity. 
The 60 amino acid homeodomain comprises residues 97 through to 156 of the 494 amino acid bicoid protein. An 
extra N-terminal glycine residue remains after HRV-3C cleavage of the GST tag (purple), and an extra seven C-
terminal residues beyond the homeodomain fold were included to increase solubility (red). Full length bicoid 
was provided by Michalis Averof of Institut de Génomique Fonctionnelle de Lyon (IGFL) in pET18b and was 
used as a template to clone the DNA encoding the above amino acid sequence into pGEX-6P.  
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Expression of the recombinant protein in E. coli Rosetta(DE3)pLysS cells resulted in good soluble 
protein yields, which could be purified by GSH affinity chromatography (Figure 2.3). The fusion 
protein has a theoretical molecular weight of 36.8 kDa, and runs to the expected size on an SDS-PAGE. 
The GST tag was cleaved efficiently by HRV-3C protease, and pure BHD was obtained by cation 
exchange chromatography (Figure 2.4). BHD runs close to its theoretical weight of 7.9 kDa on an SDS-
PAGE. 
 
 
 
Figure 2.3. Overexpression and affinity purification of GST-BHD. 
SDS-PAGE analysis of GST-BHD overexpression and affinity purification. Abbreviations: L, Mark 12 ladder; 
T, total cell lysate; I, insoluble fraction; S, soluble fraction; E, GSH elutions, numbers as indicated.  
 
 
 
 
 
Figure 2.4. Cation exchange chromatography and SDS-PAGE analysis of BHD. 
(A) Cation exchange chromatography elution profile showing BHD eluting as the second major peak. Fractions 
taken for SDS-PAGE are indicated above chromatogram. (B) SDS-PAGE analysis of the selected cation exchange 
chromatography fractions. Abbreviations: L, Mark 12 ladder; C, pooled GST-BHD elutions following HRV-3C 
cleavage; F, cation exchange chromatography fractions, numbers as indicated. 
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Fractions 30 to 35 were pooled and concentrated, giving around 1 mg of BHD per litre of culture at 
>95% purity. The protein was shown to be folded via acquisition of a 1H 1D NMR spectrum, which is 
shown in Figure 2.5.  
2.3.2 Testing bicoid homeodomain binding to cad 3′-UTR  
In order to confirm the nucleic acid binding capacity of BHD, binding to different nucleic acid probes 
was tested via EMSA. For DNA-binding validation of the BHD target site, a 12 base pair single-
stranded DNA (ssDNA) oligonucleotide containing the known BHD target site TAATC was end 
labelled with [γ-32P] ATP (sense strand sequence: GCTCTAATCCCG). Binding to this ssDNA 
oligonucleotide was tested. Separately, this oligonucleotide was annealed with a complementary 
oligonucleotide to make the dsDNA oligonucleotide. Clear binding of BHD to its dsDNA target site 
 
 
 
Figure 2.5. Partial 1D 1H NMR spectrum of BHD. 
The amide proton region from a 1D 1H NMR spectrum of 150 µM BHD in 20 mM sodium phosphate and 1 mM 
DTT. Spectrum was recorded at 298 K on a 600 MHz Bruker Avance III NMR spectrometer equipped with a 
cryoprobe.  
 
Figure 2.6. DNA target site binding of BHD. 
EMSAs confirming that BHD binds to dsDNA, but not ssDNA, containing target site TAATCC. Increasing 
concentrations of BHD were incubated with 32P-labelled oligonucleotides then resolved on a 6% polyacrylamide 
native gel. 
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was confirmed by the observation of a single shifted band, the intensity of which increased as a function 
of BHD concentration (Figure 2.6). In contrast, negligible binding was seen to the ssDNA 
oligonucleotide. 
In order to confirm binding of BHD to the BRE of cad, EMSAs of BHD with 32P-labelled ssRNA were 
carried out. Templates for transcription were created as oligonucleotides containing T7 promoters with 
regions complementary to the relevant cad sequence; these were amplified from the plasmid 
pSLfa1180fa (provided by Michalis Averof) which contains the full length cad 3′-UTR. Internal 
labelling of transcripts with 32P was achieved by using 32P UTP in in-vitro run off transcription reactions, 
followed by PAGE purification.  
Binding of BHD was tested to two RNA sequences initially: full length cad 3′-UTR (855-nt in length) 
and an 83-nt fragment, BRE(257-319) (see Appendix A1 for RNA sequences tested throughout this 
Chapter). Nucleotides 257-319 (63-nt) of the cad 3′-UTR constitute the highly conserved region 
identified by Rodel et al. [111], however the transcript generated to contain this fragment consists of 
83-nt (nucleotides 242-324) in order to conserve the predicted fold. The predicted secondary structures 
of these sequences (from the software RNAfold [83]) are shown in Figure 2.7(A). BHD bound both 
probes with comparable apparent affinity, with dissociation constants between 0.15 and 0.7 µM, as seen 
in Figure 2.7(B). These results are consistent with the published BHD:BRE_257-319 EMSAs detailed 
 
 
 
 
Figure 2.7. Binding of BHD to cad 3′-UTR. 
(A) Predicted structure of cad 3′-UTR, including the BRE(257-319) fragment (pink). BRE(257-319) was designed 
as an 83-nt transcript to conserve the predicted secondary structure. Structures were predicted using RNAfold 
software. (B) EMSAs confirming that BHD binds to both full length cad 3′-UTR and BRE(257-319). Increasing 
concentrations of BHD were incubated with 32P-labelled transcripts then resolved on a 6% native polyacrylamide 
gel. 
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in Figure 1.9(C), but not with the tighter association seen between GST-BHD and BRE seen in Figure 
1.9(A). 
For both free probes, multiple bands were observed, most likely indicating either different 
conformations or self-association of the transcripts (single bands were excised under denaturing 
conditions during purification). Multiple shifted bands were also observed, representing either BHD 
bound to different conformations of the transcripts or a varying number of BHD molecules bound to 
transcripts, or both. At high protein concentrations (7 M or more), the RNA transcripts failed to 
migrate in to the gel, likely due to protein:RNA aggregates that were too large to enter the gel pores. 
The affinity of BHD for the full length UTR is around three to four-fold higher than for the 83-nt 
BRE(257-319) fragment; however the full length UTR is around 10 times longer, and therefore provides 
around 10 times more protein binding potential. Thus, when accounting for RNA oligonucleotide 
length, the affinity of BHD for both of the tested oligonucleotides is, overall, quite similar per available 
binding site. These data indicate that there are no significant sequence elements outside the 83-nt 
BRE(257-319) that are required for binding.  
In order to identify the sequence and/or structural elements of BRE(257-319) that are required for 
binding, this transcript was split into two overlapping halves in such a manner as to conserve the 
predicted secondary structure shown in Figure 2.7(A). BRE(257-319) is predicted to form a double 
stranded structure with multiple loops and abundant base pairing (shown in detail in Figure 2.8(A)).  
BRE39nt and BRE38nt were designed with five overlapping base pairs, and the 5′ and 3′ overhangs of 
BRE39nt were removed and the remaining sequence was joined to create a terminal hairpin loop. An 
unrelated sequence controlling for predicted secondary structure of BRE38nt was also designed and 
made, named ShapeControl, which is predicted to form base pairs and loops in the same positions but 
with a different nucleotide sequence. 
Again, BHD bound all tested sequences with comparable apparent affinity (Kd ~ 1 µM), as seen in 
Figure 2.8(B). This was an unexpected result given the different sequence composition of the RNAs 
tested. However, all sequences are predicted to form similar hairpin loop structures, suggesting the 
possibility that BHD primarily recognises RNA structure rather than sequence. To further assess this 
possibility, a 32-nt RNA sequence that is predicted to be unstructured (Unst, with the sequence 
UCGAAGCCCUCUCUCAGUUUGUCAUAUACCCU) was designed and tested for binding to BHD 
via EMSA (Figure 2.9). 
At least two bands appeared for the Unst probe alone; one much fainter than the primary band. This 
pattern probably indicates the formation of some secondary structure, either within individual probes 
or between probes. It is very unlikely that this RNA sequence forms a hairpin loop given the base pairing 
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probabilities. Both Unst bands disappear to an equal degree, and the disappearance occurs at a similar 
protein concentration to BRE(257-319) and BRE38nt, so, assuming that at least one of the Unst bands 
is unstructured, these data support the idea that BHD is not recognising structural elements of RNA.  
Looking at all of the EMSAs presented in this Section collectively, it can be seen that the band pattern 
of the probes was not consistent across different samples. Multiple bands were often seen for free probes 
despite single bands being excised under denaturing conditions during PAGE purification.  
The multiple bands signify different conformations of the RNA and/or association between RNA 
molecules. Sometimes shifted bands were seen in samples containing protein; however, this was not 
consistent between different protein preparations. The inconsistencies observed may be partly due to 
 
 
 
Figure 2.8. Binding of BHD to BRE transcripts. 
(A) Design of BRE(257-319) truncated transcripts. Two overlapping halves of BRE(257-319) were designed to 
conserve the predicted fold (BRE39nt: blue, BRE38nt: red, overlapping bases: purple). ShapeControl (green) was 
designed to display the same secondary structure as BRE38nt in a different sequence context. Structures were 
predicted using RNAfold software. (B) EMSAs demonstrating that BHD binds to BRE(257-319), BRE38nt, 
BRE39nt and ShapeControl with comparable affinity. Increasing concentrations of BHD were incubated with 32P-
labelled transcripts, and then resolved on a 6% polyacrylamide native gel. 
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the short half-life of 32P radiation; when the signal is not as strong shifted bands are not visualised. 
Despite these inconsistencies, the affinity of the interactions remain relatively constant, at least within 
the limits of what is discernible by radiolabelled EMSAs.  
The observation has been made that smearing and a lack of discrete bands in EMSAs for RNP 
complexes can be associated with higher koff rates [158, 159], which could in turn be a feature of non-
specific RNA-binding [160]. Alternatively, smeared bands may signify complexes that are not stable 
because the protein and/or RNA constructs are not optimal [161]. Taken together, the data presented 
here indicate either that BHD may require extra elements in order to achieve RNA-binding specificity 
or that the EMSAs are reporting on non-specific (and perhaps biologically irrelevant) RNA-binding 
activity.  
2.3.3 Investigation of possible miRNA involvement in BHD binding 
MicroRNAs are ~22-nt regulatory RNAs that are well known for their involvement in Argonaute (Ago) 
mediated translational repression and mRNA decay [162]. Primary miRNAs consist of stem-loops that 
are processed in to mature miRNA strands and then loaded onto the Ago-containing RNA-induced 
silencing complex (RISC) [163]. The miRNA directs RISC mediated post-transcriptional gene 
regulation by hybridising with target mRNAs. More than 60% of human protein-coding genes are 
regulated by miRNAs [164]. 
 
 
 
 
Figure 2.9. Binding of BHD to BRE38nt and Unst, an RNA predicted to be unstructured. 
EMSAs assessing the binding of BHD to an RNA sequence that is predicted to be unstructured (right), BRE38nt 
(middle) and BRE(257-329) (left). The protein-RNA complexes that are formed do not migrate into the gel and 
appear to form at similar concentrations. Increasing concentrations of BHD were incubated with 32P-labelled 
transcripts then resolved on a 6% polyacrylamide native gel. 
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Besides this canonical role, new roles of miRNAs continue to be discovered, indicating that there is still 
more to be learnt about miRNA biology. For example, miR-122 has been shown to upregulate internal 
ribosome entry site (IRES) translation via an unknown mechanism [18].  
As discussed in Section 1.2.5, miRNAs are likely implicated in bicoid-mediated repression. Given that 
no specific RNA-binding motif could be located in the cad 3′-UTR, EMSAs of BHD and BRE were 
carried out in the presence of a mir-2 family member, mir-308 (as used by Rodel et al. [111]), to 
investigate whether or not miRNAs can contribute to specific BHD binding. As shown in Figure 
2.10(A), miR-308 is imperfectly complementary to the distal hairpin loop of BRE38nt. A negative 
control sequence was designed to conserve predicted fold, named miR-Fold (Figure 2.10(B)). 
Perhaps surprisingly, no binding of miR-308 was seen to BRE(257-319), as shown in the EMSA on the 
left in Figure 2.10(C). Both miR-308 and BRE(257-319) are predicted to form hairpin loop structures, 
and therefore would need to overcome self-association in order to bind each other. Accordingly, RNA 
samples were incubated together and heated to 70 °C in order to overcome existing secondary structure 
but this did not facilitate hybridisation of the two RNA species. However, when a constant amount of 
BHD was included in an EMSA in which BRE(257-319) was titrated with miR-308, a distinct difference 
in migration of the BRE(257-319) probe was observed (Figure 2.10(C), right). The free probe band 
disappeared and was replaced with a more slowly migrating band (labelled with “?”, lower, in Figure 
2.10(C)). At higher miR-308 concentrations, this band became more smeared and an additional band 
was observed high on the gel (labelled “?”, upper, Figure 2.10(C)).  
Gel shifts with two RNA species in each sample are rare in the literature but several have been reported; 
one study showed 50% binding of a ~300-nt RNA to a ~100-nt RNA at the top concentration of 500 nM. 
When the 11-kDa protein Hfq was added in at a concentration of 1 µM, this resulted in 100% binding 
at the much lower RNA concentration of 20 nM [165]. 
When the binding assays were reversed to comprise a constant amount of miRNA and increasing 
concentrations of BHD, miR-308 caused the appearance of discrete shifted bands (“?” in 
Figure 2.10(D)).  In order to test for specificity, addition of mir-Fold to a BHD-BRE(257-319) EMSA 
also altered the observed pattern of shifted bands, although the bands were more smeared than those  
observed with miR-308. 
If a three-way complex is not formed between BHD, BRE and miR-308, then it might be expected that 
BHD would bind separately to both miR-308 (or miR-Fold) as well as to BRE(257-319), given its 
promiscuity observed in the current work. The miRNAs are at a much higher concentration than 
BRE(257-319) in these binding assays, so it is reasonable to expect a decrease in the amount of BHD 
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binding to BRE(257-319) as miR-308 and BRE compete for BHD. A decrease in apparent binding, 
however, is not observed.  
Alternatively, if miR-308 does form a ternary complex with BHD and BRE, then it would be reasonable 
to expect an increase in affinity when miR-308 is included in the binding assays. The appearance of 
discrete bands in EMSAs with miRNAs Figure 2.10(D) does suggest the formation of a complex with 
a slower off-rate than observed in BRE-BHD EMSAs. Despite the effect being observed for both miR-
308 and miR-Fold, it does seem to be slightly more pronounced for miR-308. 
 
 
Figure 2.10. BRE contains a putative miRNA binding site.  
(A) Sequence alignment of miR-308 with the predicted miRNA target site contained in BRE. The putative target 
site is indicated in the predicted structure of BRE38nt in black. (B) Sequences and predicted folds of miRNA 
transcripts tested for binding to BHD and BRE. miR-Fold was designed to have a different sequence but the same 
predicted structure as miR-308. Structures were predicted using RNAfold software. (C) 32P-labelled BRE(257-
319) was incubated with an increasing amount of miR-308, with and without a constant amount of BHD, right and 
left respectively, then resolved on a 6% polyacrylamide native gel. (D) 32P-labelled BRE(257-319) was incubated 
with an increasing amount of BHD, without any miRNA (left), with an increasing amount of miR-308 (middle) 
and with an increasing amount of miR-Fold (right), then resolved on a 6% polyacrylamide native gel. 
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As far as is known, miRNAs bind their 3′-UTR targets in complex with Ago proteins, as mentioned 
above. This alliance speeds up the complex job of finding targets within the crowded cellular milieu 
[166]. Structures of Ago proteins in complex with cognate miRNAs have shown that this association 
elicits presentation of the highly complementary seed region of miRNAs in an A-form helix, which is 
optimal for interacting with target mRNA sequences [167, 168]. Moreover, it has been shown that 
association of Ago proteins with miRNAs changes the base pairing preferences for miRNA-target 
interactions [169]. Given, however, the results presented here, it seems a possibility that BHD binds to 
duplex RNA consisting of BRE and miRNA elements, which would represent a novel miRNA 3′-
UTR binding mechanism. This would need to be followed up, however it was not pursued further here 
due to time constraints. Experiments with resolution superior to that of EMSA would be required; 
NMR-based chemical shift mapping of isotopically labelled BRE, miRNA and BHD might yield 
helpful data, or x-ray crystallography if crystals of the trimer can be obtained. 
2.3.4 N-terminal extension of homeodomain to include potential arginine-rich motif 
As no RNA-binding specificity could be determined for BHD within the canonical boundaries of a 
homeodomain, and given that smeary bands observed in EMSAs may indicate suboptimal constructs as 
mentioned in Section 2.3.2, a longer construct was cloned. This construct incorporated two arginine 
residues immediately N-terminal to the original BHD construct, making a total of five arginines in close 
proximity in the sequence. It is known that low complexity arginine sequences are overrepresented in 
the RNA-binding proteome [68]. A common RBD, known as the arginine-rich motif (ARM), is 
characterised simply by a high local density of arginine residues. A list of ARMs that have been 
demonstrated to bind RNA is shown in Table 2.1, illustrating the considerable variation in their 
sequences. ARMs characterised to date tend to bind RNA in a hairpin conformation [170-172].  
 
 
 
 
 
 
Despite not being required for DNA target recognition, four residues flanking the N-terminal end of the 
homeodomain are conserved in all organisms that have bicoid (Figure 2.11(A)).  In order to determine 
if these conserved residues and putative ARM contribute to BHD RNA-binding, a longer construct of 
Table 2.1. List of ARM sequences with characterised RNA targets. 
 
Species Protein ARM sequence RNA target
Human 60S ribosomal protein L7ELKIKRLRKKFAQKMLRKARRK Preference for structured RNA
Human HEXIM KKKHRRRPSKKKRHWKPYYKLTWEEKKK GUAC repeat motif in hairpin loop of 7SK RNA
Phage P22 N NAKTRRHERRRKLAIER GGUGCGCUGACAAAGCGCGCC
Phage λN MDAQTRRRERRAEKQAQWKAAN GGGCCUGAAGAAGGGCCC
Virus BIV Tat SGPRPRGTRGKGRRIRR GGCUCGUGUAGCUCAUUAGCUCCGAGCC
Virus HIV-1 Tat SYGRKKRRQRRRPPQ CCAGAUCUGAGCCUGGGAGCUCUCUGG
Virus HTLV-1 Rex MPKTRRRPRRSQRKRP GCUCAGGUCGAGGTACGCAAGTACCUCCCUUGGAGC
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the bicoid homeodomain was made, named homeodomain with extra arginines (HDER). HDER was 
cloned to include an extra nine N-terminal residues, as depicted in Figure 2.11(B). 
 
 
Figure 2.11. Amino acid sequence of recombinant BHD extended to include conserved N-terminal residues.  
(A) Sequence alignment of bicoid homeodomain and flanking sequences in all species that have a bicoid gene. The 
start of the canonical homeodomain sequence is indicated by an arrow. Red indicates conserved residues, cyan 
shows residues with strongly similar properties and green shows residues with with weakly similar properties. 
Alignment of sequences was done with Clustal Omega. (B) Sequence and context of the HDER construct. This 68-
residue construct included an extra nine N-terminal residues (blue). As per the BHD construct, an extra N-terminal 
glycine residue (purple) remains after HRV-3C cleavage of the GST tag, and an extra seven C-terminal residues 
(red) are included to increase solubility.  
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Expression and purification of HDER was carried out in a similar fashion to BHD, although protein 
expression levels were lower for HDER (Figure 2.12), and substantial protein was lost during 
concentration, resulting in much poorer yields at ~200 µg per litre of culture. 
There was no discernible difference between the ability of BHD and HDER to bind to 32P-labelled 
BRE(257-319) in an EMSA (Figure 2.12(A)). As with the EMSA experiments described above, 
micromolar protein concentrations resulted in the formation of protein-RNA complexes that did not 
migrate into the gel. As always, it is difficult to interpret EMSAs that give rise only to complexes that 
are retained in the wells, other than to conclude that some sort of interaction is taking place. 
As an alternative approach to assessing these interactions, we turned to MST. A shorter RNA was used 
so that it could be ordered as a fluorescently-tagged oligonucleotide, avoiding lengthy purification and 
labelling procedures. A 19 base RNA sequence from BRE38nt was chosen (BRE19nt) that encompasses 
the distal hairpin loop of the BRE (Figure 2.12(B)). Two different salt concentrations were tested in 
order to gauge the robustness of the interaction.  
Good quality, reproducible MST data were obtained. These data were fitted to a simple 1:1 binding 
model. At either salt concentration, the binding of HDER to BRE19nt was 3–4-fold stronger than the 
binding of BHD (Figure 2.12(C). Dissociation constants of 1.1 and 3.8 µM for HDER and BHD, 
respectively (50 mM NaCl), are consistent with typical affinities for single RNA-binding domains for 
their target. For example, dissociation constants of ~1 µM have been reported for ZFs and KH domains 
binding to RNA [47, 49]. The higher salt concentration substantially reduced binding affinity for both 
 
Figure 2.12. Purification of HDER compared with BHD.  
(A) SDS-PAGE analysis of GSH affinity purification for BHD and HDER. Abbreviations: L, Mark 12 ladder; S, 
soluble fraction; W, wash; FT, flow-through; E, GSH elutions 1 to 6 (pooled). (B) SDS-PAGE analysis of 
selected cation exchange chromatography fractions. Abbreviations: L, Mark 12 ladder; C, HRV-3C cleavage of 
pooled elutions; P1, first peak in cation exchange chromatogram; P2, second peak in cation exchange 
chromatogram. 
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proteins, by six to eight fold in both cases. Some caution should be given to the binding constants as 
complete binding curves could not be attained at the higher salt concentration.  
The reduction in affinity with increasing salt concentration indicates that this interaction has a 
significant electrostatic component. This interpretation is somewhat corroborated by the observation 
that BHD binds unstructured ssRNA (Figure 2.9) but doesn’t substantially bind ssDNA (Figure 2.6). 
Despite DNA having the same overall charge as RNA, the extra hydroxyl group of RNA provides 
slightly more hydrogen bonding potential. Moreover, the preference for ssRNA over ssDNA is 
consistent with the interaction being non-sequence-specific, as non-sequence-specific interactions in 
RBPs usually comprise electrostatic interactions with the sugar phosphate backbone, as opposed to 
electrostatic interactions and hydrophobic interactions with the bases typically seen for sequence 
specific interactions [173]. For example, RIG-I binds to the end of dsRNA in a non-sequence specific 
fashion mostly through contacts with the sugar phosphate backbone, including hydrogen bonds to ribose 
 
Figure 2.12. Binding of HDER or BHD to BRE.  
(A) EMSAs of BHD and HDER binding to BRE(257-319). Increasing concentrations of BHD (left) and HDER 
(right) were incubated with 32P-labelled transcripts then resolved on a 6% polyacrylamide native gel. (B) Design 
of the RNA sequence for use in MST. BRE19nt (light blue) consists of the distal hairpin loop of BRE38nt (red). 
Structures were predicted using RNAfold software. (C) MST curves for BHD (blue) and HDER (red) following 
titration of these proteins into fluorescently labelled BRE19nt. Titrations were carried out both in 50 mM and 
150 mM NaCl. Data points from two independent titrations are shown for each protein and salt combination and 
fitted to a 1:1 binding isotherm.  
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2′-OH groups [174]. Specificity for RNA is also provided to some degree in Ago proteins through 
interactions with ribose 2′-OH groups [175]. 
Interestingly, even though the highest protein concentration in MST is an order of magnitude higher 
than that of the EMSAs, no aggregation of protein and RNA was seen, as evidenced by consistent 
fluorescent signals (+/- 10%) prior to establishment of the heat gradient (Figure 2.13). The protein:RNA 
complex formed in EMSA must be somehow affected by the conditions of experiment; it is possible 
that the complex has reduced solubility in the running buffer, for example. 
2.4 Discussion 
Given that RNA sequence or structural elements of the cad 3′-UTR required for bicoid homeodomain 
recognition were not able to be defined, two interpretations are possible. The bicoid homeodomain 
might function in vivo as a non-specific (or low-specificity) RBD, or the experimental conditions 
utilised in this Chapter were not optimal to detect specificity. These scenarios will be discussed below, 
with reference to current RBP research.  
2.5.1 The bicoid homeodomain might be a low-specificity RBD 
It is possible that the bicoid homeodomain might be a genuine RBD that binds RNA without much 
discrimination between sequence and structural elements. Specificity might arise from the action of the 
full-length protein, or from a binding partner. 
Non-specific RBPs have important roles in biology, with recent estimates suggesting that up to 50% of 
RBPs may be non-specific [81]. Many biological processes necessitate that RBPs interact with a large 
 
Figure 2.13. Example of MST fluorescence data collected prior to establishment of the temperature gradient. 
Initial fluorescence data for the BHD:BRE19nt titration, before establishment of the temperature gradient. The 
absence of a concentration dependant change in fluorescence indicates that there is no aggregation of a protein-RNA 
complex. 
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variety of RNAs. For example, YB-1 downregulates translation initiation broadly through promiscuous 
binding of mRNAs [176]. Similarly, RNA interference requires promiscuous RNA binding; the PAZ 
domains of Ago1 and Ago2 bind ssRNA by accommodating the 3′ end in a hydrophobic pocket [177, 
178]. Additional non-specific roles of RBPs may be yet to be unearthed. For example, YY1 was recently 
shown to increase the occupancy of transcription factors at enhancers and promoters by binding to the 
nascent transcript of the enhancer or promoter [100]. It is an interesting hypothesis that other 
transcription factors may bind RNA transcripts in a non-specific fashion in order to create positive 
feedback loops in transcription. 
In the case of bicoid, however, it has been shown that bicoid downregulates cad translation by forming 
some sort of inhibitory complex, which necessitates that functional specificity comes from somewhere. 
How RBPs achieve biological specificity in many cases is still not known [71]. Biological specificity 
refers to sequence preferences of proteins in vivo, contrasted with intrinsic specificity which refers to 
protein sequence preferences determined in vitro [81]. 
Despite the early literature report that the bicoid homeodomain binds BRE specifically, as outlined in 
Chapter 1, we know that RBPs that recognise RNA in a specific manner almost always utilise multiple 
RBDs to do so. For example, zinc fingers four through six of Unkempt (Figure 1.2(D)) together only 
specify three bases, 5′-UAG-3′.  
The requirement for multiple RBDs to achieve biological specificity complicates the study of these 
proteins, particularly given that specificities of individual domains are often not the same when part of 
a full-length protein [173]. An isolated RBD that binds RNA non-specifically, may, in the context of 
the full length protein, provide sequence discriminating capacity. For example, the mRNA-binding 
protein TIA-1 contains three RRMs; when analysed as single domains, RRM2 displays high affinity for 
U-rich RNA, whilst RRM3 binds U- and C-rich RNA weakly. However, as part of the full length 
protein, RRM3 provides the sequence discriminating capacity to bind target RNAs [179]. Different 
molecular mechanisms may be at play depending on the number of domains present, as was shown by 
the observation that an additional N-terminal helix present in RRM3 of TIA-1 was important for binding 
of double, but not single, RRM polypeptides to similar RNA sequences [180, 181].  
Of particular relevance to this Thesis, homeodomains have been shown to have altered specificity for 
DNA depending on the length of the protein tested. For example, the homeodomain containing protein 
ultrabithorax (Ubx), in the context of the full length protein, discriminated between several DNA 
sequences with affinity differences of ~ten-fold. However, when the homeodomain alone was probed 
for binding, it bound all sequences similarly, with a higher affinity than the full-length protein [182]. 
Ubx, like many homeodomain-containing proteins, gains affinity and specificity by binding DNA with 
other homeodomain-containing proteins. This is illustrated by the structure of a ternary complex of Ubx 
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and extradenticle (Exd) bound to a DNA target site (Figure 2.14(A)); Ubx is bound to Exd through the 
YPWM motif of Ubx. The YPWM motif, as well as disordered regions on both sides of this motif which 
were not visualised in the crystal structure (six residues N-terminal to YPWM and eight residues C-
terminal to YPWM) were shown to have separable effects on the sequence-discriminating capacity of 
the protein, through modulation of both intra- and inter-protein interactions. These examples, taken 
together, show that the binding analysis of single domains can often yield results that are not indicative 
of their function in full length proteins. 
Biological and functional specificity is often achieved not only by multiple RBDs in one protein but 
through the concerted action of multiple RBPs. The requirement for multiple RBPs for RNA target 
specification is being increasingly documented, particularly for mRNA-binding proteins. For example, 
the mRNA transport protein She3p, which contains no known RBDs, binds RNA non-specifically in 
isolation; however synergistic binding between She3p and She2p results in stable, specific mRNA 
binding [183]. Similarly, Rna15 is an RRM containing 3′-mRNA processing factor that alone displays 
little sequence discriminating capacity for RNA. Target recognition is achieved through the combined 
effect of various weak interactions between multiple proteins and RNA; Rna15 interacts with the 
proteins Hrp1 and Rna14. The binding of Hrp1 to RNA serves to position Rna15 on target sequences, 
and Rna14 stabilises the two RBPs on the RNA without binding RNA itself [184, 185].  
Several structures have been published that exhibit the intricate interplay observed in multi-RBP:RNA 
complexes. One such structure is that of a pair of RRMs, one each from the widely expressed ASD-1 
and the muscle-specific SUP-12; the proteins interact to achieve tissue specific splicing, creating a cleft 
that accommodates a guanine base [186], as shown in Figure 2.14(B). Another example that underscores 
the complex network of interactions that can arise is the structure of an RRM from the Drosophila 
female-specific Sex-lethal (Sxl) bound to the cold shock domain of Upstream-of-N-ras (Unr). This 
dimer creates an intricate ternary arrangement with msl2 mRNA [187] that is illustrated in Figure 
2.14(C).  
As well as providing biological specificity to non-specific RBPs, the association of multiple RBPs can 
also relax the intrinsic specificity of RBPs. This is illustrated in an elegant example that also 
demonstrates how functional specificity can arise through the interplay of cellular RBP gradients. In 
Drosophila, the non-specific double ZF-containing RBP Nanos (Nos) is concentrated at the posterior 
end of the developing embryo, whilst Pumilio (Pum) and hb mRNAs are spread throughout the embryo. 
Nos and Pum form a ternary complex with hb mRNA, repressing translation of hb in the posterior of 
the embryo. This ternary complex is shown in Figure 2.15(A), and involves a cytosine base that is 
flipped out from the Pum binding interface [188]. In the same study, the ability of Nos to modulate the 
RNA-binding specificity of Pum was illustrated. Pum does not bind CycB RNA in isolation, however 
Nos is able to stabilise Pum on CycB RNA. This stabilisation produces a change in the method that Pum 
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recognises bases that are located away from the Pum and Nos binding interface. Instead of the base flip 
method seen in Figure 2.15(A), recognition of CycB RNA involves the 1:1 (base to helix repeat) method, 
as seen in Figure 2.15(B) [188]. This change in recognition mechanism results in suboptimal contacts 
with an adenine base, and the disordering of a terminal base.  
The molecular details of the complexes that bicoid forms whilst repressing cad translation are still 
lacking. As discussed in Section 1.2.5, there are several proposed models for bicoid-mediated cad 
silencing. Both Bin3 (a probable methyltransferase, discovered as a bicoid-interacting protein via a 
yeast two-hybrid screen) and 7SK RNA (a snRNA primarily known for its transcriptional role of 
inhibiting the positive transcription elongation factor (P-TEFb)) have been shown to stabilise bicoid at 
the BRE, and other proteins that could possibly interact with bicoid and regulate binding to cad include 
Ago2, poly-A binding protein, Larp1, eIF4E [130] and 4EHP [112]. The studies outlined in the 
 
 
Figure 2.14. Ternary complexes of proteins and nucleic acid. 
(A) Ubx (purple) and Exd (orange) bound to DNA target site (white) (PDB: 1B8I). Sidechains of the YPWM 
motif of Ubx are shown as sticks. Disordered residues flanking the YPWM motif that are not visualised in this 
structure, but that act as specificity determinants, are indicated by dotted purple lines. (B) RRMs from ASD1 
(light blue) and SUP-12 (light green) bound to each other and RNA target site (black) sandwiching a guanine base 
in the middle (PDB: 2MGZ). (C) Cold shock domain of Unr (light green) and two RRMs of Sxl (light blue) bound 
to RNA target site (black) (PDB: 4QQB). Selected RNA-binding residues are shown in stick format (blue: 
nitrogen, red: oxygen, yellow: sulphur).  
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paragraphs above indicate that, in order to determine how bicoid specifically recognises cad mRNA, 
further characterisation of the protein interaction network of bicoid might be required.  
The reduction in BHD binding of BRE19nt induced by an increase in salt concentration to 150 mM 
may be an indication of the role of the domain in the full length protein. The binding of the cold shock 
domain of Lin28 with RNA is disrupted by ionic strength (although at a much higher concentration than 
150 mM), whereas when the ZnK domain of the same protein is present, ionic strength no longer 
perturbs the interaction. The proposal is that the CSD samples the transcriptome through transient 
electrostatic interactions [189]. 
2.5.2 Experimental conditions might not have been optimal to detect specificity 
An alternative explanation to the bicoid homeodomain being a non-specific RBD is that the domain 
does indeed bind RNA specifically but that the current work was not able to detect this specificity. 
There are several possible reasons why this may be the case. 
 
 
 
 
 
Figure 2.15. Nos modulates Pum specificity to associate with different mRNAs. 
(A) Ternary complex of Nos (light green, coordinated zincs as green spheres) and Pum (light blue) bound to hb 
RNA (PDB: 5KL1). A cytosine base that is flipped away from Pum is indicated. (B) Ternary complex of Nos (light 
green, coordinated zincs as green spheres) and Pum (light blue) bound to CycB RNA (PDB: 5KL8). Suboptimal 
binding interactions are observed between Pum and the specified adenine base, and the disordered terminal base 
not observed in the crystal structure is indicated. 
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First, it is possible that the bicoid homeodomain recognises a short redundant motif that is present in all 
RNA sequences tested. We know that most RBDs recognise sequences of only two to eight nucleotides, 
with considerable sequence variation frequently permissible [190]. For example, the optimal binding 
motif of the RRM from the splicing factor hnRNP G is a 5′-AA-3′ motif, however the domain can also 
bind 5′-CCC-3′ and 5′-CCA-3′ motifs [191]. In the work described in this Chapter, care was taken to 
design unique RNA transcripts as controls, but it is difficult to design sequences utilising all four bases 
that don’t contain instances of the same trinucleotides. To illustrate this point, all tested sequences 
include at least one instance of 5′-GAA-3′ and 5′-GUU-3′ trinucleotides.  
It is also possible that the bicoid homeodomain binds non-target RNA non-specifically, but we have 
failed to find its target sequence because it was not contained in the RNA sequences tested in this 
Chapter. Given the experimental procedure for making radiolabelled RNA, it is difficult to accurately 
estimate the size of the RNA product (in contrast to the situation for non-radioactive RNAs). Therefore, 
if transcription of the full length cad 3′-UTR was partially truncated, a critical element of the bicoid 
homeodomain target might have been omitted. Alternatively, the target sequence might not be contained 
in the cad 3′-UTR. Reports of the bicoid homeodomain target sequence within the cad 3′-UTR have 
varied as previously mentioned in Section 1.2.4, and it has even been reported that the binding site 
might extend upstream in to the coding region of cad [87]. Further, 7SK RNA is reported to be part of 
a repressive complex formed with bicoid to inhibition cad translation [130], which foreseeably could 
be directly bound by the homeodomain.  
It is also possible that assay conditions might not have been optimal for detecting a specific interaction 
between the bicoid homeodomain and RNA. Many reasons for this possibility arise due to the structural 
flexibility of RNA and RBPs that was introduced in Chapter 1. For example, the RNA might not be 
folded correctly, or the RNA or homeodomain might be missing required post-transcriptional or post-
translational modifications.  
RNA secondary structure complicates the study of RBP:RNA interactions as binding interfaces can 
become exposed or sequestered depending on the length of RNA used in one’s experiments [192]. An 
excellent example of this phenomenon is the bacterial global translation repressor protein CsrA/RsmE 
that exhibits modulation in affinity to a GGA motif from ~10 nM to 3 mM; the highest affinities are 
observed when the A(N)GGAX  motif is at the top of a hairpin loop, and the affinity is reduced when 
the motif is obstructed due to base pairing [193]. Further, the hairpin loop is a preferred target compared 
to the same motif in ssRNA, due to the lower entropic cost of binding to a hairpin. This study highlights 
how in vitro results can be distorted from the underlying biology if the RNA is not optimally folded. 
The structural flexibility of RNA and RBPs can also mean that there is often plasticity in their binding 
interfaces. Transcriptome wide studies of RBPs have shown binding of individual RBPs to multiple 
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RNA targets with extensive sequence and/or structural variation [194, 195]. The accommodation of 
various RNA sequences has been shown via structural adaptations of the protein [56, 196] and RNA 
[80, 197]. As a result, it is being increasingly understood that domain arrangements and conformational 
dynamics of RBPs have important implications for the recognition of biological targets [173]. This is 
of particular relevance to the bicoid homeodomain, with multiple studies indicating that sidechain 
conformational heterogeneity in the domain’s DNA-binding residues (that is, the sidechains have been 
observed to adopt a variety of conformations when bound to different DNA sequences) leads to the 
homeodomain’s unique nucleic acid binding properties [122, 198, 199]. Such flexibility presumably 
makes finding biologically relevant targets more difficult.  
Post-transcriptional and post-translational modifications of proteins and RNA further complicate the in 
vitro study of their interactions. For example, phosphorylation has been shown to up-regulate binding 
of the Ezh2 domain of PRC2 to HOTAIR lncRNA [200]. Some RBPs recognise PTMs specifically. 
PIWI proteins, for example, recognise piRNAs that are 2′-O methylated at their 3′ ends [201], and 
piRISCs bind RNAs that are 2′-O methylated at 3′ ends. When proteins are expressed outside of their 
host organism, and RNA is transcribed in vitro, any relevant PTMs will be missing. 
Whilst in vitro quantification of binding interactions often provides useful information, the inherent 
affinity an interaction is only one factor determining biological specificity. Often specificity is not an 
inherent property of RBPs but rather it is dictated by the cellular context in which RNP interactions take 
place [81]. The concentration and accessibility of each binding partner (including the accessibility of 
the RNA-binding site as discussed above), as well as the concentration of competitive binders, to a large 
extent dictates what interactions will take place. A demonstration of the effect of cellular context on 
specificity is the inhibition of PRC2 histone methyltransferase activity made at the vestigial locus in 
Drosophila. In vitro, inhibition can occur by both forward and reverse noncoding RNAs; however, in 
cells only the latter appears to bind PRC2, indicating that biological specificity is being driven by 
something other than affinity, such as availability of RNAs [202].   
Moreover, the highest affinity interactions do not always indicate biological targets. This was 
demonstrated by an innovative, high-throughput kinetics approach which showed that the biological 
substrates of C5 (a component of the tRNA processing RNAse P in Escherichia coli) are not the 
sequences it binds tightest but rather those near the middle of the affinity distribution [203].  
An excellent review detailing the complexity often encountered in vivo for RNA:RBP interactions has 
been published recently, highlighting how the categorisation of these interactions as inherently specific 
or non-specific is often not overly meaningful to the underlying biology [81]. Notably, this review 
outlines the impact of the kinetic context in which a binding event takes place. Strikingly, the kinetics 
of reactions that are separate to, but preceding or following, binding interactions can counterbalance the 
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inherent affinity of a protein for an RNA. The potential relevance of this analysis to bicoid is clear; as 
depicted in Figure 1.7(A), the developing Drosophila embryo is patterned precisely by differential 
concentrations of protein and RNA molecules, creating unique kinetic contexts for bicoid throughout 
the embryo. Bicoid binds tens of DNA targets as well as cad mRNA, so the differing concentration of 
the protein (and binding partners and competitive binders) throughout the embryo is likely instructive 
to its biological RNA-binding specificity. 
 
2.4 Summary  
This Chapter has demonstrated that BHD binds RNA promiscuously in vitro. The strategy employed 
was to test binding of BHD to various RNA sequences in an attempt to observe differential binding, as 
a starting point to be able to define sequence or structural elements that were both necessary and 
sufficient for binding. However, BHD was observed to bind equally well to RNAs of differing sequence 
composition, and with both the presence and absence of predicted secondary structure. The involvement 
of a miRNA complementary to a conserved hairpin loop in BRE was investigated, with results 
indicating the possibility that BHD might bind a miRNA:mRNA duplex. The N-terminal boundary of 
the homeodomain was then extended by nine residues to include a potential ARM; this extended 
domain, HDER, had a four-fold higher affinity for the conserved distal loop of BRE than that of BHD. 
The ability of physiological salt concentration to reduce the RNA-binding affinity of both BHD and 
HDER by six to eight-fold indicates that this interaction is largely electrostatic.  
The RBP research presented in the previous Section highlights that determining how RBPs find their 
cellular targets is a highly complex task, requiring in-vivo and in-vitro techniques to work side by side. 
The involvement of the bicoid homeodomain in the specific repression of cad has been postulated based 
on previous in-vivo and in-vitro research [87, 123, 126], however, the in-vitro work presented in this 
Chapter was unable to define specificity determinants of the interaction. Further characterisation of the 
homeodomain’s interaction with RNA using techniques that yield superior molecular resolution may 
help to resolve its role in cad translational repression. 
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Chapter 3: NMR analysis of BHD and the interaction between 
BHD and RNA 
3.1 Introduction 
The previous Chapter addressed the RNA-binding specificity of the bicoid homeodomain but no clear 
specificity could be discerned. However, the analysis at the end of the Chapter highlighted the point 
that ascertaining how RBPs achieve biological specificity is a very complex question. We therefore 
sought to characterise the BHD-RNA interaction in more detail, in the hope that knowledge of the 
molecular basis for the interaction would be of value in understanding (a) how proteins can recognise 
both DNA and RNA and (b) how proteins find their cellular targets. The bicoid homeodomain is of 
particular interest in these regards as it is the only homeodomain that is currently known to bind both 
DNA and RNA. 
Accordingly, this aims of this Chapter are to characterise the molecular details of RNA-binding by BHD 
and to further interrogate its RNA-binding specificity. 
 
3.2 Techniques used in this Chapter 
3.2.1  Nuclear magnetic resonance spectroscopy 
The NMR data presented in this Chapter go beyond the simple 1D 1H NMR spectra presented in the 
previous Chapter, and employ uniform 15N and 13C isotopic labelling of the protein to both improve 
resolution and to permit assignment of signals to specific atoms in the protein.  
3.2.1.1 Two dimensional NMR spectroscopy 
At the two-dimensional (2D) level, the introduction of isotopic labelling results in less signal overlap 
by spreading signals over another dimension, providing the resolution required to distinguish signals 
for individual residues. As the size of a protein increases, so too does the chance of signal overlap, 
which makes the task of distinguishing signals progressively more difficult. The 2D experiment used 
most widely in protein biochemistry is the 15N-1H heteronuclear single quantum coherence (15N-HSQC) 
spectrum. 15N-HSQC experiments are set up such that only directly bonded N/H groups give rise to 
signals, yielding signals for each amide group of the protein backbone as well as any amide groups 
contained in sidechains.  
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The chemical shift and intensity of each signal is dependent on the chemical environment of the amide 
group, and therefore 15N-HSQC experiments can provide extremely valuable structural information. For 
example, information about the flexibility or secondary structure of residues is garnered as those that 
are contained in rigid sections of secondary structure will show reasonably strong peak intensities, 
whereas flexible residues will often show significantly more intense signals or, conversely, are 
sometimes not observed. Further, as the chemical environments of magnetic nuclei are altered by 
binding events, the ability to observe binding induced changes, known as chemical shift mapping, 
makes it possible to characterise the molecular details of binding interactions. For suitable proteins, 
these changes can be observed by 15N-HSQC experiments. The contribution of specific residues to a 
binding interaction can be quantified by chemical shift, linewidth or intensity differences between the 
free and bound state.  
Chemical shift change is the most commonly used parameter for assessing interactions. As mentioned, 
a nucleus perturbed by a binding interaction will display a different chemical shift in the free and 
complexed form. The signal(s) that this nucleus gives rise to in an NMR spectrum depend on both the 
rate of exchange between the free and complexed form, and also the difference in the chemical shift 
between these two forms. A fast exchange regime occurs when the exchange between the two forms is 
faster than the difference in frequency (chemical shift) between the nucleus in the two (or more) states, 
and generates a single signal with a population weighted average chemical shift. A slow exchange 
regime occurs when the exchange between the two forms is slower than the frequency difference, and 
gives rise to two individual signals for the free and complexed state. An intermediate exchange regime 
lies in the middle, and results in signal broadening, to the extent that resolution can become so poor that 
signals are not observed.  
In order to quantify the chemical shift changes upon RNA addition, the following equation is applied 
to the data to calculate weighted average chemical shift changes; this equation factors in empirically 
determined differences in resonance sensitivity of amide nitrogen and protons [204]: 
∆       = 	 (      )
  + (    )
                                      Equation 3.1 
where ∆   is the chemical shift change between nucleus/nuclei i in the free and complexed state and    
is empirically determined weighting factor for each nucleus; in this thesis     = 1 and    = 0.154 
[205].  ∆       is then plotted as a function of residue number. Residues for which ∆       is greater 
than the average ∆       plus one standard deviation are deemed to be significantly influenced by RNA 
binding.  
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3.2.1.2 Three dimensional NMR spectroscopy 
Three dimensional (3D) protein NMR spectra typically are acquired on proteins that are 13C as well as 
15N labelled. Many different spectra can be acquired that correlate the absorption frequencies of three 
(or more) nuclei; often two of these are the amide proton and nitrogen. In the most commonly used set 
of experiments, amide groups are correlated with 13Cα/13Cβ or 13CO atoms from the same and/or 
preceding residues. 
Like other nuclei, different backbone carbon atoms display characteristic chemical shifts: carbonyl 
carbons display different chemical shifts to that of α and β carbons, and α and β carbon resonance ranges 
vary for each amino acid. Particular residues such as alanine, serine and threonine display diagnostic 
Cα and Cβ chemical shifts. Spectra are acquired in pairs so that one spectrum will obtain 13C signals for 
both the same residue as the amide signal (ri) and the residue preceding the amide signal (ri–1); the paired 
spectrum will correlate the amide group just with the carbon(s) of residue for ri-1. This linkage between 
pairs of spectra, coupled with knowledge of the protein sequence and characteristic carbon shifts, 
facilitates the sequential assignment of signals to protein residues. Therefore, 13C/15N triple resonance 
experiments allow the connection to be made between NMR signals and protein residues. This 
information can be used in conjunction with 2D chemical shift mapping to identify which residues are 
involved in a binding event. 
 
3.3 NMR analysis of bicoid homeodomain and RNA interaction 
This section details NMR experiments aimed at further validating and characterising the bicoid 
homeodomain and its interaction with RNA. 15N-HSQC experiments were carried out to map chemical 
shift changes of BHD upon titration with RNA to gain further insight in to the nature of the interaction, 
and 15N/13C triple resonance experiments were collected to allow assignment of protein residues in order 
to determine which residues are important for binding RNA.  
Despite HDER having a higher affinity for RNA than BHD as discussed in Section 2.3.4, the lower 
yield obtained from overexpression and purification deems it a poor candidate for detailed NMR 
studies. Therefore the BHD construct was chosen for further binding analysis.  
3.3.1 BHD 15-N HSQC spectrum 
Initially, a two dimensional 15N-HSQC spectrum of BHD was acquired. As introduced above (Section 
3.2.1.1), a 15N-HSQC spectrum contains signals that correlate the absorption frequencies of directly 
bonded H-N atom pairs. Signals are thus observed for backbone amides and for some sidechains.  
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15N-labelled BHD was expressed in minimal medium (Section 7.2.2.4) and purified as per unlabelled 
protein (Section 2.3.1). 15N-labelled BHD expression and purification gave a similar yield to unlabelled 
BHD, at around 1 mg per litre of culture and >95% purity. A 15N-HSQC spectrum of BHD alone was 
acquired; the domain gave rise to a spectrum with good line widths and well-defined peaks. Signals 
were observed for 43 out of 65 residues expected to give rise to an HSQC signal, shown in Figure 3.1. 
As for 1D 1H spectra, well-defined and dispersed peaks indicate an ordered protein. Correspondingly, 
this spectrum indicates that BHD is well-folded, as expected. According to the structure of the bicoid 
homeodomain bound to DNA, there are 46 α-helical residues with the remainder of the residues located 
in loops or terminal arms [122]. It is perhaps likely that many of the missing signals are from these 
more flexible regions that are not located in the α-helices of the domain. Amide protons that are not 
located in stable structure can often undergo millisecond to microsecond timescale dynamics. These 
dynamics can give rise to the intermediate exchange phenomenon described above, which can have the 
effect of broadening the signals beyond detection. 
 
 
 
 
Figure 3.1. 15N-HSQC spectrum of 15N-labelled BHD. 
15N-HSQC spectrum of 200 µM BHD in 50 mM HEPES pH 7.3, 50 mM KCl, 1 mM MgCl2, 1 mM TCEP. 
Spectrum was recorded on an 800 MHz Bruker Avance III NMR spectrometer equipped with a cryoprobe (NS 
= 6; 1TD = 256) at 298 K. 
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3.3.2 Assignment of BHD residues 
In order to make the backbone assignments for the domain, BHD was overexpressed as 13C/15N-labelled 
protein in minimal medium (Section 7.2.2.4) and purified as per 15N and unlabelled protein (Section 
2.3.1). 13C/15N-labelled BHD expression and purification gave a lower yield compared with that of 15N 
and unlabelled BHD, at around 500 µg per litre of culture and >95% purity. Expression was scaled up 
to two litres to enable ~200 mM samples to be made. A series of 3D, triple resonance spectra were 
acquired on the protein alone, namely HNCACB, CBCA(CO)NH, HN(CA)CO and HNCO. 
Correlations of the amide proton and nitrogen with 13Cα and 13Cβ nuclei are obtained from the HNCACB 
(ri and ri-1) and CBCA(CO)NH (ri-1) spectra, and 13CO correlations are obtained from the HN(CA)CO 
(ri and ri-1) and HNCO (ri-1) spectra, as depicted in Figure 3.2(A). The strategy employed for assignment 
of the protein backbone residues is illustrated in Figure 3.2(B), which shows assignment of residues 
D129 to A132. These spectra illustrate the linkage of signals between residues (indicated by dotted 
lines), specifically demonstrating the low 13Cβ shift that is diagnostic of alanine, and the high 13Cβ shift 
that is diagnostic of serine. Residues with diagnostic shifts are typically identified first, and carbon 
signals are allocated to the previous residue if they are observed in the CBCA(CO)NH spectrum, then 
connections between adjacent residues are made by tracing signals through the HNCACB spectrum. 
The CO resonances assist in assignment by connecting carbonyl signals to amide signals in an analogous 
manner from the HN(CA)CO and HNCO spectra, which can be helpful if there are missing or faint Cα 
and Cβ signals.  
Some undesirable features are also shown, namely; signal overlap between D129 and L130 (for both 
13Cα and 13CO), and a missing 13CO signal for S131 in the S131 strip of the HN(CA)CO. The frequency 
of signal overlap and missing signals depends on the individual protein; the probability of the former 
increases with the size of the protein, and the latter depends in part on the quality of the spectra and on 
a variety of other factors, including the presence of chemical exchange processes. When spectral quality 
is less than ideal, multiple pairs of spectra may need to be acquired to facilitate assignment, as was the 
case here for BHD. 
Assignments of amide N/H resonances were made for 44 residues. This included two separate situations 
in which the 15N-HSQC signals for two residues were coincident peak overlaps, resulting in assignment 
of 42 out of the total count of 43 separable peaks in the spectrum. The assigned 15N-HSQC spectrum is 
shown in Figure 3.3(A). 
The chemical shifts obtained from this data set were used to predict the secondary structure of the 
domain by MICS (Motif Identification by Chemical Shift) program [206]. This program uses an 
artificial neural network algorithm to predict the likelihood that each residue will be located in particular 
types of secondary structure. The domain is predicted to be primarily α-helical as expected, and the  
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Figure 3.2. Triple resonance spectral assignment of BHD residues.  
(A) Schematics indicating magnetisation transfer for each spectrum. HNCACB: magnetisation is transferred via 
α and β hydrogens from ri and ri–1 (indicated in bold text) to both α and β carbons respectively, with β carbon 
magnetisation transferred to the attached α carbon, then α carbon magnetisation from both ri and ri–1 is transferred 
to the amide nitrogen of ri before being transferred to the amide hydrogen. CABCA(CO)NH: magnetisation is 
transferred via α and β hydrogens from ri–1 (indicated in bold) to the attached β and then α carbon, then to the 
carbonyl carbon (where it is not evolved hence no signal), then to the nitrogen and hydrogen of ri. HN(CA)CO: 
magnetisation is transferred from the amide hydrogen of ri to the attached amide nitrogen, then to both α carbons 
(not evolved) and then onto attached carbonyl carbons. Magnetisation is then transferred back via the same route 
for detection. HNCO: magnetisation is transferred from the amide hydrogen of ri to the amide nitrogen and then 
to the attached carbonyl carbon, before being transferred back via the same route for detection. Abbreviation: r, 
residue. Shaded circles indicate a signal is obtained for that atom. (B) Strips from nitrogen planes for HNCACB, 
CBCA(CO)NH, HNCACO and HNCO showing signal links (indicated by dotted lines) between spectra that allow 
sequential assignment of BHD residues. Signals are coloured to indicate identity consistent with schematics in 
(A).  
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predicted helical regions largely correspond to the helical regions identified by the solution structure of 
the bicoid homeodomain bound to DNA [122] (Figure 3.3(C)). This analysis suggests that BHD purified 
for this work likely adopts a similar secondary structure to the domain when bound to DNA.  
Residues that were not assigned mapped to a number of regions throughout the protein, and have been 
highlighted on the structure of the domain (when bound to DNA) in Figure 3.3(B).  Six out of eight N-
terminal residues were unassigned, indicating that this region is probably undergoing some 
conformational exchange. Following DNA binding, it has been shown that this region becomes ordered 
by making contacts with the DNA minor groove [122]. Eight out of 22 residues from helix three were 
not observed. This helix is known to display a high degree of conformational flexibility [122, 198]. 
Recently, thermal denaturation studies indicate that the flexibility of this helix is attributable to the 
availability of multiple folded conformations with similar stability [199]; this is a likely explanation for 
why a large number of residues were not observed in this region. The majority of the remaining missing 
residues are located in the loop region between helix one and helix two, a region that is also likely to 
exhibit conformational flexibility.  
3.3.3 Mapping the RNA-binding residues on BHD 
The chemical shift assignments made in the previous Section were used to determine which residues in 
BHD are involved in RNA binding. The first RNA target tested was BRE19nt, the conserved distal 
hairpin loop of BRE shown in Figure 2.13(B); BHD binds BRE19nt with a Kd ~ 3.8 µM. In initial 
experiments, BRE19nt was titrated into a solution of 15N-labelled BHD in 0.2 molar equivalent 
increments. However, in all cases precipitation was observed at lower ratios of RNA and protein. In the 
aim of avoiding precipitation, the protein was added to 0.2 molar equivalent increments of RNA (instead 
of 0.2 molar equivalents of RNA added to the protein), however some precipitation still occurred. 
Finally, precipitation was avoided was by adding two molar equivalents of RNA to the protein at once.  
Figure 3.4(A) shows a 15N-HSQC spectrum of BHD alone and in the presence of two molar equivalents 
of BRE19nt. Figure 3.5(A) shows the magnitudes of chemical shift changes upon RNA addition, which 
were calculated using Equation 3.1. 
As a titration was unable to be carried out, signal changes could not be tracked unambiguously. Instead, 
the nearest neighbour method was used [207], whereby new signals are assigned to the nearest residue 
as outlined in Section 7.2.7.4. In this method, the assignments of the bound state are based on proximity 
to the nearest peak in the free protein state, with a correction of 1/7 used for 15N resonances in order to 
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Figure 3.3. Assigned 15N-HSQC spectrum of BHD. 
(A) 15N-HSQC spectrum of BHD alone (blue). Starting concentration of BHD was 200 µM, in 50 mM HEPES 
pH 7.3, 50 mM KCl, 1 mM MgCl2, 1 mM TCEP. Spectrum was recorded on an 800 MHz Bruker Avance III NMR 
spectrometer equipped with a cryoprobe (NS = 6, 1TD = 256) at 298 K. (B) Residues missing from the assigned 
15N-HSQC spectrum are mapped onto the structure of bicoid homeodomain (PDB: 1ZQ3). Residues that could not 
be assigned are shown in red and assigned residues are shown in grey. N′ and C′ terminal ends are indicated, and 
helices one, two and three are indicated as H1, H2 and H3 respectively. (C) Predicted likelihood that BHD residues 
are located in an α-helix, obtained using the algorithm MICS and based on analysis of available 1H, 15N and 13C (α, 
β, CO) chemical shifts. Residues known to be helical from the structure of bicoid homeodomain bound to DNA 
(PDB: 1ZQ3) are indicated above the graph. The yellow bar indicates the likelihood of this residue being an N-
terminal helix capping motif. 
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give a roughly equal weighting to the 1H signals. Moreover, assignment of new signals that appeared in 
the spectrum with RNA was not possible; this would have required the acquisition of more triple 
resonance spectra of BHD in the presence of BRE19nt.  
All signals moved at least slightly upon RNA addition, with a ∆      of 0.05 ppm. There were more 
new signals than signals that disappeared (12 versus two, respectively), indicating that the domain 
becomes more ordered on binding RNA, or at least that more amide protons are protected from 
exchange with the solvent water. The extent of signal change implies that the interaction with RNA is 
widespread across the domain, and/or that some conformational change takes place upon binding.  
The observed chemical shift changes for the BHD:RNA interaction are relatively small with significant 
perturbations ranging between 0.09 and 0.16 ppm. Chemical shift perturbations of this magnitude have 
been reported for non-sequence specific RNA-binding interactions. Examples include the non-sequence 
specific binding of RNA by both the YY1 ZFs (which resulted in significant chemical shift perturbations 
of 0.06–0.14 ppm [160, 208]) and ZF1 of JAZ (0.05–0.11 ppm [160]). In contrast, some larger chemical 
shift perturbations of non-sequence specific interactions have been reported. For instance, ZF3 from 
JAZ, like ZF1, binds dsRNA without regard to sequence (except the requirement of A-form RNA), 
however significant shifts were between 0.12 and 0.55 ppm [160]. Certainly, the magnitude of the 
perturbations observed for the BHD:RNA interaction are smaller than those commonly seen for 
sequence specific RBP:RNA interactions. As illustrations of these larger chemical shift perturbations, 
ZF2 of ZRANB2 displayed significant shifts in the range of 0.2–1.2 ppm [49] and the RRM of SRp20 
displayed significant shifts between 0.4–2 ppm [209] upon binding RNA sequence specifically. These 
larger chemical shifts are generally indicative of base-specific hydrogen bonding interactions, which 
effect large downfield shifts [210] or the intercalation of aromatic rings between bases [211]. There is 
a notable absence of significant downfield 1H shifts in the BHD:BRE19nt spectrum, perhaps indicating 
an absence of specific hydrogen bonds, at least with the protein backbone. Taken together, the chemical 
shift changes observed for this complex are likely indicative of a non-specific interaction.  
Residues that displayed the largest chemical shifts changes upon RNA addition are shown on the bicoid 
homeodomain structure in Figure 3.6(A). The residues that undergo the largest perturbation map to 
helix three (the DNA-binding recognition helix) and to the loop between helices one and two, which is 
in broad agreement with the regions most perturbed by DNA-binding (DNA-binding residues are 
highlighted in Figure 3.6(B)) [122].  
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Figure 3.4. Overlay of 15N-HSQC spectra of BHD in the presence and absence of BRE19nt. 
(A) 15N-HSQC spectra of 200 µM BHD alone (blue) and with 2 molar equivalents of BRE19nt (cyan). Buffer 
composition was 50 mM HEPES pH 7.3, 50 mM KCl, 1 mM MgCl2, 1 mM TCEP. Spectra were recorded on an 
800 MHz Bruker Avance III NMR spectrometer equipped with a cryoprobe (NS = 3 for protein alone and NS = 6 
for 2 molar equivalents BRE19nt, 1TD = 256) at 298 K. (B) Specific residues of interest; likely direction of change 
is indicated by arrows.  
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Hydrophobic interactions are likely important for the interaction between BHD and RNA; three 
hydrophobic residues in helix three displayed significant shifts (V141, I143 and I154). Three charged 
residues were also observed to be key to this interaction; Q118, Q140 and R149, as well as a single 
glycine, G119.  
Some degree of conformational change upon binding is indicated by these spectra. Firstly, movement 
of the helices relative to one another is suggested by a number of hydrophobic core residues (as 
determined in the structure of the domain bound to DNA [122]) displaying shift changes over 0.05 ppm. 
These residues consist of F104, L130 and L136 as well as the significantly perturbed V141 (with a 
 
 
 
 
 
 
 
Figure 3.5. BRE19nt RNA-induced chemical shift changes of BHD backbone amides.  
(A) Weighted chemical shift changes of BHD residues plotted as a function of residue number following the 
addition of 2 molar equivalents of BRE19nt. Horizontal dashed line at ~0.082 indicates the threshold level of 
significance at one standard deviation above the average chemical shift change. Asterisks indicate residues which 
disappeared with BRE19nt addition. α-helices of BHD (when bound to DNA) are indicated above the graph, and 
are derived from the published structure of the BHD-DNA complex (PDB: 1ZQ3). (B) Amino acid sequence of 
BHD with assigned residues underlined in blue and significantly perturbed residues highlighted in orange. α-
helices of BHD (when bound to DNA) are indicated above the sequence.  
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weighted chemical shift change of 0.14 ppm). Given more limited solvent accessibility, shifts in internal 
regions of proteins are affected primarily by bond geometries and packing interactions [212]. Secondly, 
Baird-Titus et al., in their analysis of the BHD:DNA interaction, make the point that it is unusual to 
have a glycine in position 119, and speculate that this residue allows helix one to move closer to helix 
two than is typical for homeodomains [122]. A prominent shift in the signal of G119 of 0.12 ppm 
(Figure 3.4(B), right)) may imply that there is movement of helix one relative to helix two upon binding 
RNA. This is corroborated by chemical shifts greater than 0.05 ppm observed for Q114, L117 and 
Q118, residues which are also key to this 2.5-Å deviation of helix one [122].  
 
 
Figure 3.6. BRE19nt RNA-induced chemical shift changes of BHD backbone amide residues.  
(A) Structure of BHD, taken from the BHD-DNA structure (PDB:1ZQ3). RNA-binding residues (identified by 
weighted average backbone chemical shift changes between free and RNA-bound BHD) are mapped on to the 
structure as sticks (teal indicates carbon, blue indicates nitrogen, red indicates oxygen, white indicates hydrogen 
(hydrogen only indicated for G118). Structures are rotated 180° along the y-axis relative to each other. (B) 
Structure of BHD bound to DNA consensus sequence (PDB:1ZQ3), with DNA-binding residues mapped on to 
structure as sticks. The right-hand image has been rotated 45° along the y-axis, relative to the left-hand image. 
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The broad regions of secondary structure utilised by the domain to bind nucleic acid appear to be 
conserved between DNA and RNA recognition, with the residues that are significantly perturbed by 
both DNA and RNA-binding located primarily in helix three as well as the loop between helices one 
and two, and the N-terminal arm (Figure 3.6).  
However, identification of the specific residues involved in RNA recognition cannot be determined 
unequivocally. The residues that contact DNA directly are I143, K146 and R150 from helix three, Y121 
located in the loop between helix one and two and R98 from the N-terminal arm. The data presented 
here provides evidence that I143 and R98 are also involved in RNA recognition. I143 displayed a 
significant chemical shift of ~0.1 ppm. R98 was one of only two N-terminal arm residues that were 
visible in the protein alone spectrum. It is notable that this signal was very faint in the protein-alone 
spectrum, but that a more intense signal appears close by after RNA addition (Figure 3.4(B), middle)). 
Y121 and R150 were not observed, and therefore their role in RNA recognition cannot be confirmed. 
Lastly, K146 was assigned to a slightly shifted signal (ΔδK146 = 0.04 ppm) using the nearest neighbour 
method of assignment. As can be seen in the left schematic of Figure 3.4(B), there is some ambiguity 
with this assignment. It is possible that the closely shifted signal could be from I143, with K146 
exhibiting the large 1H downfield shift attributed to I143; however, further studies either involving 
optimisation of the conditions for triple resonance spectral acquisition, or triple resonance spectral 
assignment of BHD bound to BRE19nt, will be required to confirm this. In any case, given that it is the 
lysine sidechain that contacts DNA, a lack of substantial chemical shift change observed for the 
backbone amide cannot rule out a sidechain interaction.  
3.3.4 Further BHD:RNA chemical shift mapping 
The results from Chapter 2 demonstrated that BHD possibly binds RNA non-specifically, in a primarily 
electrostatic fashion. In order to corroborate these assertions, further chemical shift mapping involving 
both a new RNA sequence and increased salt concentration was utilised in conjunction with the 
assignments made in Section 3.3.2.  
3.3.4.1 Molecular characterisation of the binding of BHD to an unrelated RNA sequence  
To gain further insight into how BHD recognises different RNA sequences, binding to an unrelated 
RNA transcript, 12AG (AAGGGAAAGGAA), was tested by 1H-15N chemical shift mapping. This 
RNA is predicted to be unstructured, unlike BRE19nt which is predicted to form a hairpin loop. 15N-
HSQC spectra were acquired of BHD alone and with two molar equivalents of 12AG. These spectra 
are shown annotated with residue assignments and overlaid with BHD:BRE19nt spectrum in Figure 
3.7(A). Chemical shift changes upon RNA addition were quantitated using Equation 3.1, and plotted as 
a function of residue number. These spectra are shown overlaid with chemical shifts calculated for 
BHD:BRE19nt in Figure 3.8(A).  
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Chemical shift changes of BHD upon binding of 12AG were overwhelmingly in the same direction but 
of a lesser magnitude than the changes observed upon titration with BRE19nt, indicating that overall 
the interaction mode is likely to be very similar but that the interaction with 12AG is likely to be weaker 
in affinity and/or the resulting complex less well ordered. Overall, the mean chemical shift change, 
 
 
 
 
Figure 3.7. Overlay of 15N-HSQC spectra of in the presence and absence of RNA. 
(A) Overlay of 15N-HSQC spectra of BHD alone (blue), BHD with 2 molar equivalents of BRE19nt (cyan) and BHD 
with 2 molar equivalents of 12AG (magenta). Starting concentration of BHD was 200 µM, in 50 mM HEPES pH 
7.3, 50 mM KCl, 1 mM MgCl2, 1 mM TCEP. Spectra were recorded on an 800 MHz Bruker Avance III NMR 
spectrometer equipped with a cryoprobe (NS = 3 for protein alone and NS = 6, 1TD = 256) at 298 K. (B) Specific 
residues of interest; likely direction of change is indicated by arrows.  
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Δδmean, for 12AG was 0.035 ppm, compared to 0.051 ppm for BRE19nt. Signals in the BHD:12AG 15N-
HSQC spectrum were often more intense compared with the corresponding signals in the 15N-HSQC of 
 
 
 
 
Figure 3.8. 12AG versus BRE19nt induced chemical shift changes of BHD backbone amide residues.  
(A) Weighted chemical shift changes of BHD residues plotted as a function of residue number following the 
addition of 2 molar equivalents of 12AG (magenta) or BRE19nt (cyan). Horizontal dashed lines indicate the 
threshold level of significance at one standard deviation above the average chemical shift change. α-helices of BHD 
(when bound to DNA) are indicated above the graph, and are derived from the published structure of the BHD-
DNA complex (PDB: 1ZQ3).  (B) BHD with RNA-induced chemical shift changes for 12AG (left) and BRE19nt 
(right) mapped on to structure BHD (PDB:1ZQ3), colour coded by weighted average chemical shift (Δδ > 0.05 
ppm, red; 0.02 ppm ≤ Δδ ≤ 0.05 ppm, yellow; Δδ < 0.02 ppm, teal; residues not observed in unbound state, grey). 
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the BHD:BRE19nt complex, indicating that there is a difference in the nature of the exchange processes 
between the samples. 
It can be seen in Figure 3.8 that the regions of the domain that display the largest chemical shift changes 
are conserved between the 12AG and BRE19nt complexes, namely helix three and the loop between 
helices one and two. The biggest differences between the two complexes are observed for helix two, 
with no residues in this region in the 12AG complex displaying a chemical shift greater than 0.05 ppm. 
Helix two contains four leucine residues that contribute to the hydrophobic core of the domain [122], 
two of which display a shift change greater than 0.05 ppm upon formation of the BRE19nt complex. 
This may suggest that BHD does not undergo the same degree of conformational change or tightening 
up upon formation of a complex with 12AG as with BRE19nt.  
It is notable that although both R149 and I154 disappear with BRE19nt addition (implicating them in 
RNA binding), the observed changes for these residues were much less pronounced following treatment 
of BHD with 12AG. Both signals did undergo some chemical shift change (ΔδI154 = 0.058 ppm, ΔδR149 
= 0.047 ppm) but were still very intense (Figure 3.7(B), middle and right)). Further, Q155 in helix three 
is notable in that it displayed a greater shift for 12AG (ΔδQ155 = 0.081 ppm) than for BRE19nt 
(ΔδQ155 = 0.061 ppm) (Figure 3.7(B), left)). These differences are perhaps an indication that there may 
be some degree of flexibility in recognition mechanisms for different RNA sequences. 
3.3.4.2 Molecular characterisation of BHD:BRE19nt under physiological salt conditions 
In Chapter 2 it was shown that increasing the salt concentration in the binding buffer from 50 mM to 
150 mM increased the dissociation constant of the BHD and BRE19nt interaction from ~4 µM to 
~26 µM. This is a marked reduction in affinity and calls into question the biological relevance of the 
interaction, given that 150 mM salt is no higher than physiological concentration.  In order to gain 
further insight into the ionic strength dependence of the BHD:RNA interaction, 15N-HSQC spectra of 
BHD in the presence and absence of two molar equivalents of BRE19nt were acquired in 150 mM KCl. 
These spectra are shown in Figure 3.9(A).  
There were fewer amide signals in the protein alone spectrum in 150 mM salt compared to the spectrum 
recorded in 50 mM salt (38 versus 44, respectively), indicating that some signals have been lost due to 
line broadening. An increase in salt concentration reduces the strength of electrostatic interactions and 
may be altering the rate of dynamic exchange processes taking place within the protein. 
Signal changes upon RNA addition were modest compared with samples in 50 mM KCl; only a small 
number of signals shifted and no new signals appeared. Most of the residues that shift are hydrophobic, 
namely I154, L117, V141, F104 and I143. The chemical shift changes observed for non-hydrophobic 
residues were significantly smaller, with Q118, Q140, R149 and G119 displaying markedly reduced 
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shifted signals. This observed reduction in chemical shift changes is consistent with electrostatic shift 
 
 
 
Figure 3.9. 15N-HSQC spectral changes of BHD in the presence and absence of BRE19nt in 150 mM KCl. 
Overlay of 15N-HSQC spectra of BHD alone (blue) and BHD with 2 molar equivalents of BRE19nt (orange). 
Starting concentration of BHD was 300 µM, in 50 mM HEPES pH 7.3, 150 mM KCl, 1 mM MgCl2, 1 mM TCEP. 
Spectra were recorded on an 800 MHz Bruker Avance III NMR spectrometer equipped with a cryoprobe (NS = 3 
for protein alone and NS = 6, 1TD = 256) at 298 K. (B) 15N-HSQC 1H linewidths of BHD with (red) and without 
(blue) BRE19nt in 150 mM NaCl, plotted as a function of residue number. α-helices of BHD (bound to DNA) are 
indicated above the graph, and are derived from the published structure of the BHD-DNA complex (PDB: 1ZQ3). 
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changes. This observation is consistent with electrostatic attraction between BHD and BRE19nt 
constituting a major driving force for the interaction. 
Of note, there is both global and selective line broadening observed upon RNA addition. Linewidths 
were obtained in Sparky by integrating the signals, and plotted as a function of residue number, shown 
in Figure 3.9(B). These changes indicate that an interaction is definitely taking place between BHD and 
BRE19nt, albeit a substantially weaker one. 
 
3.4 Summary and Discussion 
This Chapter provides evidence that BHD is able to bind different RNA sequences in a primarily 
electrostatically driven manner. The backbone resonances of the domain were assigned using standard 
triple resonance NMR experiments, which facilitated the identification of residues that are likely to be 
involved in binding RNA. Overall, the regions of secondary structure of the domain used to recognise 
RNA appear to be the same as those in DNA recognition. BHD recognition of DNA involves the loop 
between helices one and two, the N-terminal arm and helix three. The data here show that this is also 
likely to be the case for RNA recognition. Helix three contains the most perturbed residues, presumably 
reflecting its role as the primary recognition helix, followed by the loop between helices one and two.  
Some residues were implicated in the binding of both RNA and DNA. However, given that some 
residues were unable to be assigned, future studies should aim to obtain more complete assignments of 
BHD in the RNA-bound state in order to make a full characterisation and comparison of the residues 
involved. If complete BHD assignments in the unbound state cannot be obtained through the trialling 
of different sample conditions such as a lowering of temperature, then assignment of BHD residues in 
the RNA-bound state should be carried out, achieved by acquiring triple resonance spectra of BHD 
bound to RNA.  
BHD was then shown to recognise a less chemically diverse RNA in a similar but weaker fashion. The 
ability of BHD to bind different RNA sequences, as well as the observation that ~30% of signals were 
missing in the BHD alone 15N-HSQC spectra, may be reflections of the conformational dynamics of 
this domain and the flexibility it displays in its nucleic acid binding interface [122, 198, 199]. The 
nuances observed in RNA recognition mechanisms by BHD might not manifest as large differences in 
in vitro affinities, but are likely to be significant if BHD does indeed bind RNA in vivo.  Further analysis, 
particularly solving structures of RBDs bound to different sequences, will contribute to a more 
comprehensive understanding of how RBPs recognise their biological targets in the presence of many 
‘decoy sequences’ in the cell. 
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Finally, the effects on binding affinity of BHD for RNA produced by an increase in salt concentration 
was observed at the residue level, manifesting as a marked reduction in chemical shift changes with less 
contribution from charged residues, providing corroborating evidence that this interaction is driven 
primarily by electrostatic attraction. Further, the substantial line broadening observed indicates that the 
salt ions are significantly altering the rate of exchange between BHD and RNA.  
Overall, these data provide more evidence that BHD is a promiscuous binder of RNA in vitro, however, 
the biological relevance of the observed RNA-binding of this domain remains unproven. Based on the 
data presented so far in this Thesis, it appears that BHD does not bind RNA in a specific manner in 
isolation. The next Chapter will consider the domain in the context of the full length protein in order to 
determine if there are other elements within the protein that might contribute to the biological RNA-
binding specificity of this domain.  
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Chapter 4: Further investigations into the RNA-binding capacity 
of bicoid 
4.1 Introduction 
Data presented previously in this Thesis suggest the possibility that bicoid requires elements outside 
the homeodomain that have not been considered so far in order to achieve biological specificity in its 
RNA-binding capability. This Chapter considers features of the full-length protein to determine if 
specificity might be provided in this manner. The role of potential dimerisation of bicoid is investigated 
using EMSA, and a putative RRM in bicoid is produced with the aim of assessing its RNA-binding 
potential in a similar manner. Finally, the potential role of intrinsic disorder and repetitive regions 
present in bicoid is analysed in the context of the recent scientific literature, and particular consideration 
is given to RBPs that are components of phase separated bodies and how this affects the in-vitro study 
of such molecules. 
 
4.2 Techniques used in this Chapter 
4.2.1 Cy5 labelled RNA EMSAs 
EMSAs were introduced in Section 2.2.1. Unlike the EMSAs presented in Chapter 2, however, the 
EMSAs described in this Chapter were carried out using fluorescently labelled RNA instead of 32P 
labelled RNA. The fluorophore label is Cy5; production of the labelled RNA involved an in-vitro 
transcription reaction in which a fraction of the total UTP (~10%) in the reaction is replaced by 5-[3-
aminoallyl]-2'-uridine-5'-triphosphate (aminoallyl UTP). Amine groups thereby incorporated into RNA 
transcripts are then reacted with amine-reactive Cy5.  
Given the relatively larger size of the Cy5 label compared with 32P, this technique is suited to longer 
RNA transcripts where the fraction of UTPs that incorporate a Cy5 label can be kept low, in order to 
reduce potential interference of the label with the RNA structure and/or binding of the RNA to partners.  
This Chapter uses an RNA Pentaprobe in EMSAs to assess RNA-binding potential. Pentaprobes are a 
set of twelve 100-nt RNA sequences that were designed to together encompass all possible five-base 
combinations, making them a tool for the rapid detection of potential RNA-binding capacity of proteins 
[213]. Given the effects of RNA secondary structure, Pentaprobes will not contain every five-base 
sequence in every structural context, but because RBPs can often bind suboptimal binding sites, there 
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is a high chance that most single-stranded RBPs will recognise one or more of the Pentaprobes. For 
example, the RRM of Fox-1 was shown to bind all twelve Pentaprobes [213]. 
 
4.3 Does bicoid homeodomain bind RNA as a dimer? 
As discussed in Section 1.2.4, there is ample evidence that the bicoid homeodomain is involved in cad 
translational silencing, but the only evidence that the domain alone binds cad with appreciable 
specificity is the EMSA published by Chan and Struhl (1997) [126], which is reproduced in Figure 4.1. 
This EMSA shows a tight interaction between GST-tagged bicoid homeodomain and the 343-nt BRE 
RNA (Kd of ~ 50 nM). Because GST is known to dimerise [214], it is therefore possible that this 
interaction comprises a dimer of the homeodomain bound to BRE.  
Supporting this possibility is evidence that bicoid binds DNA cooperatively in yeast and in vitro. It 
binds as a monomer to high affinity sites, and forms pairwise cooperative interactions once bound to 
DNA to recruit another bicoid molecule to a lower affinity site [215, 216] (Figure 4.2(A)). The 
homeodomain alone does not bind DNA cooperatively; however, the homeodomain is required for 
cooperative interactions, and the homeodomain residues S106, A124, S131, and K153 have been shown 
to be important for cooperativity. Binding isotherms for A124T, S131T, K153R and the wild type 
homeodomain with DNA containing either either three strong sites (SSS), two strong sites surrounding 
a weak site (SWS), or two strong sites with a non-binding spacer sequence (SXS) are shown in Figure 
4.2(A)) [216]. These residues involved in cooperativity are shown mapped onto the structure of BHD 
bound to DNA in Figure 4.2(B). Sequences flanking either side of the homeodomain are also required 
for DNA-binding cooperativity, likely to facilitate intermolecular bicoid interactions [217]. 
 
 
Figure 4.1. GST-BHD binds specifically to BRE. 
Radiolabelled BRE or Tubα1 3′-UTRs were incubated with different amounts of GST-BHD, with or without cold 
competitor RNAs as indicated, demonstrating that BHD binds BRE but not Tubα1. The highest quantity of 80 ng 
equates to ~200 nM GST-BHD. This data is taken from Chan and Struhl (1997). 
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In order to determine whether or not dimerisation of bicoid might be facilitating the high-affinity 
interaction between GST-BHD and BRE observed in Figure 4.1, GST-BHD was purified and tested for 
binding to the cad 3′-UTR by Cy5 labelled RNA EMSAs.  
4.3.1 Expression and purification of GST-BHD 
GST-BHD was expressed and purified in the same manner as for the cleaved protein in Section 2.3.1 
up to the GSH affinity purification step, at which point the stringency of the wash buffer and number 
of wash steps were increased in order to optimise the purity of GST-BHD. Elutions two to seven were 
pooled (Figure 4.3) and dialysed into EMSA buffer (20 mM HEPES pH 7.5, 50 mM KCl, 1 mM DTT) 
ready for use in EMSAs; ~1.2 mg of purified GST-BHD was obtained per litre of culture at >95% 
purity.  
4.3.2 Testing binding of GST-BHD to cad 3′-UTR 
In order to determine if GST-BHD binds the cad 3′-UTR with a greater affinity than BHD, EMSAs 
were carried out with GST-BHD and Cy5 labelled RNA. 
 
 
Figure 4.2. Bicoid binds to DNA cooperatively. 
(A) Binding isotherms (calculated from EMSA data) of bicoid homeodomain and mutants binding to either three 
strong sites (SSS), two strong sites surrounding a weak site (SWS), or two strong sites with a non-binding spacer 
sequence (SXS). This data, as well as beta-galactosidase activity assays that incorporated these binding sites into 
a lacZ reporter gene, indicate bicoid homeodomain cooperativity of binding, as well as a reduction of this 
cooperativity by the S106C, A124T, S131T and K153R mutants. These data were reported by Burz and Hanes 
(2001). (B) Expansion of the first part of the binding curves from (A). (C) The homeodomain residues involved in 
cooperativity are shown mapped on to the BHD structure bound to DNA (PDB: 1ZQ3). Binding residues are 
shown in yellow and cooperativity residues are shown in blue and numbered according positions in the full length 
protein.  
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A different approach to cad 3′-UTR production was taken in comparison to that presented in Chapter 2. 
This time the cad 3′-UTR was divided into three overlapping fragments (Figure 4.4(A)), named 
according to the number of nucleotides in each sequence. The reasons for this were twofold, and 
founded on discussion points raised in Section 2.5.2. Firstly, there were some concerns over obtaining 
a full length cad 3′-UTR from in-vitro transcription and purification methods, and there was no 
straightforward method by which to determine the size of this RNA, as is commonly done in non-
radiolabelled gels. RNA species of >800 nt in length could be too large to enter the pores of 
polyacrylamide gel matrices, and therefore it is possible that the full length cad 3′-UTR purified may 
have been a truncation. Secondly, given that there has been some uncertainty regarding the location of 
the specific target site within cad (see Section 1.2.4), if the bicoid homeodomain does indeed bind 
outside the BRE then these interactions may have been missed as all tested sequences (except for the 
full length 3′-UTR) were contained within the BRE. The sequences designed were: cad411, which 
contains most of the bicoid binding region defined by Rivera-Pomar et al. [87]; cad525, which contains 
the BRE; and cad186, which contains three repeats of an AU-rich element (AUUUA). AU-rich elements 
are sequence motifs that have been implicated in AU-mediated mRNA decay [218]. A small amount 
(~20 bases) of the 5′ end of the cad 3′-UTR was not included, due to primer design considerations.  
Internal Cy5 labelling of RNA was performed instead of the 32P labelling used in Chapter 2, as noted 
above. This procedure allowed the transcripts to be sized on a gel, and it is also a more practical labelling 
technique given that the RNAs can be stored for use for longer periods of time without the signal from 
the label deteriorating. Templates for transcription were amplified through the use of primers containing 
a T7 promoter with regions complementary to the relevant cad sequence, as per Chapter 2. Internal 
labelling of transcripts with Cy5 was achieved by incorporating amino allyl UTP (~1:10 molar ratio of 
 
 
 
Figure 4.3. Overexpression and affinity purification of GST-BHD. 
SDS-PAGE analysis of GST-BHD purification. Abbreviations: L, Mark 12 ladder; S, soluble fraction; F, flow 
through from GST-beads; W, wash steps (numbers as indicated); E, GSH elutions (numbers as indicated).  
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amino allyl UTP to normal UTP) in in-vitro run-off transcription reactions; the product was extracted, 
labelled with Cy5 and then purified using a PureLink® RNA Mini Kit. 
Binding of GST-BHD was tested to cad411, cad525 and cad186 by EMSA (Figure 4.4(B)). GST-BHD 
bound all probes similarly, with the majority of the bound complex failing to either migrate out of the 
wells or be resolved as distinct bands within the gel. Instead, protein-bound RNA was observed in the 
wells, or as smears indicative of binding in the gel. Despite using the same binding conditions as Chan 
and Struhl (1997) [126], their GST-BHD EMSA results were not able to be replicated here. Instead, 
GST-BHD binds cad RNA transcripts with a similar affinity to BHD as presented in Chapter 2.   
It is difficult to explain the inconsistencies between these results. Chan and Struhl (1997) expressed 
their homeodomain construct in E. coli as is the case here, although they did use a construct that encoded 
the 60 amino acid homeodomain plus three N-terminal amino acids (Met, Gly and Arg). The BHD 
 
 
 
Figure 4.4. EMSAs of GST-BHD with cad 3′-UTR sequences. 
(A) The 855-nt cad 3′-UTR was divided into three overlapping fragments, as indicated here. Numbers indicate 
length of RNA transcripts. (B) EMSAs demonstrating GST-BHD binding of cad411, cad525 and cad186. 
Increasing concentrations of GST-BHD were incubated with Cy5-labelled RNAs then resolved on a 6% 
polyacrylamide native gel. 
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construct used in this Thesis consists of the 60 amino acid homeodomain plus seven C-terminal amino 
acids added for solubility, as per Figure 2.2. Ubx was shown in Section 2.5.1 to have unstructured 
regions that increase the selectivity of its homeodomain for DNA. It is therefore possible, but perhaps 
unlikely, that the seven C-terminal amino acids contained in BHD have the effect of reducing the 
affinity of the domain for RNA. 
Chan and Struhl (1997) did not describe their method of RNA production in detail, besides noting that 
the RNA sequence contained the 343-nt BRE and was produced by in-vitro transcription. Unsuccessful 
attempts were made here to amplify just the BRE sequence as a template for in-vitro transcription. 
Failure to do so was likely attributable to suboptimal primer sequences.  
 
4.4 Bioinformatic analysis of bicoid 
The inability to reproduce the only published work that demonstrates specific binding of the bicoid 
homeodomain to cad calls into question the validity of this result. At this point, the possibility that in 
vivo specificity is provided by elements outside the homeodomain must be considered. The presence of 
extra specificity determinants outside the homeodomain does not contradict previous results that 
indicate bicoid-mediated regulation of cad is dependent on elements contained within the homeodomain 
[87, 105]. To examine the possibility that other protein features may affect specificity, a bioinformatic 
analysis of bicoid will be presented here.   
4.4.1 Sequence features of full length bicoid 
As mentioned in Section 1.2.2, bicoid is the product of a gene duplication event. Specifically, the 
homeobox gene Hox3 was duplicated in higher dipterans, resulting in the paralogs bicoid and zerkneullt 
(zen) [219]. In lower dipterans, the single Hox3 gene is closer in sequence to zen than bicoid. In D. 
melanogaster, the zen gene duplicated again, and therefore there are two zen genes. The homeodomain 
is the only region that displays high conservation overall, as shown in Figure 4.5. However, within the 
homeodomain there have been two key mutations that have been pivotal to bicoid acquiring both RNA-
binding capability (the M54R mutation) [123] and a change in DNA-binding specificity (the Q50K 
mutation) [220]. Despite the requirement of R54 for bicoid-mediated repression of cad translation 
[123], there still may be other elements outside of the homeodomain that are required for RNA target 
recognition. 
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Notably, bicoid has acquired two regions of low-complexity sequence: a histidine/proline repeat region 
at the N-terminus, and a glutamine/glycine repeat region C-terminal to the homeodomain (Figure 4.5). 
Low-complexity motifs are known to be enriched in both transcription factors and RBPs [221]. The 
high-throughput poly-A capture methods introduced in Section 1.1.2.2 have shown that mammalian 
mRNA-binding proteins (mRBPs) contain an overrepresentation of low-complexity, repetitive motifs 
[68, 69]. The same has also been shown recently for Drosophila, with glycine, glutamine and 
asparagine, in particular, shown to be common in repeat regions of RBPs [222, 223]. It is notable that 
bicoid was not detected as an RBP in either of these high-throughput RBP-ome studies in Drosophila. 
 
 
 
 
Figure 4.5. Sequence alignment of D. melanogaster proteins bicoid, zen1 and zen2.  
Conserved residues are shown in red, residues with strongly similar properties shown in cyan and residues with 
weakly similar properties shown in green. Q50K and M54R mutations, important in the evolution of DNA-binding 
specificity and RNA-binding capability respectively, are shaded grey. Low-complexity repeat regions are shaded 
yellow. The three α-helices, loop regions and terminal arms of the homedomain are mapped above the sequence in 
blue. Protein residue numbers are indicated on the right of each row. Alignment of sequences was done with Clustal 
Omega.  
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The roles of these low-complexity motifs are beginning, in some instances, to be elucidated. In certain 
cases, it appears that such repeat motifs can bind RNA directly. For example, RGG repeat motifs, 
introduced in Section 1.1.1.2, are a type of non-canonical RBD. Aside from directly mediating RNA 
contacts, low-complexity motifs are being increasingly implicated in RNP bodies [224]. These cellular 
bodies are a diverse group of membrane-less, phase-separated granules that are enriched in IDR 
containing RBPs and RNA, and will be discussed in further detail in Section 4.6. 
The second low-complexity region in bicoid is a ~60 residue glutamine-rich domain that is part of a 
longer ~80 amino acid stretch that is predicted to be prion-like by PLAAC, a hidden-Markov model 
that detects probable prion-like sequences [225] (Figure 4.6). Prion-like behaviour in proteins 
encompass a range of properties that involve self-templating conformational change [226]. Prion-like 
domains (PLDs) are also prevalent in paraspeckle (another type of phase-separated RNP complex) 
proteins [227], and the relevance of these domains to paraspeckle phase separation is just beginning to 
be elucidated. For example, the prion-like domains of RBM14 and FUS have been shown to be required 
for paraspeckle formation [228].  
 
 
 
Figure 4.6. The predicted PLD within bicoid maps to a region of disorder. 
The DISOPRED3 disorder prediction of bicoid is shown graphed in blue and the PLAAC prion-like domain 
prediction is shown in red. The threshold of 0.5 (indicated by a grey line) signifies that these amino acids are 
either likely to be disordered (blue) or part of a PLD (red). Low complexity sequences and putative RBDs of 
bicoid are indicated above the graph, as well as the amino acid sequence of the predicted PLD. Abbreviations: 
H/P, histidine/proline repeat region; HD, homeodomain; RRM, putative RNA-recognition motif (introduced in 
the next Section). 
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Both the bicoid PLD and the histidine/proline repeat map to regions of predicted disorder. Figure 4.6 
shows a disorder prediction made by the DISOPRED3 algorithm [229]. There is now ample evidence 
that divergent IDRs are not only associated with RNP granules as mentioned above, but are specifically 
involved in the assembly of these granules [224, 230-235], particularly poly-glutamine repeats [236-
238] and glutamine/asparagine rich sequences [239-241]. Further, both histidine repeats [242] and 
proline repeats [232] have been implicated in RNP granule formation. Therefore, it is possible that these 
predicted disordered regions in bicoid may be involved in the formation of some sort of phase-separated, 
bicoid-containing RNP complex.  
4.4.2 Bicoid contains a putative RRM 
RRMs were introduced in Section 1.1.2.1 as the most common RBD. The typical RRM fold, βαββαβ, 
with RNP-1 and RNP-2 motifs located on β-strands 3 and 1, respectively, is depicted in Figure 4.7(A). 
However, with only ~30% sequence conservation among RRMs [41] and the many different varieties 
of atypical domain folds [40], they are also possibly the most divergent RBD.  
 
 
 
 
 
Figure 4.7. Bicoid contains a putative RRM. 
(A) The typical RRM fold is depicted schematically with two α-helices packed against a four strand β-sheet; 
RNP-1 and RNP-2 consensus motifs are located on the two central β-strands. (B) The RNP-1 consensus motif is 
shown in comparison to the similar motif found in bicoid. (C) A range of secondary structure prediction tools (I-
TASSER, PredictProtein and PSIPRED) were utilised to predict the structure of residues 300 – 494 of bicoid. 
Arrows indicate predicted β-strands, and α-helices are indicated by curves.  
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This diversity in sequence and structures of RRMs has made the discovery of RRM variants 
complicated. Pairwise alignments of divergent RRM sequences have often proven insufficient to detect 
RRMs due to the highly varying nature of sequence and structural elements that are recognised in the 
domain [44]. As a result, several different methods have been used to identify potential RRMs. Initially, 
searches were based on conservation of the RNP-1 and RNP-2 motifs, but given the degeneracy and 
sometimes absence of these motifs, the criteria were broadened to consider domain topology [243], for 
instance by looking for the presence of conserved residues in positions relative to subdomains, such as 
hydrophobic core residues or loop residues [44]. Even today, search criteria for subclasses of RRMs are 
not well defined [244], and variant domains that fit into the broad category of RRMs continue to be 
discovered. For example, xRRMs, with an atypical βαββαββα fold and a unique RNA-binding 
mechanism, have recently been classified; these domains are likely to be present solely in La and 
LARP7 proteins that bind RNAPIII transcribed ncRNAs [245]. 
It was first postulated that bicoid contains an RRM at its C-terminus (see Figure 4.6) several decades 
ago [246], given similarity to an RRM consensus sequence that was devised through the alignment of 
known RRMs at the time, and subsequent observation of conserved amino acid properties in certain 
positions, allowing for conservative substitutions [247]. This consensus sequence is shown in Figure 
4.8 and is compared with some known RRMs; bicoid fits the consensus at 14 out of 32 highly conserved 
positions, and 10 out of 16 positions that are dictated by one or two specific residues. In particular, 
bicoid contains an eight-residue motif in this region that is similar to the RNP-1 motif (Figure 4.7(B)). 
A range of secondary structure prediction tools (I-TASSER [248], PredictProtein [249], and PSIPRED 
[229]) predict some secondary structure in this region of bicoid, as shown in Figure 4.7(C). The 
secondary structure elements predicted by these software programs, however, do not indicate a 
likelihood that this protein sequence forms enough secondary structure to form an RRM fold.  
The putative bicoid RRM (BRRM) does not readily appear to fit any current subclasses of RRMs based 
on primary sequence or predicted secondary structure. It may be that this region of bicoid constitutes a 
novel RRM. Alternatively, the domain may bind RNA without fitting the classification of an RRM, 
given that other proteins such as cold shock domains [250] and the bacteriophage protein T4gp32 [251] 
have the RNP-1 motif but not the RRM fold and have been shown to bind RNA. 
Despite its identification some decades ago, no published studies have reported on the structure or the 
RNA-binding properties of this region of bicoid; it was therefore decided to determine if this domain 
might play a role in forming the bicoid complex with the cad 3′-UTR. 
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4.5 Investigation of the RNA-binding properties of the putative RRM in 
bicoid 
4.5.1 Expression and purification of BRRM 
In order to ascertain the RNA-binding capacity of BRRM, recombinant protein production and 
purification was required. To assist in construct design, secondary structure elements were predicted by 
a variety of online tools, as shown in Figure 4.7(C) (for secondary structure prediction of the full length 
protein, see Appendix A.5). No reliable tertiary structures were predicted by I-TASSER [248], when 
various fragments of the C-terminal portion of bicoid were used as input (data not shown). The construct 
 
 
 
Figure 4.8. Comparison of conserved features of putative bicoid RRM with other RRMs.  
RRM consensus (shown above sequence alignment) devised by Query et al. (1989) through the alignment of 
RRMs and subsequent observation of conserved amino acid properties in certain positions, allowing for 
conservative substitutions. Blue indicates highly conserved positions, red indicates well conserved with the 
remainder being less well conserved, + indicates that bicoid conforms to the consensus (with residue positions 
shaded accordingly), single capital letters in the consensus header indicate a conserved amino acid based on 
standard single letter amino acid abbreviations, x indicates that there is no consensus feature for that position. All 
RRMs are from Drosophila except for U1-70K which is from human. The conserved RNP-1 octapeptide is 
outlined in a box.  
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was designed to include all predicted secondary structural elements in this region of the protein, with 
eight N-terminal residues in addition to the consensus sequence (Figure 4.9). BRRM was cloned from 
full-length bicoid contained in the vector pET16b, provided by Michalis Averof of Institut de 
Génomique Fonctionnelle de Lyon (IGFL), into pGEX-6P. BRRM was thus expressed as a GST fusion, 
and then cleaved from the GST tag with HRV-3C to yield a 127 amino acid protein.  
Expression of the recombinant protein in E. coli Rosetta(DE3)pLysS cells resulted in a large amount of 
soluble protein, which was purified by GSH affinity purification. The recombinant GST-fusion protein 
appeared to run as two different bands on an SDS-PAGE, as seen in Figure 4.10. 
GSH elutions one to six were pooled, and the GST tag was cleaved efficiently by HRV-3C 
(Figure 4.11(A)). The resulting cleaved protein was purified by sizing exclusion chromatography on a 
 
 
 
 
 
 
Figure 4.9. Amino acid sequence of BRRM produced to test RNA-binding. 
The 127 amino acid recombinant protein comprises residues 378 to 494 of the 494 amino-acid protein bicoid. This 
construct contains residues 387 to 473, which is the sequence that bears resemblance to an RRM, plus an extra eight 
N-terminal residues and 21 extra C-terminal residues highlighted in green. An N-terminal glycine (purple) will 
remain following HRV-3C cleavage.  
 
 
 
 
 
Figure 4.10. Overexpression and affinity purification of GST-BRRM.  
SDS-PAGE analysis of GST-BRRM overexpression and affinity purification. Abbreviations: L, Mark 12 ladder; 
S, soluble fraction; F, flow through from GST beads; W, wash; E, GSH elutions, numbers as indicated. 
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Superdex 75 column. BRRM contains no tryptophan residues, and therefore has a low extinction 
coefficient of 4470 M-1 cm-1. As a result, the protein did not appear as a clear peak on the size exclusion 
chromatograms. Analysis of chromatography fractions showed that BRRM elutes directly after the GST 
tag (Figure 4.11(B)). The protein runs as quite a diffuse band on SDS-PAGE, running close to its 
theoretical molecular weight of 13.2 kDa.  
Fractions 47 to 51 were pooled and concentrated. Around 700 µg of protein was obtained per litre of 
culture at >95% purity, judging by bands on SDS-PAGE (Figure 4.11). A 1D 1H NMR spectrum of the 
protein (Figure 4.12) indicated this protein does not appear to form a stable, well-folded domain.  
 
 
 
 
 
Figure 4.11. Size exclusion chromatography and SDS-PAGE analysis of BRRM. 
(A) SDS-PAGEs of the selected size exclusion chromatography fractions. Abbreviations: L, Mark 12 ladder; C, 
HRV-3C cleavage of pooled GSH elutions; F, size exclusion chromatography fractions, numbers as indicated. 
(B) Size exclusion chromatography elution profile. Fractions taken for SDS-PAGE are indicated above the 
chromatogram.  
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Binding of BRRM to RNA was tested despite the fact that the domain was not highly ordered, given 
the presence of the peptide sequence very similar to the RNA-binding RNP-1 motif (Figure 4.7(B)), 
which alone might display RNA-binding capability. Further, given the remarkable demonstrations 
concerning the role of disorder in RBPs in recent years (see Section 4.4), it was possible that either (a) 
this domain might bind RNA without taking up a well-defined fold in the unbound state or (b) that it 
might fold upon binding, into an RRM (or another) fold. By way of example, a ~500 residue disordered 
basic domain of the microtubule scaffolding protein APC has been shown to bind mRNA [252]. 
Additionally, there are many examples of intrinsically disordered proteins that fold upon binding [253]. 
Indeed, disorder to order transitions have been observed in some RBPs upon binding RNA [172]. This 
has even been seen for certain secondary structural elements in RRMs (albeit not the whole domain); 
for example, an additional α-helix 3 of the RRM from the splicing factor Snu17p only folds upon ternary 
complex formation [254]. 
4.5.2  Testing binding of BRRM to cad 3′-UTR and Pentaprobes 
In order to determine if BRRM displays any RNA-binding capacity, Cy5 labelled RNA was made by 
in-vitro transcription as described in Section 4.3.2. Binding of BRRM was tested to cad411, cad525, 
cad186 as well as Pentaprobe 7 (PP7) by EMSA. A Pentaprobe was included in addition to cad 3′-UTR 
sequences in order to increase the diversity of RNA sequences tested. BHD was used as a positive 
control. 
No substantial binding of BRRM to any of the tested RNA sequences was seen (Figure 4.13). There is 
a faint shifted band observed for the cad411 probe, but given that it is only a minor shift at the highest 
concentration of 15 µM, the interaction is very weak. BHD, consistent with its behaviour in the 
 
 
 
 
Figure 4.12. 1D 1H NMR spectrum of BRRM. 
The amide (left) and methyl (right) proton region of 200 µM BRRM in 20 mM sodium phosphate and 1 mM DTT 
at 298K.  
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preceding sections of this Thesis, bound all sequences to a similar extent. It might be that BRRM 
requires extra N-terminal amino acids in order to fold properly. Nevertheless, these results demonstrate 
that the RNP-1 motif in bicoid is unlikely to bind RNA in the context of the isolated domain. 
 
 
 
 
 
Figure 4.13. EMSAs of BRRM with cad 3′-UTR fragments and PP7. 
EMSAs of BRRM and BHD binding to cad411, cad525, cad186 and PP7. Increasing concentrations of BRRM 
(right) and BHD (left) were incubated with Cy5-labelled RNAs then resolved on a 6% polyacrylamide native gel. 
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4.6 Phase-separated RNP granules 
In the final part of this Chapter, the possible role of disordered regions of bicoid (Section 4.4.1) in the 
formation of phase-separated RNP granules is discussed.  
It is notable that phase-separated RNP bodies are prevalent in Drosophila development [255]. Thus, 
30% (143 of 476) of all mRBPs identified in the early fly embryo were also found in RNA granules in 
Drosophila S2 cells [222]. Even bicoid mRNA itself is known to form phase-separated bodies during 
development together with the RBP Staufen, localising the mRNA to the anterior pole [256]. 
Dimerisation of bicoid mRNA is required for Staufen recognition, which probably involves structural 
read out of the RNA by multiple dsRBMs of Staufen [257]. Another characterised example is that of 
the Drosophila protein Bruno, which binds to Bruno recognition elements within the oskar 3′-UTR, and 
this can result in oligomerisation of oskar mRNA into large, translationally silenced RNP particles 
[258].  
Indeed, it appears that translational silencing often occurs in phase separated bodies; characterised 
examples of mRNP silencing granules in eukaryotic cells include P-bodies [259, 260], GW-bodies 
[261], stress granules [262] and germ granules [263]. Translation repression and the formation of phase 
separated RNP bodies may even be directly coupled in some instances, as demonstrated by the ability 
of the DDX6-4-ET complex to effect both de-novo P-body assembly and miRNA-dependent translation 
repression [264].  
The prevalence and variety of these RNP granules that have been discovered recently in biology is 
changing the way some RNA-protein complexes need to be studied, and fundamentally changing our 
understanding of how proteins and RNA function in the cell. Therefore, a brief analysis of recent 
biochemical research involving RNP granules will be given here.  
4.6.1 What do we know about RNP granules? 
RNP granules are an assortment of membrane-less, phase-separated granules that are enriched in IDR 
containing RBPs and RNA. These granules, which are found in eukaryotic cells, act as liquid or 
hydrogel droplets that are capable of distortion, budding and fusion [265]. Phase separation is thought 
to be driven by the large-scale effects of weak, multivalent interactions [232], primarily by highly 
dynamic interactions between RBDs, IDRs and low-complexity regions within proteins, and modulated 
through interactions with RNA [233]. This type of network of interactions is depicted in Figure 4.14(B), 
and shown in contrast to a monomeric RNP complex in which one protein molecule is complexed with 
RNA via multiple RBDs and disordered regions (Figure 4.14(A)).  
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A variety of common cellular RNP granules are depicted in Figure 4.14(C). The largest RNP granule is 
the nucleolus, which forms around regions of ribosomal DNA in chromosomes and organises protein 
translation machinery [266]. The nucleolus has been shown to consist of multiple phase-separated sub-
compartments with unique properties; fibrillar centres are located inside dense fibrillar components 
which are contained within the less dense granular component [267]. Cajal bodies are another common 
type of RNP granule, forming on regions of active snRNA loci and likely functioning to assemble 
spliceosomal snRNPs [268]. Other nuclear bodies include speckles and paraspeckles which both contain 
mRBPs, mRNA and lncRNAs, and display distinct, granular morphologies. Nuclear speckles are foci 
that contain mRNA production and processing factors [269], and paraspeckles are thought to be 
involved in the retention of certain RNA species and transcription factors within the nucleus [270, 271]. 
Cytoplasmic bodies include stress granules [272], and P-bodies, two different types of mRNA silencing 
granules [273, 274].  
The formation of these structures appears in general to be reversible. Under in vitro conditions, 
temperature, salt concentration, post translational modifications and RNA-binding capacity all can 
affect granule formation, leading to suggestions that the formation and disassembly of structures is 
functionally regulated [234, 275-277]. 
 
 
 
Figure 4.14. Phase separated RNP bodies. 
(A) A typical monomeric RNP complex with one protein bound to an RNA molecule through multiple RBDs and 
an IDR that becomes ordered on binding. (B) A phase-separated RNP complex consisting of a variety of RNA 
species and proteins with multiple RBDs and IDRs. Multivalent interactions, which can be dynamic and transitory, 
and involve low complexity sequences, drive RNP granule formation. Protein is shown in green and RNA in black. 
(C) Representation of some common nuclear and cytoplasmic RNP granules. Descriptions of these bodies are 
contained in the text.  
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Both RBDs and IDRs are important in granule formation. The presence of both have been shown to be 
required for RNA-induced granule formation in the cases of hnRNPA1 (stress granules) [234] and Whi3 
(microorganism RNP body protein) [238]. In some instances, the specific role of these protein domains 
has been elucidated. For example, the low-complexity R/G domain of FIB1 has been shown to drive 
phase separation of the dense fibrillar components of nucleoli, and, whilst not required for droplet 
formation, the RBD of FIB1 (RNA methyltransferase domain (MD)) prevents mixing of the fibrillary 
component and the granular component [267].  
General rules for RNP granule assembly are still lacking. However, the latest evidence suggests that 
multivalent interactions between low-complexity sequences, RBDs and RNA likely create scaffolds for 
the formation of granules, which can then exchange lower-valency binding partners (that is, components 
with a lesser number of potential binding sites) on free scaffold binding sites [278].  
Specific amino acids are enriched in the low-complexity regions that are involved in phase separation, 
namely glycine, glutamine, asparagine, tyrosine, serine, glutamic acid, aspartic acid and phenylalanine 
[241]. Brangwynne et al. (2015) propose in their analysis of recent data that there is a ‘hierarchical 
interplay’ of interactions that result in the formation of these bodies. That is, there are long-range 
electrostatic interactions that are supplemented by short-range, directional dipolar interactions between 
glycine, glutamine, glutamic acid, asparagine and serine, or cation-π interactions between the positively 
charged arginine and the aromatic sidechains of phenylalanine and tyrosine [241].  
How RNP granules regulate their composition is also not well understood in most cases [234, 235]. 
There is some evidence, however, that low-complexity motifs can target proteins to granules; for 
instance the progressive mutation of [G/S]Y[G/S] motifs in FUS resulted in reduced recruitment of the 
protein to stress granules [279]. 
A recent study elegantly highlighted how RNP germ granules can form according to the interplay of 
RNA and RBP concentration gradients. All sexually reproducing organisms contain germ granules 
within their germ cells, and these granules appear to function broadly in post-transcriptional control of 
gene expression [263]. P-granules in C. elegans are a well-studied type of germ granule. They are named 
due to their posterior localisation that materialises over repeated cell divisions during zygotic 
development (notwithstanding their role in zygotic development, they are classified as germ granules 
as they are passed directly from mother to daughter). The primarily disordered RBP MEG-3 has no 
known RBDs and is required for P-granule formation in embryos. The protein phase-separates in vitro 
in a concentration dependent manner (at micromolar concentrations) and this behaviour is stimulated 
by RNA (Figure 4.15(A)). Another RBP, MEX-5, contains two RNA-binding zinc fingers and 
competitively binds RNA that is required for this phase transition, thereby inhibiting granule formation. 
In vivo, MEX-5 is localised at high concentration at the anterior end of the zygote, blocking granule 
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formation at this end of the cell. RNAi-mediated depletion of LET-711 (a scaffolding component of the 
primary mRNA deadenylase that functions during early development) prevents mRNA turnover, 
resulting in the formation of MEG-3 granules extending further into the anterior end of the zygote [280] 
(Figure 4.15(B)).  
Both MEG-3 and MEX-5 display little RNA-binding specificity in vitro [280, 281], and specificity 
determinants dictating which mRNAs are bound by these proteins have not been identified.  
4.6.2 Bicoid might repress cad in an RNP translationally silenced granule 
Given the presence of the low-complexity sequences in bicoid detailed in Section 4.4.1, and the 
prevalence of translationally silenced mRNP granules [282] it seems possible that bicoid might repress 
cad in a phase-separated granule.  
Supporting this possibility is new evidence that bicoid binding events in the nucleus occur in localised 
hubs, as visualised by single molecule fluorescence in developing embryos (Figure 4.16) [283]. In the 
posterior region of the embryo where bicoid concentration is low, the majority of bicoid binding events 
are localised to these foci. This heterogeneous spatial distribution of bicoid binding events in the nucleus 
involves another protein, Zelda, which contains a high proportion of low-complexity sequence, 
including multiple stretches of glutamine repeats. The authors surmise that these foci, by creating high 
local concentrations of bicoid, enable regulation of bicoid target genes at posterior locations where the 
overall concentration of bicoid is very low (~2 nM). The molecular details of bicoid foci formation are 
not known, however the process may involve a change in chromatin state given that both bicoid and 
 
 
 
 
Figure 4.15. Germ granules can form according to the interplay of RNA and RBP gradients. 
(A) The RBP MEG-3 forms phase-separated droplets (orange) in vitro at micromolar concentrations, and this 
separation is stimulated by RNA and inhibited by MEX-5. (B) Schematic of developing zygotes. MEX-5 is at a 
high concentration at the anterior end of the zygote (MEX-5 concentration is indicated by cyan shading) and 
competes for binding to mRNA with MEG-3. In normal zygotes, MEG-3 granules (orange) form only at the 
posterior pole of the zygote (left schematic). When mRNA turnover is blocked, MEG-3 granule formation spreads 
into the anterior end of the zygote (right schematic). 
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Zelda have been previously shown to increase chromatin accessibility [284]. In the case of bicoid, this 
capacity to increase chromatin accessibility requires the presence of the C-terminal portion of the 
protein that includes the predicted PLD and the putative RRM. Moreover, given the high proportion of 
low-complexity sequence in Zelda, it is foreseeable that these foci might involve multivalent, protein-
protein interactions between disordered segments in bicoid and Zelda. Indeed, it has recently been 
proposed that the cooperativity in binding interactions that phase separation can elicit might be a crucial 
factor in transcriptional gene regulation [285]. 
The sequestration of non-translating mRNAs in phase-separated P-bodies is pivotal in Drosophila 
development [286-288]. How proteins and RNAs are targeted to P-bodies is not well understood, 
however aggregation prone poly-glutamine and glutamine/asparagine rich domains are believed to play 
a role in P-body localisation and assembly given the prevalence of such sequences in P-body 
components such as Edc3, Lsm4 and GW182 [240].  
Interestingly, P-bodies have been reported to contain RISC components such as Ago2 [289, 290], and 
therefore bicoid may be associated with P-bodies because Ago2 has been shown to genetically interact 
with bicoid, and miRNAs have been implicated in bicoid mediated repression of cad (both detailed in 
Section 1.2.5). Ago2 in Drosophila, as well as in many other invertebrates, contains a long poly-
glutamine repeat region at its N-terminus [291]. The localisation of RISC components as well as the 
mRNA degradation machinery such as the deadenylase CCR4-NOT complex and decapping enzymes 
within P-bodies may increase the efficiency of translation inhibition due to the increased local 
 
 
 
Figure 4.16. Distribution of bicoid binding events in normal and Zelda- mutants in the nucleus. 
Representative data for the distribution of nuclear bicoid binding events in normal and Zelda-null (ZLD-) embryos, 
visualised using single molecule fluorescence of eGFP-tagged bicoid. The length of the bar represents 2.5 µM. 
The image in this Figure is taken from Mir et al. (2017).  
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concentration of required components. It may be that bicoid, through its low-complexity domains, 
targets cad to repressive bodies such as P-bodies. 
Alternatively, a repressive RNP granule specific to the bicoid:cad interaction might form, with 
contributions from other disordered proteins similar to Zelda (involved in the formation of bicoid 
nuclear foci, introduced above). More generally, given the overrepresentation of low-complexity 
sequences in RBPs, it might be that phase separation is a common strategy for the repression of 
particular mRNAs and that these phase-separated granules have been below the limit of detection by 
microscopes.  
Such spatial regulation may be particularly important to Drosophila during development, firstly, 
because the Drosophila embryo is a syncytium (consisting of many nuclei that exist in the shared 
cytoplasm and are not segregated by individual cell membranes), and secondly, because there is a high 
concentration of both maternally deposited and zygotic mRNAs, the expression of which is required to 
be tightly regulated in space and time. Accordingly, the further division of the syncytial cytoplasm into 
non-membrane bound partitions may be an essential feature of the embryo. For example, removing non-
translating mRNA species from the bulk cytosol might result in increased translation efficiency by 
lowering the concentration of binding partners that can compete for limiting translation machinery.  
In order to explore this possibility, existing in situ immunofluorescence data of bicoid and cad in 
Drosophila embryos in the scientific literature were examined, because RNP granules can sometimes 
be observed as distinct foci using this technique. The bicoid and cad protein gradients in an early stage 
Drosophila embryo are shown in Figure 4.17, in work by Rivera-Pomar et al. (1996) [87]. The green, 
spherical cad-containing bodies are syncytial nuclei. Cad is a transcription factor and is therefore found 
in the nucleus. Bicoid, being a transcription and translation factor, is found in both the nucleus and 
 
 
 
Figure 4.17. Bicoid and cad protein gradients in the early Drosophila embryo. 
Anti-cad and anti-bicoid monoclonal antibodies were used to visualise the overlapping bicoid (red) and cad (green) 
gradients in the developing Drosophila embryo. Bicoid localisation is diffuse due to its presence in the cytoplasm 
as well as nuclei of the embryo, but no indication of phase separation is visualised. The image in this Figure is 
taken from Rivera-Pomar et al. (1996).  
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cytoplasm, and as a result is not localised to distinct spherical nuclei like cad; its distribution is more 
diffuse.  
No clear evidence that bicoid forms RNP granules with cad was found in the literature. Given, however, 
the high spatiotemporal variability in protein and RNA distribution in the Drosophila embryo due to 
the complexity of embryonic gene regulation, in-vitro and in-situ experiments that test specifically for 
the phase separation of bicoid with cad will be required to more rigorously assess this possibility.  
4.6.3 Specificity in RNP granules?  
Determining specificity in phase-separated bodies is unchartered territory. Current determinants of 
specificity that have, by and large, served well for more well-defined, conventional macromolecular 
assemblies will likely need to be reassessed in mixed-phase cell biology.  
Weak, multivalent binding drives droplet formation, as discussed above. This means that RBP:RNA 
interactions that have traditionally been classed as weak may be acting in aggregate to elicit phase 
compartmentalisation of the cell to establish localised, dynamic environments. For example, the IDR 
of the mRNA decapping protein Edc3 has been shown to have micromolar affinity for RNA and this 
interaction is sufficient to induce phase separation [292]. It is therefore possible that the prevalence of 
RNP granules goes some way to explaining the commonly observed weak binding in RNA:protein 
complexes [39]. If bicoid does indeed inhibit cad in phase-separated granules in the cytoplasm, this 
may rationalise the weak in-vitro affinity of BHD for RNA observed in this Thesis (Kd of BHD and 
BRE19nt ~3.8 µM, Section 2.3.4).  
Moreover, RNP granules result in a high concentration of a particular subset of proteins and RNAs in a 
restricted area, with binding partners often at a much higher concentration than their dissociation 
constants [266]. Therefore, granule formation constitutes a type of spatial regulation of the cell which 
can foreseeably effect functional specificity in intermolecular interactions. Indeed, localised high 
concentrations of reactants can increase the kinetics of reactions. For example, mathematical modelling 
based on available empirical data have shown that the localisation of U4 and U6 snRNP components in 
Cajal bodies increases the rate of snRNP assembly by at least an order of magnitude [293].  
The research presented in this Section highlights that there is much more biophysical analysis needed 
to define the kinetics and thermodynamics covering the formation and maintenance of RNP granules. 
This will involve determining the repertoire of macromolecules involved in phase separated bodies and 
measurement of the constituent interactions. Further, we will require a better understanding of how the 
compositions of these bodies are regulated, as well as the rules dictating interactions under what are 
quite different physiochemical conditions.  
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4.7 Summary 
This Chapter investigated whether dimerisation of the bicoid homeodomain might be responsible for 
achieving RNA-binding specificity, but no increase in affinity of GST-tagged BHD was seen for RNA. 
A putative RRM in bicoid was investigated and produced, but this protein domain was not folded and 
little RNA-binding activity was detected. A bioinformatic analysis of full-length bicoid was presented, 
with a focus on low-complexity, disordered regions present in the protein. The potential role of these 
domains in the RNA-binding functionality of bicoid was discussed in the context of the latest research 
on RNP phase-separated bodies. Finally, the implications of phase separation to functional and 
biological specificity was considered, highlighting a need for innovative biochemistry research that will 
inform the reassessment of specificity determinants in these poorly understood cellular conditions.  
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Chapter 5: Investigation of AA-repeat RNA-binding by the 
transcription elongation factors Spt4 and Spt5 
5.1 Introduction 
As introduced in Chapter 1, Spt4/5NGN from Saccharomyces cerevisiae has been described by our 
collaborators (Alice Vrielink’s laboratory at the University of Western Australia) to bind in a sequence 
specific manner to ssRNA containing one or more repeats of the dinucleotide AA. Given these data, it 
was decided to characterise the structural basis for this interaction in order to ultimately further 
understand the important role that the Spt4/5 heterodimer plays in transcription.  
To summarise the results presented in Chapter 1, SELEX was performed on Spt4/55K and the 
heterodimer was observed to enrich AA-repeat RNA. The sequence preference of Spt4/55K for AA-
repeat RNA was confirmed through EMSAs and MST. The conserved core of the heterodimer, 
Spt4/5NGN, was observed to bind AA-repeat RNA with a similar affinity to Spt4/55K, and MST assays 
demonstrated that Spt4/5NGN could also bind shorter RNA oligonucleotides with one, two and four AA 
repeats (Figure 5.1). 
 
 
 
 
Figure 5.1. Spt4/5NGN binds AA-repeat RNA. 
(A) MST assays of Spt4/5NGN binding to RNA with varying numbers of AA-repeats. Increasing concentrations 
of Spt4/5NGN were incubated with fluorescently labelled RNA then resolved on a 6% polyacrylamide gel. 
Binding isotherms were fitted using the Hill method. Data were acquired by Amanda Blythe. (B) Sequences 
of RNAs tested. (C) Domain arrangements of Spt4/5 constructs.  
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This Chapter describes the use of NMR spectroscopy and EMSAs to investigate and characterise the 
molecular underpinnings of the AA-repeat RNA-binding of Spt4/5NGN.  
 
5.2 Techniques used in this Chapter 
5.2.1 NMR spectroscopy 
This Chapter employs both 2D and 3D NMR methods, which were introduced in Section 3.2.1 as tools 
that can be used to identify residues involved in binding events. These techniques are used with the 
same aim in this Chapter. Some brief coverage of theoretical concepts relevant to the application of 
these techniques in this Chapter will be given here.  
5.2.1.1 Sources of line broadening in NMR 
The nuclear magnetisation that gives rise to an NMR signal decays with time, a process known as 
relaxation (one particular form of relaxation – so-called transverse relaxation – is most relevant to line 
broadening effects). This decay process results in a loss of signal intensity and, in general terms, the 
more rapid the relaxation is, the broader the NMR signals are in the resulting spectrum. Therefore, 
slower relaxation rates are desirable for good quality NMR spectra. There are many factors that affect 
the relaxation properties of nuclei, but when analysing changes in spectral appearance due to a binding 
event, line broadening due to two different scenarios is usually considered.  
The first of these is line broadening caused by chemical exchange processes, introduced in Section 
3.2.1.1. For a nucleus undergoing a chemical exchange process (whether it is folding-unfolding, 
binding, or simply conformational dynamics), the question of whether the nucleus appears as a single 
signal or as two (or more) discrete signals is dictated by the difference in the rate of exchange between 
the different forms (kex), and by the chemical shift of each of these states (Δω). The observed effects of 
exchange processes on NMR spectra fall on a continuum defined by the limits of fast (kex >> Δω) and 
slow (kex << Δω) exchange, where either one or two signals is/are observed per nucleus, respectively. 
Intermediate exchange lies in the middle of these two extremes (kex ~ Δω), and often results in signals 
failing to be resolved due to broadened signal lines. The signals obtained for each of these exchange 
regimes are depicted in Figure 5.2.  
The other main binding-induced source of line broadening arises from slower molecular tumbling, a 
common occurrence when a multimer or biomolecular complex is substantially larger than the 
monomer/unbound protein. Generally, the tumbling time of a molecule increases with molecular 
weight, but it is also dependent on shape. Broadly speaking, the magnetised spins of molecules that 
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tumble more slowly have a higher susceptibility to the transient local magnetic fields as the relatively  
slower movement means that the two are aligned longer. This means that phase coherence of magnetised 
spins of nuclei are lost more quickly. Therefore, transverse relaxation is more efficient for molecular 
systems with a slower tumbling time, resulting in broader signals.  
In general, slower molecular tumbling will affect all signals. In contrast, in the case of chemical 
exchange, ∆ω varies amongst nuclei within a protein, and therefore the line broadening effects will be 
different for different signals in the NMR spectrum. 
5.2.2 MST 
MST was introduced in Section 2.2.2 as a recently developed technique to quantify biomolecular 
binding interactions. This Chapter presents MST data acquired by collaborators of the Mackay 
Laboratory that initiated this study. Some good quality sample MST data are shown in Figure 2.1, 
demonstrating smooth thermophoresis curves with good signal-to-noise ratio; these data yielded a 
sigmoidal binding curve and are indicative of a simple 1:1 binding event. Another important 
requirement for good quality MST data that is not illustrated in sample data in Figure 2.1 is the 
requirement that the fluorescence in each capillary (which contains the same concentration of the 
fluorescently tagged partner with different concentrations of the untagged partner), before the 
temperature gradient is established, be within 10% of each other. Figure 5.3 shows some pre-MST 
fluorescence data that fit this requirement. If these initial fluorescence intensities are not within 10% of 
 
 
 
 
Figure 5.2. NMR chemical exchange regimes. 
NMR chemical exchange regimes fit in to three broad categories. Fast exchange, where kex >> Δω, results in one 
signal at a weighted-average frequency. Slow exchange, where kex << Δω, results in a separate signal for each 
populated state. In between these two states, where kex ~ Δω, line broadening results in a regime intermediate to 
these two extremes and an inability to resolve signals. 
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each other, a test involving protein denaturation by sodium dodecyl sulfate (SDS) is required in order 
to rule out loss of the fluorescent molecule due to aggregation. If the change in fluorescence is due to a 
binding event (which is acceptable for good data) this can be confirmed through denaturation of the 
protein with SDS as this will disrupt interactions between the protein and binding partner and restore 
fluorescence. Alternatively, if aggregation is responsible, fluorescence will not be restored as these 
aggregates are removed during centrifugation prior to the addition of SDS. In this case, experimental 
conditions need to be optimised in order to eliminate aggregation. 
 
5.3 Investigation of sequence specific binding of Spt4/5NGN to AA-repeat 
RNA 
5.3.1 Expression and purification of Spt4/5NGN 
The production of soluble Saccharomyces cerevisiae Spt4/5NGN in bacteria is not straightforward. An 
effective system was established by Amanda Blythe from the Vrielink laboratory, whereby soluble 
protein was obtained through the co-expression of a His6-ubiquitin Spt5 fusion in the vector pHUE with 
untagged Spt4 in the vector pETM11 [294]. pHUE-Spt5NGN was engineered to incorporate a TEV 
cleavage site by Jason Low in the Mackay laboratory because it was suspected that there was a bacterial 
protease that was cleaving the ubiquitin tag and decreasing yields.  
 
 
 
 
Figure 5.3. Fluorescence prior to heat gradient establishment in MST. 
Good quality MST data require that the fluorescence intensity in each capillary prior to establishment of the 
MST temperature gradient be within 10% of each other. If they are not, an SDS-test needs to be done in order 
to determine the nature of the protein dependent loss in fluorescence. 
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For NMR experiments, 15N and 15N/13C labelled heterodimer was expressed in minimal media 
containing 15NH4Cl or 15NH4Cl and 13C-D-glucose respectively (see Section 7.2.2.4). For EMSAs, 
unlabelled protein was expressed as per Section 7.2.2.3.  
Co-expression of Spt4/5NGN in E. coli Rosetta(DE3)pLysS cells resulted in modest soluble protein 
yields, judging from the SDS-PAGE bands observed following purification by nickel affinity 
chromatography (Figure 5.4). Curiously, Spt4 runs as a double band when the β-mercaptoethanol 
concentration is above ~ 10 mM [294].  
Elutions one to eight (Figure 5.4) were pooled and the His6-Ubq tag was cleaved by the addition of TEV 
protease. This step required deviation from Amanda Blythe’s optimised protocol as TEV protease failed 
to cleave in 0.5 M imidazole (unlike the Usp2cc deubiquitinase used in the original protocol). 
Substantial optimisation was necessary as dialysis of the pooled elutions to reduce the imidazole 
concentration prior to cleavage resulted in precipitation of Spt4/5NGN. The use of a desalting column 
avoided precipitation however concentration of the subsequently diluted protein solution to 
concentrations of ~50 µM resulted in up to 50% loss of protein due to binding to the centrifugal filter 
membrane. Low yields of high purity were obtained by size exclusion chromatography; ~500 µg per 
litre of culture at close to 100% purity (Figure 5.5(A&B)). 
 
Another strategy that was trialled involved using a lower concentration of imidazole in the elution buffer 
(0.2 M instead of 0.5 M). A higher TEV concentration was however required to get the same level of 
cleavage which resulted in poor separation of Spt4/5NGN from the TEV enzyme during size exclusion 
 
 
Figure 5.4. Overexpression and affinity purification of His-Ubq-Spt5NGN and Spt4. 
SDS-PAGE analysis of Overexpression and affinity purification of His-Ubq-Spt5NGN and Spt4. Abbreviations: 
L, Mark 12 ladder; S, soluble fraction; F, flow through from nickel beads; W, wash from nickel beads; E, 
imidazole elutions, numbers as indicated.  
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and consequently resulted in yields of ~1 mg per litre of culture at around 90% purity (Figure 
5.5(A&C)).  
Overall, Spt4/5NGN was poorly behaved. There was significant batch to batch variation in protein 
behaviour, resulting in varying yields. The proteins often precipitated at one or more of several steps 
throughout the purification, and had to be kept in at least 150 mM KCl. Protein behaviour deteriorated 
with isotopic labelling (15N/13C Spt4/5NGN being the most poorly behaved); batches were therefore 
scaled up accordingly to increase protein yields. 
 
 
 
 
 
Figure 5.5. Size exclusion chromatography and SDS-PAGE analysis of Spt4/5NGN. 
(A) Size exclusion chromatography elution profiles of Spt4/5NGN. The blue trace was from a preparation using a 
desalting column to dilute the imidazole, and the red trace was from a preparation using a reduced imidazole 
concentration of 0.2 M in elution buffer. Fractions taken for SDS-PAGE are indicated above chromatogram, 
with correspondence to each trace indicated by colouring. (B) SDS-PAGE analysis of the selected size exclusion 
chromatography fractions from the desalting column purification technique (blue). Abbreviations: L, Mark 12 
ladder; C, TEV cleavage of pooled His6-Ubq-Spt4/5NGN elutions; CC, cleavage solution of pooled His6-Ubq-
Spt4/5NGN elutions, concentrated to 5 mL for size exclusion chromatography; F, size exclusion chromatography 
fractions, numbers as indicated. (C) SDS-PAGE analysis of the selected size exclusion chromatography fractions 
from the reduced imidazole concentration purification technique (red). Abbreviations: L, Mark 12 ladder; F, size 
exclusion chromatography fractions, numbers as indicated. 
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5.3.2 15N-HSQC analysis of Spt4/5NGN binding to AA-repeat RNA 
NMR spectroscopy was used to characterise the RNA-binding properties of Spt4/5NGN. This technique 
excels at characterising the molecular details of binding interactions, because individual residues can 
be identified in the spectra and their response to the addition of the binding partner can be directly 
observed. The first goal of this analysis was to collect 15N-HSQC spectra of Spt4/5NGN and to assign the 
spectrum both in the absence and presence of AA-repeat RNA in order to identify the complement of 
residues involved in binding.  
Recombinant 15N-labelled Spt4/5NGN was overexpressed and purified as per Section 5.3.1 and 15N-
HSQC spectra were acquired with Spt4/5NGN alone and in the presence of RNA.  
The initial spectrum of Spt4/5NGN (Figure 5.6(A)) shows approximately 90% of the expected number of 
signals (~164/183). This spectrum closely resembles 15N-HSQC spectra previously acquired by 
Amanda Blythe (data not shown), indicating that the fold of the protein is essentially unaltered by the 
change in the purification protocol. The line shapes look reasonable given the experimental conditions 
(only ~50 µM protein, and a relatively high salt concentration of 150 mM KCl) and for a heterodimer 
of this size (21.6 kDa). The signals are widely dispersed, consistent with a structure containing 
significant amounts of β-sheet. This is in agreement with the known structure of the heterodimer (see 
structure in Figure 1.12(B)). A degree of variation in signal intensity is, however, observed (shown 
plotted for each residue Figure 5.6(B)), suggesting the presence of a conformational exchange process. 
Initially, an RNA oligonucleotide with the sequence AACCAA (T2AA) was selected for binding 
analysis. This was 4-nt shorter than the 2AA sequence previously tested by Amanda Blythe, and was 
designed to minimise the length of the RNA oligonucleotide. Shorter oligonucleotides are preferred if 
possible because, as discussed in Section 5.2.1.1, larger molecules have a longer tumbling time which 
results in signal broadening and consequently a reduction in both sensitivity and resolution. 15N-HSQC 
spectra of Spt4/5NGN alone and with T2AA RNA were acquired and are shown in Figure 5.7. 
Unexpectedly, no substantial changes were observed upon RNA addition indicating that Spt4/5NGN does 
not bind AACCAA RNA with an appreciable affinity. This sequence was designed based on the 
hypothesis that a double AA motif might be the minimal Spt4/5NGN binding sequence; one possible 
explanation for the lack of binding observed in the 15N-HSQC experiment is that the AACCAA repeat 
alone is insufficient for binding and that Spt4/5NGN may require sequence flanking the AA-repeats in 
order to bind. Given that MST binding data indicates that Spt4/5NGN binds a six nucleotide sequence 
with one AA-repeat (1AA) with an affinity of 16 µM (Figure 5.1(A)), the oligonucleotide 1AA was 
next tested by NMR for its ability to bind the heterodimer. 15N-HSQC spectra of Spt4/5NGN alone and 
with 1AA RNA were acquired and are shown in Figure 5.8. 
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Figure 5.6. 15N-HSQC spectrum of Spt4/5NGN in 150 mM KCl. 
(A) 15N-HSQC spectrum of 50 µM Spt4/5NGN alone. Spectrum was recorded at 298 K in 50 mM sodium 
phosphate, 150 mM KCl, 1 mM MgCl2, 10 mM β-mercaptoethanol, pH 7.4. (B) Plot of relative intensity for 
each signal. Peaks are numbered by Sparky according to positions as they are unassigned at this point. Peak 
heights were obtained from Sparky.  
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Again, no signal changes were seen upon addition of 1AA RNA to Spt4/5NGN. Assuming that the protein 
and RNA in this assay have been accurately quantified, this rules out any binding with a dissociation 
constant of around 100 µM or stronger. Examination of the MST data for the interaction with this 
oligonucleotide (Figure 5.1(A)) shows that a complete MST curve for Spt4/5NGN:1AA was not obtained. 
It is possible that the fitted dissociation constant of 16 µM is inaccurate, but even if it was 10-fold 
weaker, changes would still be expected in the HSQC spectrum under the conditions used here. As a 
next step, 4AA was tested for binding to Spt4/5NGN, given that more AA-repeats should strengthen the 
affinity of the interaction. Again however, no signal changes were seen upon the addition of 2.5 molar 
equivalents of 4AA RNA (Figure 5.9). 
Finally, the 24-nt AArich – the full sequence obtained from SELEX enrichment, was tested for binding 
to Spt4/5NGN. This is the only RNA sequence for which there is both EMSA and MST binding data, 
with a clearly shifted band visible in EMSAs (Figure 1.12(D)). Whilst less favourable for structural 
 
 
 
 
Figure 5.7. Overlay of 15N-HSQC spectra of Spt4/5NGN with and without T2AA RNA in 150 mM KCl. 
Overlay of 15N-HSQC spectra of Spt4/5NGN alone (red), Spt4/5NGN with 1.5 molar equivalents of T2AA RNA, 
offset slightly for clarity (blue). Starting concentration of Spt4/5NGN was ~50 µM, in 50 mM sodium phosphate, 
150 mM KCl, 1 mM MgCl2, 10 mM β-mercaptoethanol, pH 7.4. Spectra were recorded at 298K. 
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studies due to the size of the RNA, binding was tested via NMR in order to try to reconcile the current 
and previously acquired data. 
The first time binding was assessed to AArich, the protein precipitated upon RNA addition, suggesting 
an interaction between Spt4/5NGN and AArich. In an effort to circumvent the precipitation issue, the 
binding buffer was changed to 50 mM MOPS (instead of 50 mM sodium phosphate or HEPES, which 
had been trialled previously), and the protein was added to the RNA instead of the reverse. This time, 
substantial changes in the HSQC spectrum were observed, with 71 of the ~220 signals disappearing 
(Figure 5.10(A)). No new signals were observed.  
The intensity of each peak was measured in Sparky by integrating with Gaussian fitting to obtain fit 
heights. The differences between relative peak intensities in the bound and unbound state are shown in 
Figure 5.10(B). It can be seen that there is considerable variation between peak intensities, both within 
 
 
 
 
 
Figure 5.8. Overlay of 15N-HSQC spectra of Spt4/5NGN with and without 1AA RNA in 150 mM KCl. 
Overlay of 15N-HSQC spectra of Spt4/5NGN alone (red), Spt4/5NGN with 1 molar equivalent of 1AA RNA, offset 
slightly (blue). Starting concentration of Spt4/5NGN was ~60 µM, in 50 mM HEPES, 150 mM KCl, 1 mM MgCl2, 
1 mM TCEP, pH 7.4. Spectra were recorded at 298K.  
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and across the two samples. On the whole, peaks that are present in the bound state are less intense than 
the same peak in the unbound state, as expected. 
This experiment was repeated once more and a similar pattern of spectral change was observed (Figure 
5.11).  
The failure to observe new signals could be due to either an intermediate exchange regime or a slower 
molecular tumbling time of the complex. These concepts were introduced in Section 5.2.1.1; both 
scenarios result in line broadening but via different mechanisms. To reiterate, an intermediate exchange 
regime describes the situation where differences in signal frequencies between the bound and unbound 
state is similar to the exchange rate between the two states. Such situations are common for interactions 
with dissociation constants in the micromolar range. The EMSA data for Spt4/5NGN also indicates that 
there may be more than one heterodimer bound due to multiple shifted bands (Figure 1.12(D)), in which 
case multiple chemical exchange events would be taking place at the same time. In addition, the protein-
RNA complex has a larger molecular weight than the protein alone and signal broadening resulting  
 
 
 
 
Figure 5.9. Overlay of 15N-HSQC spectra of Spt4/5NGN with and without 4AA RNA in 150 mM KCl. 
Overlay of 15N-HSQC spectra of Spt4/5NGN alone (red), Spt4/5NGN with 2.5 molar equivalents of 4AA RNA, offset 
slightly (blue). Starting concentration of Spt4/5NGN was ~65 µM, in 50 mM sodium phosphate, 150 mM KCl, 
1 mM MgCl2, 10 mM β-mercaptoethanol, pH 7.4. Spectra were recorded at 298K.  
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scenarios result in line broadening but via different mechanisms. To reiterate, an intermediate exchange   
 
 
 
 
Figure 5.10. Overlay of 15N-HSQC spectra of Spt4/5NGN with and without AArich RNA in 150 mM KCl. 
(A) Overlay of 15N-HSQC spectra of Spt4/5NGN alone (red), Spt4/5NGN with 3 molar equivalents of AArich RNA 
(blue). Starting concentration of Spt4/5NGN was 50 µM, in 50 mM MOPS, 150 mM KCl, 1 mM MgCl2, 1 mM 
TCEP, pH 7.4 buffer. Spectra were recorded at 298K. (B) Plot of intensity for each signal: Spt4/5NGN alone (cyan), 
Spt4/5NGN + AArich (pink). Fit heights were obtained in Sparky by integrating with Gaussian fitting. Peaks are 
numbered by Sparky according to positions as they are unassigned at this point. 
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from slower molecular tumbling will also contribute to drops in signal intensity across the spectrum. In 
this situation, flexible (disordered) regions of the protein can retain sharp lines as they can effectively 
reorient (tumble) faster than the whole molecule by undergoing local motions. 
5.3.3 Reconciling 15N-HSQC spectra with MST data 
The 15N-HSQC spectrum for Spt4/5NGN shows substantial signal changes only for the 24-nt RNA 
sequence which was enriched in SELEX; no binding to any of the shorter AA-repeat RNA sequences 
was observed, which is in contrast to the MST data presented in Figure 1.12.  
Upon closer inspection of the MST data, it can be seen that the change in thermophoresis for AArich is 
at least five-fold bigger than the shorter RNA sequences (Figure 5.12(A)). MST guidelines stipulate 
that there needs to be a minimum change in thermophoresis between the bound and the unbound state  
 
 
 
 
Figure 5.11. Overlay of 15N-HSQC spectra of Spt4/5NGN with and without AArich RNA in 150 mM KCl. 
Repeat of 15N-HSQC spectra Spt4/5NGN with (red) and without 3 molar equivalents of AArich (blue). Starting 
concentration of Spt4/5NGN was 50 µM, in 50 mM MOPS, 150 mM KCl, 1 mM MgCl2, 1 mM TCEP, pH 7.4 buffer. 
Spectra were recorded at 298K. 
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of more than five units to obtain reliable data. For 1AA, 2AA and 4AA the change in thermophoresis 
is 10-18 units, but it should be noted that complete binding curves were not obtained. In contrast, the 
change in thermophoresis for AArich is over 100 units.  
Examination of the fluorescence signals before the establishment of the MST heat gradient reveals 
protein dependent loss in fluorescence for 1AA, 2AA and 4AA, and in contrast, an enhancement of 
fluorescence for AArich (Figure 5.13). The enhancement in fluorescence is consistent with Spt4/5NGN gel 
shifts with AArich, where there is a marked increase in the fluorescence of the shifted band compared to 
the probe alone (Figure 1.12(D)).  
In MST, the concentration of the fluorescently labelled RNA should be equal for each titration point 
per sample and thus, as outlined above, variation in fluorescence prior to the establishment of the heat 
gradient should be within 10% for good quality data (as outlined in Section 5.2.2). A protein dependent 
reduction in fluorescence prior to heat gradient formation suggests material loss of the fluorescent 
        
              
 
 
 
Figure 5.12. MST data of Spt4/5NGN with AA-repeat RNA. 
(A) MST curves of ubiquitin-tagged Spt4/5NGN with 1AA, 2AA, 4AA and AArich fluorescently labelled RNA 
oligonucleotides and ubiquitin with fluorescently labelled AArich. Data points represent the average from three 
independent titrations. (B) The same MST curves of Spt4/5NGNUbq with 1AA, 2AA and 4AA as in (A) this time 
plotted without AArich. Data points represent the average from three independent titrations. Data were acquired by 
Amanda Blythe.  
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molecule due to aggregation or adsorption. Because the SDS test described above has not been carried 
out for these oligonucleotides, it therefore is possible that the binding data presented for 1AA, 2AA and 
4AA constitute false positive results. At the very least, there is clearly a difference in behaviour in the 
MST experiments between Spt4/5NGN with the shorter AA-repeat RNAs and AArich. 
Given the 15N-HSQC spectra presented above look very similar to spectra of Spt4/5NGN acquired by 
Amanda Blythe, it is reasonable to assume that the protein is behaving similarly under both the MST 
and NMR conditions. 
Differences in experimental conditions for the MST and NMR experiments may have contributed to 
the contradictory data. Spt4/5NGN is His6-ubiquitin tagged in the MST assays. Ubiquitin only controls 
were carried out with AArich in order to rule out the tag contributing to RNA-binding. Ubiquitin alone 
does elicit some small change in thermophoresis upon addition to the labelled oligonucleotide; this 
change is around seven units at the highest ubiquitin concentration, which is very similar to the change 
seen for Spt4/5NGN with 1AA that is shown in Figure 5.12(B). Additionally, the RNA utilised in MST 
is fluorescein labelled. The fluorescein tag is relatively hydrophobic and so the possibility exists for a 
non-specific interaction to take place between the tag and the protein.  
     
                                    
 
 
Figure 5.13. Pre-thermophoretic fluorescence of Spt4/5NGN with AA-repeat RNA. 
Fluorescence from ubiquitin-tagged Spt4/5NGN MST data prior to establishment of the heat gradient for AA-repeat 
RNA as indicated. 1AA, 2AA and 4AA all exhibit a loss in fluorescence with increasing protein concentration. In 
contrast, there is a protein dependent enhancement in fluorescence seen for AArich. Fluorescence is shown in 
arbitrary units (A.U.). 
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The existence of EMSA, MST and 15N-HSQC data that show binding of Spt4/5NGN to AArich provides a 
significant level of confidence that this interaction is real. In contrast, the MST data for Spt4/5NGN 
binding to 1AA, 2AA and 4AA is of poorer quality due to the small changes in thermophoresis 
(<20 units), the incomplete binding curves obtained, the unverified nature of the protein dependent loss 
of fluorescence and, perhaps most clearly, the lack of an observed interaction in the 15N-HSQC 
experiments presented in this Chapter. 
Another possible explanation is that AArich is forming some sort of transient secondary structure that 
Spt4/5NGN recognises. Most RNA secondary structure prediction tools, including RNAfold, are based 
on canonical Watson-Crick (A:U and G:C) and Wobble (G:U) base pairs, however, non-canonical base 
pairing is commonly observed in RNA structures [295, 296]. Moreover, non-canonical base pairing has 
been shown to be important for more accurate detection of RNA structural motifs [297] and to give 
better inference of RNA structure from sequence [298]. MC-fold, an RNA structure prediction tool that 
takes into account non-canonical base pairing, indicates that AArich may potentially sample a variety of 
transient secondary structures [298]. It is therefore possible that Spt4/5NGN requires some structural 
elements of AArich that do not form in any of the truncated sequences tested.  
5.3.4 Investigation of binding determinants for Spt4/5NGN and AArich RNA by NMR 
The data presented in this Chapter so far indicate that Spt4/5NGN binds AArich RNA but not shortened 
AA-repeat RNA sequences. In order to determine which elements of the RNA are required for binding, 
further HSQC spectra were acquired of the proteins in the presence of truncated versions of AArich.  
AArich was first divided into two overlapping 13-nt halves, 1HAArich and 2HAArich (Figure 5.14(A)), and 
15N-HSQC spectra were acquired in the presence and absence of these RNA sequences. No binding was 
seen to either sequence (Figure 5.14(B&C)). Next, three bases were trimmed off the 5′ end and two 
bases trimmed off the 3′ end (TrimAArich), and perhaps surprisingly, no binding was seen to this 
sequence either (Figure 5.14(D)).  
These results suggest the possibility that the RNA-binding to Spt4/5NGN might require the formation of 
structure that can only be formed by AArich and not by any of the shorter sequences. However, AArich is 
predicted to be unstructured by a variety of RNA structure prediction tools, such as RNAfold [83]. If 
AArich is indeed unstructured, it is surprising that we cannot observe any binding at all – even at reduced 
affinity - of Spt4/5NGN to the truncated AArich sequences. The size of the Spt4/5NGN heterodimer suggests 
that it is unlikely to require the full 24-nt of RNA for binding if the RNA is not structured. A possible 
explanation is that Spt4/5NGN binds AArich cooperatively as a dimer of heterodimers, and requires the 
entirety of (or close to) the AArich sequence in order to do so, or just that both sets of terminal bases are 
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required together. However, there is no evidence currently that the Spt4/5 heterodimer forms a 2:2 
tetramer. 
                                                 
 
 
 
 
 
 
Figure 5.14. Overlays of 15N-HSQC spectra of Spt4/5NGN with and without AArich derived RNA 
oligonucleotides in 150 mM KCl. 
(A) Sequences of AArich derived RNAs tested for binding to Spt4/5NGN. (B) Overlay of 15N-HSQC spectra of 
Spt4/5NGN alone (red), Spt4/5NGN with 4.5 molar equivalents of 1HAArich RNA (blue). Starting concentration 
of Spt4/5NGN was 40 µM, in 50 mM MOPS, 150 mM KCl, 1 mM MgCl2, 1 mM TCEP, pH 7.4. Spectra were 
recorded at 298K. (C) Figure on the next page - overlay of 15N-HSQC spectra of Spt4/5NGN alone (red), 
Spt4/5NGN with 4.5 molar equivalents of 2HAArich RNA (blue). Starting concentration of Spt4/5NGN was 40 µM, 
in 50 mM MOPS, 150 mM KCl, 1 mM MgCl2, 1 mM TCEP, pH 7.4. Spectra were recorded at 298K. (D) Figure 
on the next page - overlay of 15N-HSQC spectra of Spt4/5NGN alone (red), Spt4/5NGN with 2 molar equivalents 
of TrimAArich RNA (blue). Starting concentration of Spt4/5NGN was 80 µM, in 50 mM MOPS, 150 mM KCl, 
1 mM MgCl2, 1 mM TCEP, pH 7.4. Spectra were recorded at 298K. 
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5.3.5 Investigation of binding determinants for Spt4/5NGN and AArich RNA by EMSA 
In order to determine what elements of AArich are required for binding, Spt4/5NGN was tested for binding 
to a series of mutants of AArich (Figure 5.15(A)). AA5 is designed to test whether the three 5′-nt are 
required, whereas A4 through to A1 progressively replaces AA-repeats with CC repeats.  
Spt4/5NGN was expressed and purified as per Section 5.3.1. Internal labelling of RNA transcripts with 
32P was carried out using 32P UTP in in-vitro run off transcription reactions, followed by PAGE 
purification, as detailed in Section 7.2.4.5. Templates for transcription consisted of annealed 
oligonucleotides containing a T7 promoter.  
Binding of Spt4/5NGN to AArich and mutated sequences was tested via EMSA as shown in Figure 5.15(B-
D). There was no discernible difference in behaviour for any of the sequences. At high protein 
concentration and without the presence of heparin (a non-specific negatively charged competitor), the 
RNA fails to move out of the wells, indicating that whatever complex is forming is insoluble and/or too 
large to enter the wells (Figure 5.15(B)). Heparin was then added to a concentration of 0.03 mg/mL, in 
line with Amanda Blythe’s EMSA data, and this abrogated binding completely (Figure 5.15(C)). The 
heparin concentration was reduced to 0.01 mg/ml (Figure 5.14(D)), which lessened some of the 
complex formation in the wells but a clearly shifted band is still not observed, in contrast to Amanda 
Blythe’s data for AArich that are shown in Figure 1.12(D)). There is, however, loss of the free RNA and 
concentration-dependent smearing that is indicative of binding. The pattern of smearing is similar for 
all oligonucleotides. 
The experiment was repeated, this time to include two control sequences that Spt4/5NGN is not expected 
to bind, GGrich and TrimAArich. 15N-HSQC data presented in Figure 5.14(D) failed to detect an 
interaction between Spt4/5NGN and TrimAArich. Similarly, Amanda Blythe’s data shows Spt4/55K does 
not bind GGrich, by either EMSA or MST analysis (Figure 1.13(A&B)). 
As shown in Figure 5.16, Spt4/5NGN interacts with all RNA sequences tested in an analogous manner. 
In this instance, the acrylamide concentration of the gel was increased from 6% as in Figure 5.15 to 9% 
and electrophoresis was run for an extra hour in order to try to get better resolution. However, once 
again, no clearly shifted band was visualised for Spt4/5NGN with AArich. Unexpectedly, the RNA probes 
for GGrich and TrimAArich shift from resolved bands to smears with increasing Spt4/5NGN concentration, 
indistinguishable from the pattern with AArich. 
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Figure 5.15. EMSAs aimed at determining sequence elements required for Spt4/5NGN binding of AArich. 
(A) Sequences of RNA transcripts made by 32-P in-vitro transcription to test binding to Spt4/5NGN. AA-repeats are 
underlined, and mutations are indicated in red. (B) EMSAs of Spt4/5NGN and AArich and AA5, AA4 and AA3 with 
no heparin. Increasing concentrations of Spt4/5NGN were incubated with 32P-labelled transcripts then resolved on a 
6% polyacrylamide native gel. (C) EMSAs of Spt4/5NGN and AArich and AA5 through AA1 with 0.03 mg/ml 
heparin. Increasing concentrations of Spt4/5NGN were incubated with 32P-labelled transcripts then resolved on a 6% 
polyacrylamide native gel. (D) EMSAs of Spt4/5NGN and AArich and AA5 through AA1 with 0.01 mg/ml heparin. 
Increasing concentrations of Spt4/5NGN were incubated with 32P-labelled transcripts then resolved on a 6% 
polyacrylamide native gel. 
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Discrepancies between the EMSA data detailed in this Section and Amanda Blythe’s EMSA data 
presented in Figure 1.12 can perhaps be explained by the protein construct used. Spt4/5NGN is ubiquitin 
tagged in Figure 1.13, which helps to keep the protein soluble. In contrast, the data presented in this 
Section utilises untagged protein, which has always been observed to precipitate at salt concentrations 
less than 150 mM. Binding conditions for these EMSAs included 150 mM salt, however no salt was 
contained in the gel or running buffer as this would cause too high a current to achieve electrophoretic 
motion of the protein and RNA. Therefore, it is likely that Spt4/5NGN becomes insoluble when loaded 
on to the gel. This scenario could result in RNA being caught up with the insoluble protein non-
specifically due to electrostatic attraction.  
It is also possible that TrimAArich has some extra bases from in-vitro transcription, which might explain 
the different results observed between the MST results in this Section and the NMR binding analysis in 
Figure 5.14(D), which contained TrimAArich that was purchased as chemically synthesised RNA-
oligonucleotides.  
Nevertheless, failure to resolve a shifted band of untagged Spt4/5NGN with AArich, compared with Ubq-
Spt4/5NGN, which demonstrates clearly shifted bands in the gel (Figure 1.12(D)), means that EMSAs of 
untagged Spt4/5NGN must be deemed a poor technique for binding analysis due to the unfavourable 
experimental conditions. 
                                                 
 
 
 
Figure 5.16. Further EMSAs aimed at determining sequence elements required for Spt4/5NGN binding of 
AArich.  
EMSAs of Spt4/5NGN and AArich and AA5, AA3 and AA1 with no heparin. Increasing concentrations of Spt4/5NGN 
were incubated with 32P-labelled transcripts then resolved on a 9% polyacrylamide native gel. 
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5.3.6 Analysis of Spt4/5NGN RNA-binding specificity 
Data presented in this Chapter indicate that Spt4/5NGN binds AArich RNA. The length of the RNA appears 
to be important given that no chemical shift changes were observed upon addition of TrimAArich, an 
oligonucleotide that has three and two bases trimmed off the 5′ and 3′ termini, respectively.  
At this stage, it is unclear whether Spt4/5NGN interacts with GGrich as this oligonucleotide was not tested 
by NMR. Certainly, it seems that Spt4/55K does not interact with GGrich based on the EMSA and MST 
data presented in Figure 1.12. In regards to Spt4/5NGN, however; a mixture of this polypeptide with 
GGrich does exhibit an increase in fluorescence at higher protein concentrations in the MST experiment 
prior to the establishment of the temperature gradient (Figure 5.17(A)). This is similar to what is seen 
for AArich, however the enhancement of fluorescence for GGrich is smaller in magnitude than that seen 
for AArich. The increase in pre-MST fluorescence for the Spt4/5NGN:AArich mixture is around 1.8 fold 
increase, whereas for Spt4/5NGN:GGrich it is 1.5 fold increase. Curiously, in the case of GGrich, there is 
initially a decrease in fluorescence of the type seen for 1AA, 2AA and 4AA (Figure 5.13) with 
increasing Spt4/5NGN concentration, then at [Spt4/5NGN] >1 µM fluorescence is enhanced. AArich 
exhibits little change in fluorescence until [Spt4/5NGN] >1 µM after which there is an enhancement of 
fluorescence.  
There is not, however, the marked change in thermophoresis for GGrich as seen for AArich 
(Figure 5.17(B)). For Spt4/5NGN:GGrich, the Δthermophoresis changes direction from an increase in 
                                 
 
 
Figure 5.17. MST data for Spt4/5NGN with AArich and GGrich. 
(A) Pre-thermophoretic fluorescence of Spt4/5NGN protein with GGrich and AArich as indicated. Fluorescence is 
shown in arbitrary units (A.U.). (B) Thermophoresis curves for Spt4/5NGN with AArich and GGrich. Data points 
represent the average from three independent titrations. Data were acquired by Amanda Blythe. 
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thermophoresis for 1 µM ≤ [Spt4/5NGN] ≤ 10 µM to a decrease in thermophoresis for 
[Spt4/5NGN] > 10 µM. This behaviour is indicative of multiple events occurring. It is possible that 
multiple binding events are occurring for Spt4/5NGN:AArich as well but they are masked by the same 
directional change in thermophoresis. This is hinted at by the shape of the MST curve seen in 
Figure 5.17(B), which is steeper than a sigmoidal curve generated by a 1:1 binding event. 
Multiple binding events between Spt4/5NGN and AArich are also indicated by the MST data presented in 
Figure 1.12(D). Here we see multiple shifted bands, and the shifted bands display a lower 
electrophoretic mobility than the Spt4/55K:AArich band, indicating that that the species formed between 
Spt4/5NGN and AArich may be larger than that of Spt4/55K and AArich.  
5.3.7 Spt4/5NGN triple resonance data sets 
The RNA-binding behaviour exhibited by Spt4/5NGN is somewhat unusual. It is difficult to explain the 
nature of ~30% 15N-HSQC signals disappearing upon AArich addition, with no signal changes observed 
when binding was tested to any of the other AA-repeat sequences tested.  
With the aim of resolving some of the unanswered questions about the RNA-binding properties of 
Spt4/5NGN, resonance assignments of the protein backbone residues were sought using 3D NMR 
methods, as described for BHD in Section 3.3.2. With assignments in hand, the molecular details of the 
interaction could begin to be addressed. This required the production of 13C/15N-labelled protein 
(Section 7.2.2.4), which was unfortunately very poorly behaved. Individual batches were scaled up to 
three litres in order to compensate for poor behaviour and solubility; however protein concentrations 
only around 150 µM were obtained. Double labelled protein was expressed three times, with the 
following data sets collected over the three batches; HNCA, HNCO, HN(CO)CA, HNCACB and 
CBCACONH (Table 5.1). Each sample was subjected to spectral acquisition for around a week given 
the low protein concentration.  
Unfortunately, these experiments did not yield data sets of sufficient quality to assign the backbone 
residues of Spt4/5NGN (Table 5.1). HNCO, HN(CO)CA and HNCA gave the most complete data sets 
with 80-100% of the expected peaks observed (Figure 5.18(A)). These are typically the most sensitive 
of the triple resonance experiments. The HNCACB and CBCA(CO)NH datasets, on the other hand, had 
low levels of completeness (44% and 47% respectively) and were therefore not able to be used.  
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Sample strips for HNCACB, CBCA(CO)NH, HNCA and HN(CO)CA are shown in Figure 5.18(B). 
These strips illustrate two problematic features of the data sets which prevented the sequential 
assignment of Spt4/5NGN backbone residues. Firstly, due to the relatively large size of the protein by 
NMR standards (21.6 kDa), there is substantial signal overlap which makes the task of distinguishing 
signals very difficult. An example of signal overlap is demonstrated in the upper strips of 
Figure 5.18(B). Secondly, signal intensity for HNCACB and CBCA(CO)NH spectra was usually poor, 
and often expected signals were not present (expected signals not observed are indicated by empty 
squares in upper and lower strips of Figure 5.18(B)).  
The inability to obtain more complete data sets was due to inadequate protein concentration, coupled 
with the low signal-to-noise ratio. Additionally, as mentioned above, the lack of resolution in parts of 
the spectra due to a large number of signals in these areas further complicates assignment.  
The diminishing signal-to-noise returns that are available with longer spectrometer experiment time, 
coupled with the likelihood of protein degradation, means that this strategy is unlikely to yield spectra 
of sufficient quality to sequentially assign the backbone residues of Spt4/5NGN.  
In order to improve the quality of the spectra, the next logical step is to produce perdeuterated, triple 
labelled protein (2H/15N/13C Spt4/5NGN). The use of deuterium labelling can achieve narrower linewidths 
by reducing the relaxation of the nuclei and therefore increase signal-to-noise in the spectra. It is costly 
to produce triple labelled, perdeuterated protein, and an application to have the protein made by the 
Australian Nuclear Science and Technology Organisation (ANTSO) was submitted and approved. Due 
to problems encountered by ANSTO with the transformation of BL21 cells with the pETM11-Spt4 and  
Table 5.1. Triple resonance data sets acquired of Spt4/5NGN and their completeness. The expected number of 
peaks was calculated from the number of relevant peaks in the HSQC. As there were more peaks in the HSQC 
compared with the number of expected peaks based on the heterodimer sequence (225 compared with 183) it is 
likely that the extra peaks are due to contamination or slow exchange processes. 
 
 
 
 
Experiment Number of scans
Expected number       
of peaks
Observed number       
of peaks
Completeness (%)
HNCA 144 225 176 78
HN(CO)CA 144 225 243 100
HNCO 48 225 268 100
HNCACB 88 900 399 44
CBCA(CO)NH 176 450 213 47
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Figure 5.18. Spt4/5NGN triple resonance spectra. 
(A) Schematics illustrating the magnetisation transfer steps for each spectrum (indicated by arrows) and atoms 
which give rise to an NMR signal (shaded).  (B) HNCACB, CBCA(CO)NH, HNCA and HN(CO)CA strips shown 
for two nitrogen planes (upper, 118.5 ppm; lower, 110.1 ppm). Dotted lines join the same signal in different spectra, 
and squares indicate where signals are missing. 
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pHUE-Spt5NGN plasmids, a significant delay was encountered and the protein was unfortunately unable 
to be produced before the writing of this Thesis. 
 
5.4 Summary and Discussion 
The data presented in this Chapter provides evidence that Spt4/5NGN binds AA-repeat RNA that is longer 
than 19-nt. NMR-based chemical shift perturbation analysis showed binding only for the 24-nt AArich 
oligonucleotide; no binding was observed to AA-repeat RNA that was 19-nt or less in length (Section 
5.3.2). These results suggest that the MST binding curves to 4AA, 2AA and 1AA-repeat RNA 
sequences possibly constitute false positive results that arise due to loss of the fluorescent molecule 
upon protein addition.  
The RNA-binding behaviour of Spt4/5NGN appears to be somewhat complex or unusual on a number of 
grounds. It is unusual that no binding was visualised by chemical shift mapping to any of a variety of 
overlapping truncations of the 24-nt AArich RNA sequence (Section 5.3.4), given that RBPs will exhibit 
at least some binding to suboptimal sequences [299]. This result indicates that the length of the RNA is 
important; however given the compact, globular fold of the heterodimer it is difficult to rationalise how 
more than 19 bases is required to observe any binding at all. It may be that the RNA is forming some 
sort of transient secondary structure that the heterodimer recognises (and then stabilises), or that binding 
requires a minimum length of RNA to facilitate binding of a dimer.  
Analysis of the stoichiometry of the complex is not straightforward, in part because data acquired to 
date are not consistent between different techniques. The steep MST binding curve for Spt4/5NGN and 
AArich interaction (Figure 5.17(B)) suggest that the interaction is not a simple 1:1 binding event. 
However, when binding is analysed by NMR, the selective disappearance of ~30% of the heterodimer’s 
signals in the HSQC spectra upon AArich addition (seen in Figures 5.10 and 5.11) indicates that this 
complex is unlikely to consist of more than one heterodimer bound to each RNA molecule. This is 
because, as discussed in Section 5.2.1.1, line broadening due to a slower tumbling time generally affects 
all residues. If the complex consisted of two heterodimers bound to one AArich molecule, the molecular 
weight would be over 55 kDa, and one would reasonably expect all signals to disappear due to the 
slower tumbling time and faster relaxation of this large complex. This indicates that the perhaps more 
likely scenario is line-broadening on a 1:1 complex formation due to an intermediate exchange regime. 
Contributions from the ubiquitin and fluorescein tags to the MST binding behaviour, however, cannot 
be ruled out. There are indications to have some concerns about both. Firstly, there is a big increase in 
fluorescence seen in both MST (Figure 5.13) and EMSA data (Figure 1.12(D)) upon Spt4/5NGN addition. 
Secondly, ubiquitin alone, when added to AArich, gives rise to a similar change in thermophoresis to 
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1AA when treated with Spt4/5NGN (Figure 5.12(B)). Also, a discrete band for a Spt4/5NGN (without the 
ubiquitin tag) and AArich complex was not observed by EMSA (Section 5.3.5).  
Moreover, based on MST data presented in Figure 5.18 it appears likely that Spt4/5NGN interacts with 
GGrich RNA to some degree. In order to further probe the nature and specificity of this binding event, 
binding to other RNA sequences longer than 19 bases, including GGrich, should be tested by chemical 
shift mapping.  
Taken together, these results indicate that a description of the RNA-binding capacity of Spt4/5NGN as 
being specific to AA-repeat RNA is likely to be inaccurate. It remains possible, however, that the longer 
Spt4/55K construct might exhibit more specificity and this issue is worth addressing in additional binding 
studies. 
5.4.1 Recently published structures of eukaryotic RNAPII in complex with Spt4/5 
As noted in Section 1.3.1, no structures of eukaryotic Spt4/5 in complex with RNAPs had been 
published prior to the writing of this thesis. At the time of writing, structures of RNAPII TECs 
containing Spt4/5 from the yeast Komagataella pastoris were published [300], and these data are 
relevant to the work detailed in this Chapter. 
Firstly, Ehara et al. (2017) provide evidence that the KOW5 domain from Spt4/5 is the sole component 
required for the transcription elongation role of Spt4/5 in vitro, and based on this information, the co-
crystal structure of the K. pastoris RNAPII with only this domain from Spt5 was solved (Figure 
5.19(A)). In this structure, KOW5 completes the channel where the RNA is funnelled out of the TEC 
by bridging RNAPII proteins Rpb1 and Rpb2, as well as interacting electrostatically with surrounding 
RNAPII proteins. These interactions are formed by residues that are frequently conserved between 
K. pastoris and S. cerevisiae and H. sapiens (Figure 5.19(B)). The location of KOW5 and its proximity 
to the emerging RNA is consistent with previous results showing crosslinking of KOW5 to the nascent 
RNA transcript (Section 1.3.2). 
Secondly, a cryo-electron microscopy (cryo-EM) structure of the RNAPII TEC in complex with 
Spt4/55K was also reported, and this structure indicates that the NGN domain of Spt5 fills a U-shaped 
cavity created by Rpb2, and also contacts the Rpb1 clamp (Figure 5.20(A)). Through these interactions 
the Spt4/5 dimer completes the formation of the DNA exit channel. In doing so, the NGN domain 
contacts both the departing DNA double helix and the non-template strand, and this is corroborated by 
reports of the NGN domain contacting DNA [151, 152] as described in Section 1.3.2. The regions of 
the NGN domain implicated in binding RNAPII and DNA are indicated in Figure 5.20(B&C). 
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KOW1 is observed to bind to the coiled coil clamp of Rpb1 and thereby also forms part of the DNA 
exit channel on the side where the RNA exit channel is located. KOW4 is also located near the RNA 
exit channel, and the authors propose that KOW1, KOW4, and KOW5 extend the RNA exit point into 
a funnel-like structure. The location of KOW5 is consistent between this structure and the co-crystal 
structure, providing some confidence that the structures are correct. KOW2 and KOW3 domains from 
Spt5 were not visualised due to structural heterogeneity, but given the location of the other KOW 
domains it is reasonable to hypothesise that they could form part of this extended RNA exit channel.   
         
                                      
 
 
 
Figure 5.19. Co-crystal structure of RNAPII in complex with KOW5. 
(A) KOW5 co-crystal structure of RNAPII TEC (PDB: 5XOG). RNAPII subunits are shown in cartoon format in 
grey, the KOW5 domain of Spt5 is shown in surface representation in purple, and the elongation factor 1 (Elf1) is 
shown in surface representation in blue. The RNA sequence 5ʹ-UUUUUUUAUCGAGAGGU-3ʹ is shown in green, 
template DNA (5ʹ-CACTCTACCGATAAGCAGAGCTACCTCTCGATTTTTGGT-3ʹ) is shown in red and non-
template DNA (5ʹ-AATGGTTTGGCTCTGCTTATCGGTAGAGTG-3ʹ) in orange. Regions of Rpb1 and Rpb2 
that are contacted by KOW5 are labelled; Rpb1 and Rpb2 are large proteins (over 1000 residues) that extend 
throughout areas of the RNAPII TEC. (B) Sequence alignment of Spt5 KOW5 domains from K. pastoris, S 
cerevisiae and H. sapiens. Conserved resides are shown in red and residues with conserved properties are shown 
in blue, β-strands are outlined and numbered. K. pastoris Spt5 KOW5 residues that were observed to interact with 
RNAPII proteins are indicated above the sequence by asterisks. Data that instructed this figure are from Ehara et 
al. (2017). 
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5.4.2 Analysis of AA-repeat RNA-binding of Spt4/5 in light of this new structural 
information 
The structural data presented in the above Section provides further evidence that some of the KOW 
domains are RNA-binding proteins. This is consistent with the data presented in this Chapter and by 
Blythe et al. (2016) that indicate the likelihood that Spt4/55K binds AA-repeat RNA sequence 
specifically but not Spt4/5NGN; this core heterodimer exhibits less sequence specificity (detailed in 
Section 5.3.6) but requires a minimum length of between 20 and 24 RNA bases in order to bind. It is 
therefore likely that the specificity of AA-repeat RNA-binding is provided, at least in part, by the KOW 
domains.  
These new RNAPII TEC structures, however, call in to question whether the Spt4/5NGN core binds RNA 
as part of its transcription elongation function in the TEC. In the cryo-EM structure, Spt4/5NGN is located 
away from the RNA exit channel; rather than binding RNA it contacts the upstream DNA duplex and 
the non-template DNA strand. If Spt4/5NGN indeed binds RNA as part of its role in transcription 
elongation, then the RNA would need to wrap around this distal face of the heterodimer. 
The cryo-EM structure of Spt4/55K in complex with the RNAPII TEC shows that Spt4/51K has many 
surface exposed basic residues when in complex with the TEC, particularly KOW1 and Spt5NGN, as 
highlighted in Figure 5.21(A). Many of these basic residues in Spt5NGN are conserved in in S. 
cerevisiae (shown in Figure 5.21(B)). These basic residues might contribute to Spt4/5NGN RNA-
binding in a non-sequence specific fashion, with sequence selectivity achieved by KOW5 and perhaps 
KOW4. An instructive experiment would be to test Spt4/51K binding of RNA and DNA simultaneously 
to see if the heterodimer can accommodate both nucleic acids at the same time by using different 
surfaces. Initially, a traditional EMSA should be carried out (that is, one with an increasing protein 
concentration and a constant nanomolar concentration of labelled RNA). The protein concentration that 
lies around the dissociation constant of the interaction would then be chosen, and another EMSA carried 
out with this protein concentration and the same concentration of labelled RNA (both at a constant level 
throughout the titration series). In this EMSA an increasing amount of unlabelled DNA target sequence 
would be added such that the titration sees the ratio of DNA to RNA increase from ~0.1 to 10X. By 
comparing these EMSAs, the DNA concentration at which RNA-binding is reduced can be assessed 
and this will be instructive as to whether it is likely that the heterodimer can bind both oligonucleotides 
simultaneously. 
One possible hypothesis that is consistent with the data presented in this Chapter, as well as these 
recently published structures, is that Spt4/5 binds sequence specifically to nascent mRNA transcripts in 
order to prompt mRNA processing events. It is known that Spt5 interacts with an assortment of 
accessory factors such as mRNA capping enzymes [301, 302], and termination and 3′-end processing  
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Figure 5.20. Cryo-EM structures of RNAPII in complex with Spt4 and Spt55K. 
(A) Cryo-EM density map of Spt4/5 in complex with RNAPII TEC (PDB: 5XON). RNAP subunits are shown in 
cartoon format in grey, the remaining proteins are shown in surface representation (Spt5NGN, light pink; Spt5 KOW1 
domain, dark pink; Spt5 KOW4 domain, blue; Spt4, green-blue; TFIIS, black). The RNA sequence 5ʹ- 
AUCUUGAAUCUAUUUCUUUUAUCGAGAGGU-3ʹ is shown in green, template DNA (5ʹ- 
CACTCTACCGATAAGCAGACGTACCTCTCGAC CCTGTGCTAGAC ACGG-3ʹ) is shown in red and non-
template DNA (5ʹ-CCGTGTCTAGCACAGGGAAAT GGTTTGTGTCTG CTTATCGGTAGAGTG -3ʹ) in orange.  
Regions of Rpb1 and Rpb2 that are contacted by KOW5 are labelled. (B) Sequence alignment of Spt5NGN from K. 
pastoris, S cerevisiae and H. sapiens. Conserved resides are shown in red and residues with conserved properties are 
shown in blue, β-strands are outlined and numbered. Interactions between K. pastoris Spt5NGN and Rpb1, Rpb2 and 
DNA are indicated by grey shading. (C) Cryo-EM structures of Spt4 (green-blue with zinc atom as a grey sphere) 
and Spt5NGN (magenta) bound to RNAPII TEC (hidden) (PDB: 5XON). Regions of Spt5 implicated in binding RNAP 
subunits and DNA are coloured in limon. Data that instructed this figure are from Ehara et al. (2017). 
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factors [134, 150]. Spt4/5, through the concerted action of the NGN domain and all five KOW domains, 
may recognise particular RNA sequences emerging from the TEC to begin downstream processes. For 
example, the proteins may recognise a polyA or another terminal signal to help disengage a nascent 
RNA from the complex and destabilise the TEC, or facilitate some other event through the recruitment 
of accessory factors.  
         
                                      
 
 
Figure 5.21. NGN domains from both K. pastoris and S. cerevisiae contain basic residues that point away 
from the TEC.  
(A) Cryo-EM structure of Spt4/5 in complex with RNAPII TEC (PDB: 5XON) from Figure 5.19(A) with surface 
exposed basic residues of Spt4/51K in blue. (B) A high proportion of basic residues (shown in stick format) are 
conserved on one face of Spt5NGN between K. pastoris and S. cerevisiae. Residues from K. pastoris involved in 
binding DNA and RNAPII subunits are shown in limon, as per Figure 5.19(C). 
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In summary, the data presented in this Chapter indicates complex RNA-binding behaviour of Spt4/5NGN. 
Although the new published structures of Spt4/5 in complex with the TEC support a role for DNA-
binding for this core heterodimer in transcription elongation, it is very unlikely that these structures are 
representative of its full functionality. The completion of the backbone residue assignments of 
Spt4/5NGN, as attempted in this Chapter, will determine which regions of the heterodimer are involved 
in binding RNA, and will help to instruct experiments aimed at elucidating this functionality.  
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Chapter 6: Concluding discussion 
6.1 Introduction 
The aims of this Thesis were to elucidate the molecular recognition principles underlying two reported 
protein-RNA interactions in order to better understand the mechanisms by which these proteins regulate 
gene expression. These aims were not achieved in full; the inability to reproduce prior data, coupled 
with the limits of what in-vitro experiments can accomplish, saw only partial characterisation of the 
RNA-binding behaviours of bicoid and Spt4/5. This Chapter summarises and analyses the findings of 
this Thesis and addresses the challenges facing this field.   
 
6.2 The RNA-binding behaviour of bicoid 
6.2.1 BHD is a promiscuous RBD in vitro 
The studies of the RNA-binding behaviour of the bicoid homeodomain outlined in this Thesis were 
instructed by reports that the domain bound specifically to the BRE of cad mRNA. This result was 
unable to be reproduced; instead, the domain bound in an indistinguishable fashion to transcripts of 
varying sequence composition and predicted secondary structure, as observed by EMSA, and the 
relevant biological cad mRNA-binding site could not be ascertained. 
With the superior molecular resolution provided by NMR spectroscopy, it was observed that the 
recognition mechanism used by BHD to bind RNAs of differing base composition and predicted 
structure is largely similar. Thus it can be concluded that BHD displays a considerable amount of 
plasticity in recognising RNA; however, the differences in the magnitudes of the chemical shift changes 
observed for different RNA targets indicate that the domain does indeed have some sequence and/or 
structural preferences. Additionally, the NMR data showed that α-helix 3 of the domain (the DNA-
binding recognition helix) also plays a dominant role in RNA-binding. Thus, it appears likely that the 
binding mode employed by BHD to bind DNA and RNA bears some similarity, at least to the extent 
that the same broad regions of the domain are involved in binding both targets. This situation is in 
contrast to the sole RNA-binding TF for which there is structural information for both DNA and RNA-
binding (TFIIIA, see Section 1.2.1), which displays distinct recognition mechanisms for DNA and 
RNA. Overall, the RNA-binding data of BHD presented in this Thesis are consistent with RNA-binding 
capacity evolving, in part, through the reported conformational flexibility of residues in this recognition 
helix [122, 198, 199, 303].  
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The ability of physiological salt concentration to reduce the affinity of the RNA-binding interaction by 
around seven-fold, as well as to overwhelmingly abrogate binding induced chemical shift changes, are 
indications that the domain’s RNA-binding ability is driven to a significant extent by electrostatic 
attraction, and possibly largely constitutes non-specific interactions with RNA phosphate groups. The 
promiscuous RNA-binding properties of the domain coupled with the salt dependency of complex 
formation indicates that a biologically specific interaction between bicoid and cad would likely require 
elements outside the homeodomain. This idea adds to the growing amount of data reporting low inherent 
specificity of RBDs [81], indicating that biological specificity of RBPs for RNA often requires elements 
additional to individual RBDs. 
The failure to observe clear binding preferences for BHD in vitro is not overly surprising, firstly, given 
what we know about RNA recognition by RBPs (see Section 2.5), and secondly, because of the 
conformational flexibility observed in homeodomains, which results in loose DNA-binding specificity 
(see Section 1.2.3). Extra DNA-binding specificity is often conferred to homeodomain-containing 
proteins by additional DNA-binding domains (including ZF domains [304], additional homeodomains 
[305] or even less common DNA-binding domains such as paired domains [306]), other domains that 
effect oligomerisation (for example, the ubiquitin-like domain [307]) or additional binding partners 
(such as other homeodomain proteins as outlined in Section 2.5.1, or other DNA-binding proteins such 
as c-Jun [308]).  
Given that BHD does display some sequence preferences, it seems likely that it binds semi-selectively 
to RNA with binding sites that can vary substantially, and that target specification is achieved by 
multiple domains and/or binding partners. Analysis of the RNA-binding properties of the homeodomain 
in the context of the relevant biological complex may see the salt dependency of the interaction reduced 
due to the synergistic effects of cooperative binding. 
Further complicating the elucidation of RNA-binding specificity of the bicoid homeodomain is the fact 
that bicoid functions in embryos that are patterned differentially by RBP and RNA gradients. Therefore, 
specificity in RNA-binding might be modulated by these unique molecular contexts encountered by 
bicoid throughout the embryo. There are a variety of possibilities for how such specificity might be 
accomplished; examples include the presence or absence of binding partners dictating which RNA 
species are bound (see Section 2.5.1), or distinct kinetic contexts which could override an inherently 
non-specific binding regime (see Section 2.5.2). Furthermore, the interplay of RBP and RNA gradients 
can determine where phase separated granules occur (see Section 4.6.1), and little is currently known 
about how specificity is achieved under these special biological conditions. 
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6.2.2 Reports that bicoid contains an RRM are likely inaccurate 
After failing to observe a specific interaction between the bicoid homeodomain and cad mRNA, reports 
of bicoid containing an RRM were investigated. Recombinant production of this domain resulted in a 
peptide that was not well-ordered, and did not convincingly bind RNA. These results indicate that, 
excluding the possibility that additional N-terminal sequence is required in order for the domain to fold 
correctly, this domain is not an RRM, and its constituent RNP-1 motif does not readily bind RNA.  
Based on disorder predictions and the disordered nature of this peptide in isolation, it is likely that this 
region of the protein exhibits low conformational stability in its biological roles. The roles of disorder 
in RBPs and proteins more broadly are beginning to be elucidated (for instance, their role in phase-
separated granules, see Sections 4.4.1 and 4.6) but many questions remain [309]. Given the presence of 
the RNP-1 motif, it may be that this region of the protein contributes to the formation of cad containing 
RNP granules through weak binding of RNA. Disorder to order transitions necessitate an entropic 
payoff and therefore other regions of the protein or binding partners may be required in order to observe 
substantial folding and concomitant RNA binding. 
6.2.3 Future directions 
6.2.3.1 Determination of the bicoid RNA-binding site 
To determine what RNA sequences are bound by bicoid in vivo, cross-linking immunoprecipitation 
(CLIP) methods coupled to high-throughput sequencing should be used in early embryos [310]. These 
methods involve UV cross-linking of nucleic acids to proteins, followed by partial RNA digestion, 
immunoprecipitation of the protein of interest, reverse transcription and then sequencing of the resulting 
transcripts. These techniques are more arduous than in-vitro binding assays but given that specificity 
could not be determined by the latter, application of in-vivo techniques will likely be required to 
determine the domain’s biological RNA target sites. By virtue of the nature of in-vivo techniques, the 
effects of post-transcriptional and post-translational modifications as well as the accessibility and 
concentration of binding sites and that of competitive binders are accounted for. Further, information 
about what regions of the protein are involved in RNA-binding can be garnered which will be helpful 
to determine regions additional to the homeodomain that contribute to RNA binding. 
6.2.3.2 Analysis of intrinsic specificity 
Once RNA sequence or structural motifs that mediate biologically relevant binding by bicoid are 
identified, the contribution of the homeodomain to RNA binding can be quantified through chemical 
shift mapping of the domain and RNA target site. The structure of the domain bound to an RNA target 
site, as well as suboptimal RNA-binding sites, will yield valuable information to help understand how 
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such a small domain can bind both DNA and RNA, as well as illuminating the molecular mechanisms 
of binding site discrimination.  
The sequence preferences of bicoid (if the full-length protein can be successfully overexpressed and 
purified) and its homeodomain can also be more thoroughly characterised through global profiling 
methods that result in quantitative affinity distributions (as was done for the E. coli protein C5, see 
Section 2.5.2). These techniques, such as the high-throughput sequencing analysis of equilibrium 
binding (HiTS-EQ) approach [311] and RNA Bind-n-Seq [312] are more sophisticated than traditional, 
binary binding assays as they yield superior, quantitative binding information that accounts for the 
effects of RNA secondary structure. These studies will help to determine whether the intrinsic 
specificities of the homeodomain determine the RNA sequences bound by the full-length protein in 
vivo, or the extent of other factors at play. Such a comprehensive description of bicoid RNA-binding 
specificity will be of help not only to understanding its gene regulatory role, but more broadly, how 
RBPs find their cellular targets in an intertwined regulatory network. 
6.2.3.3 How common is dual DNA and RNA-binding behaviour in homeodomains? 
The conformational flexibility of the recognition helix of the bicoid homeodomain discussed in Section 
6.2.1 seems to be common to homeodomains; there are many studies that report on the dynamics of 
homeodomain side chain residues which give rise to adaptability in DNA-binding [118, 313-316]. 
Given this malleability in binding interfaces observed in homeodomains, it might be considered 
somewhat surprising that no other homeodomains have been reported to bind RNA. It would be 
interesting to test the RNA-binding potential of other homeodomains through the use of RNA 
Pentaprobes in binding assays to see if this RNA-binding capacity is indeed unique to bicoid. Also, 
given that RNA binding by the bicoid homeodomain has been attributed to it being the only known 
homeodomain with a K50 and R54 combination (see Section 1.2.3), it would be useful to test other K50 
homeodomains, as well as BHD with an R54A mutation, in order to ascertain the contribution of 
individual amino acids to the domain’s RNA-binding capacity.  
6.2.3.4 Does bicoid effect cad degradation in RNP granules? 
The observation that bicoid was not detected as an mRBP in either high-throughput, poly-A capture 
study in Drosophila embryos (see Section 4.4.1) may indicate that cad mRNA was degraded or de-
adenylated at the time of crosslinking. Indeed, the presence of a conserved miR-2 binding site in cad 
(as outlined in Section 2.3.3) attests to this possibility, because miRNAs are implicated in mRNA 
decapping, de-adenylation and degradation. Moreover, recent research has established that this miRNA-
mediated silencing can occur in cytoplasmic P-bodies [317] (see Section 4.6.2). The genetic interaction 
observed between bicoid and Ago2 (see Section 1.2.5), the propensity of Ago2 to localise to P-bodies 
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[318] as well as the presence of a poly-glutamine domain in bicoid (see Section 4.4.1) may be 
indications that bicoid-mediated degradation of cad occurs in P-bodies, or another type of RNP granule.  
As a first step to see if bicoid might form phase separated granules, in-situ hybridisation of cad in early 
Drosophila embryos using highly sensitive methods developed by Ali-Murthy and Kornberg (2016) 
[106] could help to visualise the localisation of cad mRNA to see if it condenses into granules. Further, 
single molecule fluorescence studies of GFP-tagged bicoid in vivo could help to determine bicoid 
distribution throughout the syncytial cytoplasm. 
6.2.3.5 A possible model for miRNA involvement in bicoid-mediated cad repression 
The possibility of miR-308 directly mediating specificity between BHD and cad was investigated in 
Section 2.3.3, based on a report by Rodel et al. (2013) that miRNAs are involved in bicoid-mediated 
cad repression. However, the results were ambiguous; despite the observation of a unique shifted band 
pattern in EMSAs, no synergy of binding between mir-308, cad and BHD was observed.  
Instead of miRNAs directly mediating specificity between BHD and cad, it might be that bicoid 
interacts with some component/s of RISC, as discussed above. Alternatively, an indirect interaction 
between bicoid and RISC is also possible, whereby bicoid binds cad and induces a structural 
rearrangement of the mRNA which facilitates RISC binding of the miRNA target site, or vice versa. 
Such a mechanism was hypothesised to explain the ability of Pumilio to enhance the miRNA mediated 
repression of the transcription factor E2F3 [319]. Determination of the bicoid binding site on cad will 
help to design experiments that could test the validity of this model and will help to understand the 
observed cross-talk and synergism between mRBPs and miRNAs [320]. 
 
Figure 6.1 A model for miRNA involvement in bicoid mediated cad repression. 
In this model, RISC is obstructed from binding the cad 3′-UTR due to the presence of secondary structure. 
Bicoid facilitates RISC binding by binding a separate site that disrupts the secdonary structure of the RISC 
binding site. 
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6.3 The RNA-binding properties of Spt4/5NGN 
6.3.1 Spt4/5NGN binds RNA of a minimum length 
The investigations into RNA-binding by Spt4/5NGN outlined in this Thesis indicate that a better 
description of the specificity of the interaction is that the heterodimer binds RNA of a minimum length 
of somewhere between 20 and 24-nt, rather than short AA-repeat RNA sequences. The chemical shift 
mapping data for the interaction of Spt4/5NGN with AArich indicate that it is unlikely there is more than 
one heterodimer bound to each RNA, and this raises the question of how a small heterodimer could 
require this length of RNA to display any binding at all. The assignment of the 15N-HSQC spectrum 
would have gone some way to answering this question, and this should be completed in future 
experiments using perdeuterated, triple-labelled protein in order to increase the signal-to-noise ratio of 
the acquired 3D spectra.  
6.3.2 Future directions 
If Spt4/5 does indeed bind RNA sequence specifically in vivo, elucidating the potential biological 
function is likely to be a complex task. It is probable that Spt4/5 binds nucleic acids in a dynamic and 
transitory fashion, given the nature of transcription and the movement of the transcription elongation 
complex (TEC) relative to processed nucleic acids. This conclusion is corroborated by the observation 
that Spt4/5 crosslinks to various transcribed regions, including downstream of polyadenylation sites 
[321]. A sequence-specific interaction between Spt4/5 and RNA would be expected to be persistent 
compared with the more transient interactions during transcriptional processing, and therefore may 
serve to induce a conformational change in the complex or recruit accessory factors.  
The characterisation of Spt4/55K is more complicated than Spt4/5NGN due to its larger size (~73 kDa c.f. 
~22 kDa). However, the data presented in this Thesis indicates that Spt4/5NGN does not form a specific 
1:1 complex with AA-repeat RNA. This knowledge, coupled with experiments that included KOW 
domains in binding assays (introduced in Figure 1.12), together indicate that the KOW domains are 
likely key to the formation of this complex. Further, the recently published crosslinking and structural 
data implicate the KOW5 domain, in particular, in RNA binding. Taken together, characterisation of 
Spt4/5 RNA-binding activity – with the inclusion of the five KOW domains – would be of significant 
interest. As Spt4/55K appears to form a specific complex with AArich RNA, X-ray crystallography may 
be a good technique to probe the interaction structurally. Determining which residues are involved in 
recognising AA-repeat RNA specifically will help to instruct experiments designed to assess the 
biological relevance of these data. 
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The RNA-binding capacity of Spt4/5 is likely modulated in some fashion by the TEC and other binding 
partners, necessitating binding studies in the context of its relevant biological complexes. Newly 
developed, sophisticated techniques such as single molecule FRET, which has been applied to 
elucidating the molecular dynamics of RNP complexes such as the ribosome [322], telomerase [323], 
and splicing RNPs [324], could help to achieve the goal of uncovering the biological relevance of the 
presented RNA-binding data. 
 
6.4 The prospects for studying RBPs 
The work outlined in this Thesis has demonstrated the challenges inherent in examining the interactions 
between RBPs and their RNA targets, and some of these challenges will be discussed briefly here. 
6.4.1 Potential problems with experimental techniques 
Both projects in this Thesis were instructed by reports of proteins that exhibited specific RNA-binding 
behaviour. In the case of bicoid, multiple reports showed a direct interaction between bicoid and cad, 
including cross-linking and 3′-UTR reporter construct data, and an EMSA which demonstrated specific 
binding of the bicoid homeodomain to cad [87, 123, 126]. For Spt4/5, high-affinity RNA-binding sites 
were identified through the in-vitro technique, SELEX, with the biological relevance to be elucidated 
after characterisation of the interaction.  
The aim of both projects in this Thesis was to use in-vitro techniques to further define and characterise 
the RNA-binding determinants of the selected RBPs. In both cases, the techniques applied yielded some 
information, but specificity determinants were unable to be defined. In the case of the bicoid 
homeodomain this was because the domain bound RNA promiscuously, and in the case of Spt4/5NGN, 
because the heterodimer displayed complex binding behaviour that was generally not consistent 
between techniques. 
Comparing the bicoid homeodomain MST data with the EMSA data in Chapter 2, it can be seen that 
the EMSAs presented are perhaps less sensitive to affinity differences than other methods. The MST 
data shows a dissociation constant of 3.8 µM for BHD:BRE19nt, and 1.1 µM for HDER:BRE19nt, 
whereas the EMSA data shows an indistinguishable binding pattern for these two interactions (Figure 
2.13). Such differences in affinity could have important biological implications because small 
differences in binding preferences in vitro can have large differences in vivo [325].   
The limited discriminating power of the EMSAs presented in this Thesis is in part a reflection of the 
failure of RNA-protein complexes to migrate out of the wells. Given the prevalence of this occurrence 
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throughout this Thesis, it may have been due to a problem with experimental technique. Substantial 
time and effort was invested in unsuccessful attempts to resolve these RNP complexes. Specifically, 
the purified, precipitated RNA was resuspended in MQW as well as buffer containing salt (to help the 
RNA fold correctly), and transcribed RNAs were snap-cooled, and not snap-cooled. Further, different 
running buffers, voltages and temperatures (room temperature or 4 °C) were trialled. Some differences 
were observed on occasion but no conditions resulted in the consistent removal of protein-bound RNA 
species in the wells. 
It may be that these species are a result of non-specific interactions between protein and RNA, perhaps 
resulting in complexes that are too large to enter the wells. Alternatively, it could also be due to some 
RNA electrostatic effect brought about by the gel conditions, as this effect was never observed in DNA 
EMSAs.  
As always in biochemistry, the application of multiple techniques is required to provide corroborating 
evidence for outcomes. In the case of bicoid, both NMR and MST techniques showed that an interaction 
does indeed occur in vitro. These techniques provided more information than EMSAs: MST gave detail 
on the stoichiometry of the interaction (a 1:1 binding event) and NMR spectroscopy yielded resolution 
at the individual residue level to allow determination of residues and regions of the protein involved in 
RNA-binding. The situation is a little less clear for Spt4/5, as conflicting data were provided by different 
techniques. As discussed in Section 5.4, these discrepancies might be attributed to the influence of 
ubiquitin and fluorescein tags, the inclusion of which create experimental conditions which are one step 
further removed from biology.  
6.4.2 The difficulty in identifying bona fide RBP binding sites 
The determination of in vitro binding affinities will be sufficient to instruct biological binding sites only 
in a fraction of instances. This is because, as has been described throughout this Thesis, inherent affinity 
is only one factor determining biological specificity in RNP interactions. Indeed, many current studies 
are reporting little inherent RNA-binding specificities for RBPs [208, 326-329]. For example, the two 
RRMs and connecting linker of hnRNP A1 specifically recognise the core sequence 5′-AG-3′, with the 
surrounding structural and sequence features determining binding preferences; however, non-AG 
containing RNAs can also compete for binding [326]. In instances of low reported RNA-binding 
specificities, proteins can either act as non-specific RBPs or specificity is provided by the cellular 
context in which the interactions take place. Where RNA-binding specificity cannot be ascertained from 
in-vitro techniques, experiments that take into consideration the cellular conditions that give rise to 
these interactions will be required.  
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CLIP techniques, as discussed in Section 6.2.3.1, are at present the most promising method of 
ascertaining biological RNA-binding sites due to their in vivo nature. Such techniques are not without 
drawbacks, however. For instance, it has been reported that uridines crosslink preferentially [330] and 
that some proteins don’t crosslink well due to the absence of aromatic amino acids near the nucleic acid 
binding site [331]. Such problems can be addressed to some extent in the experimental protocol, for 
example by optimising crosslinking for each protein individually, but it is possible that such techniques 
will not be suitable for all proteins. 
Overall, elucidating the determinants of RNA-binding specificity in many instances will be a complex 
task, and will often require a multifaceted and integrated biochemical approach. Recently developed, 
sophisticated techniques are likely going to be required. For the most sensitive analysis of intrinsic 
specificities of RBPs, high-throughput profiling methods (Section 6.2.3.2) should be used. Further, 
single molecule fluorescence techniques will be increasingly applied as they allow both the visualisation 
of RNP molecular dynamics (Section 6.3.2) as well as the determination of spatiotemporal regulation 
of macromolecules under in vivo conditions (Section 4.6.2), factors which are now known to be key to 
RNP interactions. Moreover, the structural characterisation of native RNP complexes is growing, and 
techniques such as NMR spectroscopy, X-ray crystallography and cryo-EM (Section 5.4) are facilitating 
this end. Such innovative biochemistry will be required if we are to grasp the underlying biology of our 
RBP binding data. 
 
6.5 Concluding remarks 
The work described in this Thesis has investigated the bicoid homeodomain, and has demonstrated that 
it is a promiscuous binder of RNA in vitro, with the regions of secondary structure used by the domain 
consistent between RNA and DNA binding. The bicoid homeodomain was shown to have some RNA 
sequence and/or structural preferences, and whilst further work will be required to prove biological 
relevance, the data presented in this Thesis are consistent with the domain recognising semi-instructive 
RNA-binding sites, with other regions of the protein and/or binding partners contributing to its specific 
translational repression of cad. In particular, recent RNP research has highlighted that disordered 
segments in bicoid may contribute to effecting biological RNA-binding specificity. 
This Thesis also detailed the AA-repeat RNA-binding properties of Spt4/5NGN, and has shown that a 
more accurate description of the RNA binding of this heterodimer is that it binds RNA of a minimum 
length of 20 or more bases. This binding behaviour is not easily rationalised, and additional experiments 
aimed at determining the repertoire of residues involved in binding RNA will help to resolve 
unanswered questions about this interaction.  
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Chapter 7: Materials and Methods 
7.1 Materials 
7.1.1 Consumables and reagents 
A list of materials used for this Thesis and their suppliers is detailed in Table 7.1. 
Table 7.1 Materials and suppliers 
 
Item Supplier
13
C D-glucose  Cambridge Isotope Laboratories (Andover MA, USA)
15
NH4Cl Cambridge Isotope Laboratories (Andover MA, USA)
2,2-dimethyl-2-silapentane-5-sulfonate (DSS) Fluka A. G. (Buchs, Switzerland)
[α-
32
P] uridine-5?-triphosphate (UTP) Perkin Elmer (Melbourne, VIC)
[γ-
32
P] adenosine triphosphate (ATP) Perkin Elmer (Melbourne, VIC)
Amicon centrifugal concentrators Merck Millipore (Bayswater, VIC)
CelluSep®H1 1 kDa MWCO dialysis tubing Membrane Filtration Products (Seguin TX, USA)
cOmplete™ EDTA-free protease inhibitor tablets  Sigma (Castle Hill, NSW)
Deuterium oxide Sigma (Castle Hill, NSW)
Dithiothreitol Quantum Scientific (Milton, QLD)
DNA ladders (2-log, 100 bp)  New England Biolabs (Beverly, MA, USA)
DNA oligonucleotides Integrated DNA Technologies (Baulkham Hills, NSW)
DNase I Roche Applied Science (Mannheim, Germany)
dNTPs  New England Biolabs (Beverly MA, USA)
Ethidium bromide  Bio-Rad (Regents Park, NSW)
Glutathione-Sepharose® 4B beads Amersham Biosciences (Castle Hill, NSW)
Isopropyl β-D-thiogalactopyranoside Quantum Scientific (Milton, QLD) 
Lysozyme Sigma (Castle Hill, NSW)
Mark12™ Unstained Protein Standards Thermo Fisher Scientific (Mulgrave, VIC)
Mini Quick Spin RNA columns  Roche Diagnostics (Castle Hill, NSW)
Nickel-NTA Agarose resin  Invitrogen/Thermo Fisher Scientific (Mulgrave, VIC)
PD-10 pre-packed desalting columns GE Healthcare (Silverwater, NSW)
Phenylmethylsulfonyl fluoride (PMSF)  Sigma (Castle Hill, NSW) 
QIAprep® spin miniprep kit  QIAGEN (Doncaster, VIC)
QIAquick® gel extraction kit  QIAGEN (Doncaster, VIC)
QIAquick® PCR purification kit  QIAGEN (Doncaster, VIC)
Quick-Stick ligase (Bioline, Alexandria, NSW)
Restriction enzymes New England Biolabs (Arundel, QLD)
RiboSafe RNAse inhibitor Bioline (Alexandria, NSW)
RNA oligonucleotides Integrated DNA Technologies (Baulkham Hills, NSW)
RQ1 RNase-Free DNase Promega (Alexandria, NSW)
T4 DNA ligase Fermentas (Ontario, Canada)
Triton X-100 Progen (Darra, QLD) 
Tween® 20 Astral Scientific (Taren Point, NSW)
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7.1.2 Plasmids and bacterial strains 
7.1.2.1 Plasmids 
Bicoid constructs (BHD, HDER and BRRM): Full length bicoid in the vector pET18b was provided by 
Michalis Averof (Institut de Génomique Fonctionnelle de Lyon, France), and this was used as a 
template to make all bicoid constructs cloned into the vector pGEX6P. 
Spt4/5: Spt5 in the vector pHUE and Spt4 in the vector pETM11 were provided by Amanda Blythe 
(University of Western Australia, WA). pHUE-Spt5NGN was engineered to incorporate a TEV cleavage 
site by Jason Low in the Mackay laboratory (University of Sydney, NSW).  
Cad transcripts: The full length cad 3′-UTR gene in the vector pSLfa1180fa was provided by Michalis 
Averof of Institut de Génomique Fonctionnelle de Lyon (IGFL), and this was used to make templates 
for cad transcription (cad 3′-UTR, BRE(257-319), BRE39nt, BRE38nt). 
Pentaprobes: Pentaprobe sequences were previously cloned by Fionna Loughlin in the Mackay 
laboratory (University of Sydney, NSW) and used to make templates for Pentaprobe 7 production.  
7.1.2.2 Bacterial strains 
DH5α (used for cloning and plasmid propagation): supE44,  ΔlacU169,  [Φ80lacZΔM15],  
hsdR17(rK- mK+),  recA1,  endA11,  gyrA1,  thi-1,  relA1 (Bethesda Research Laboratories, Gaithersburg, 
Maryland, USA). 
Rosetta(DE3)pLysS (used for protein overexpression): F- ompT hsdSB (rB- mB-) gal dcm (DE3) 
pLysSRARE (CamR) (Novagen®). 
 
7.1.3 Equipment and suppliers 
A list of equipment and their suppliers is contained in Table 7.2. 
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7.2 Methods 
7.2.1 Cloning 
7.2.1.1 Polymerase chain reaction (PCR) 
All sequences for insertion were made by PCR. The reaction mixture consisted of 1 U/50 µL Pfu DNA 
polymerase in Pfu buffer (Table 7.3) with 10% [v/v] DMSO, 0.4 µM forward and reverse primers, 
0.1 mM dNTPs and ~1 ng/uL plasmid template. PCR was carried out on a Biometra T3000 
thermocycler. PCR programs employed an initial denaturation step of 2 minutes at 95 °C and final 
extension step of 4-8 minutes at 72 °C, with 30 cycles of the following in between: 30 seconds at 95 °C 
for primer denaturation, 30 seconds at 47-60 °C for primer annealing, and 2-4 minutes extension at 
72 °C. 
7.2.1.2 Template and vector processing  
PCR products were subject to PCR clean up using a QIAquick® PCR purification kit as per the 
manufacturer’s instructions. Milli-Q® was used to elute PCR products from the spin columns. 
Purified PCR products (~1-3 µg) and vectors for insertion (~ 3 µg) were then digested with 10-30 U of 
both EcoRI and BamHI high-fidelity restriction enzymes (supplied in CutSmart® buffer, Table 7.3) at 
37 °C for at least 2 hours.  
Table 7.2 Equipment and suppliers 
 
Equipment Supplier
Bolt
TM
 Mini Gel Tank ThermoFisher Scientific, Scoresby VIC
Biometra T3000 thermocycler  Biometra, Goettingen, Germany
UNO S1 column  Bio-Rad Laboratories, Hercules CA, USA
Superdex® 75 HiLoad 16/60 column GE Healthcare, Parramatta, NSW
ProtParam web server
Swiss Institute of Bioinformatics, 
http://web.expasy.org/protparam
Nanodrop® ND-1000 UV-Vis spectrophotometer ThermoFisher Scientific, Wilmington DE, USA
Typhoon FLA900 scanner GE Healthcare, Parramatta NSW
Hoefer SE400 Sturdier™ vertical slab gel unit GE Healthcare, Parramatta NSW
Monolith NT.115 instrument 
NanoTemper Technologies GmbH, München, 
Germany
Shigemi NMR tubes Shigemi,  Tokyo,  Japan
Bruker Avance III NMR spectrometers Bruker, Karlsruhe, Germany
TOPSPIN3 Bruker, Karlsruhe, Germany
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7.2.1.3 Agarose gel electrophoresis 
Restriction digest reactions were mixed 5:1 [v/v] with DNA loading dye and then loaded onto 1-2% 
[w/v] agarose gels containing 1 µg/mL ethidium bromide, and electrophoresed in TAE running buffer 
(Table 7.3) at 100 V for ~45 minutes. Gel-separated products were visualised with ultraviolet light and 
then the relevant bands were excised. DNA was separated from the agarose gel casing using a 
QIAquick® gel extraction kit as per the manufacturer’s protocol. 
7.2.1.4 Ligation and transformation 
Digested vectors and PCR inserts were then combined in molar ratios ranging from 1:3 through to 1:10 
respectively with 0.05% [v/v] Quick-Stick ligase in the supplied buffer and incubated at room 
temperature for at least 20 minutes. This reaction (~ 5 µL) was then used to transform competent DH5α 
cells (20 µL of cells with a half volume of KCM). The reaction mixture was heat shocked for 45 seconds 
at 42 °C, and then recovered at 37 °C for an hour, before being plated out onto LB-agar plates containing 
50 µg ampicillin and incubated overnight at 37 °C. 
7.2.1.5 Colony PCR 
Single colonies were used as templates for PCR reactions by adding cells directly to the PCR mixture 
with a pipette tip. These PCR reactions contained the forward primer from the vector and the reverse 
primer from the insert in order to determine if inserts had been successfully ligated in each colony. PCR 
was carried out as per Section 7.2.1.1, with the reactions then electrophoresed as per Section 7.2.1.3. 
Colonies which yielded a band of the expected size were selected for plasmid propagation and 
purification.    
7.2.1.6 Plasmid propagation and purification 
Selected colonies were used to inoculate ~10 mL of LB (Table 7.3) supplemented with 50 µg 
ampicillin and incubated overnight with shaking at 180 x g and 37 °C. The cells were pelleted by 
centrifugation (5000 x g, 5 minutes) and plasmid DNA was purified using a QIAprep® spin miniprep 
kit according to the manufacturer’s instructions. Successful insertions were confirmed by Sanger 
sequencing, carried out by the Australian Genome Research Facility (Westmead, NSW). Milli-Q® was 
used to elute the DNA from the spin column, and plasmids were then stored at -20 °C.  
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7.2.2 Protein overexpression 
7.2.2.1 Transformations 
For each transformation, 50 µL of competent E. coli Rosetta (DE3) pLysS cells were thawed on ice for 
at least 20 minutes and 30 µL of KCM (Table 7.3) and ~ 30 ng of plasmid DNA was added and the 
mixture was left to rest on ice for 30 minutes and then heat shocked at 42 °C for 45 seconds, before the 
addition of 200 µL of sterile LB. This mixture was incubated with shaking at 180 x g and 37 °C for at 
least 45 minutes, and then streaked onto an LB-agar plate containing the appropriate antibiotics and 
incubated at 37 °C overnight.  
7.2.2.2 Sequential transformations with calcium chloride competency step 
In the special case of Spt4/5NGN expression, which required the transformation of two plasmids, pHUE- 
Spt5NGN was transformed first as described in the previous Section, and then a colony was selected to 
inoculate 10 mL of LB and this culture was grown to an optical density measured at 600 nm not in 
excess of 0.4. The culture was rested on ice for 10 minutes, and then the cells were pelleted by 
centrifugation (5000 x g, 5 mins, 4 °C). The supernatant was decanted off and the cells were gently 
resuspended in cold 0.1 M CaCl2 and then incubated on ice for 20 minutes. The cells were then collected 
by centrifugation again, and then resuspended in 1 mL of cold 0.1 M CaCl2. 500 µL of this solution was 
added to 30 ng of pETM11-Spt4 and incubated on ice for an hour, before being heat shocked at 42 °C 
for 45 seconds, and then recovered at 37 °C for an hour. The transformation solution was then streaked 
onto an agar plate containing 50 µg ampicillin, 35 µg chloramphenicol and 15 µg kanamycin and 
incubated at 37 °C overnight.  
7.2.2.3 Culture growth, induction, expression and harvest 
Starter cultures were made by inoculating 10 mL LB (containing the relevant antibiotics) with single 
colonies from transformation plates, and incubating this culture at 37 °C with shaking (150 x g) until 
the optical density at 600 nm reached induction values (Table 7.4). Protein expression was induced by 
the addition of isopropyl β-D-thiogalactopyranoside (IPTG), and expression was carried out for ~17 
Table 7.3. Cloning solutions 
 
Solution Composition
Pfu buffer 20 mM Tris, 10 mM KCl, 10 mM (NH4)2SO4, 2 mM MgSO4, 0.1% [v/v] Triton X-100,  pH 8.8
KCM 100 mM KCl, 30 mM CaCl2, 50 mM MgCl2
LB 1.0%  [w/v] casein peptone, 0.5% [w/v] yeast extract, 0.5% [w/v] NaCl, pH 7.0
LB-agar LB with 1.5% [w/v] agar
CutSmart® buffer
50 mM potassium acetate, 20 mM Tris-acetate pH 7.9, 10 mM magnesium acetate, 
100 µg/mL BSA
TAE running buffer 40 mM Tris, 40 mM glacial acetic acid, 2 mM EDTA
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hours at 18-22 °C with shaking (150 x g). Spt4/5NGN expression required the addition of ZnSO4 (3 mM) 
at induction as Spt4 is a zinc finger protein. Cells were pelleted by centrifugation at 5000 x g for 15 
minutes and either purified immediately or flash frozen in liquid nitrogen and stored at -20 °C. 
7.2.2.4 Expression of isotopically labelled protein 
For the expression of 15N or 15N/13C labelled protein, 2 L of culture for every 1 L of unlabelled protein 
expression was prepared as described in the previous Section, up to the point of reaching an optical 
density at 600 nm of 0.6-0.8. At this point the cells were harvested by centrifugation at 4000 x g at room 
temperature, resuspended gently in minimal media (1 L minimal media per 1 L culture, recipe detailed 
in Table 7.5) before being harvested by centrifugation again and resuspended in 1 L of fresh minimal 
media supplemented with 1 g of 15NH4Cl for 15N labelled protein, as well as 3 g of 13C D glucose for 
15N/13C labelled protein. The cultures were then incubated with shaking at the induction temperature for 
one hour to clear unlabelled metabolites, and then induction, expression and harvest were carried out as 
per unlabelled protein. 
7.2.3 Protein purification 
7.2.3.1 Lysis 
Cell pellets from 1 L of expression media were resuspended in 30 mL lysis buffer (see Table 7.6 for 
recipes for each protein).  
In the case of BHD, HDER and BRRM, the resuspended solution was sonicated for 30 seconds, before 
being incubated at 4 °C for 30 minutes with gentle rocking. DNAse I (100 µg/mL) and MgCl2 (100 µM) 
were then added and the solution was incubated for another hour at 4 °C with gentle rocking, and then 
sonicated three to four times for 30 seconds. The insoluble material was pelleted by centrifugation at 
10,000 x g for 30 minutes at 4 °C and the soluble fraction was kept for affinity purification. 
Table 7.4. Protein expression details by construct 
 
Construct Vector Induction OD600nm Induction conditions [IPTG] (mM) Antibiotics
BHD pGEX6P 0.8 20 °C, ~17 hours 0.5 50 µg/mL Amp, 34 µg/mL Cam
HDER pGEX6P 0.8 20 °C, ~17 hours 0.5 50 µg/mL Amp, 34 µg/mL Cam
BRRM pGEX6P 0.6 18 °C, ~17 hours 1 50 µg/mL Amp, 34 µg/mL Cam
Spt4 pETM11
Spt5NGN pHUE
0.6 22 °C, ~17 hours 1
50 µg/mL Amp, 34 µg/mL Cam, 
30 µg/mL Kan
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For Spt4/5NGN, the resuspended solution was flash frozen in liquid nitrogen, and then crunched three 
times with a French press. DNAse I (100 µg/mL) and MgCl2 (100 µM) were then added, and the 
solution was incubated at 4 °C (no rocking), before the insoluble material was removed by 
centrifugation at 10,000 x g for 45 minutes at 4 °C. 
7.2.3.2 Affinity purification 
Glutathione Sepharose® 4B beads (1.5 mL per litre of culture; BHD, HDER and BRRRM) or nickel-
nitrilotriacetic acid (nickel-NTA) beads (0.5 mL per litre of culture; Spt4/5NGN) were washed with lysis 
buffer and then incubated with the soluble fraction at 4 °C for one hour, before being washed with 
 Table 7.5. Minimal media recipe for the production of 15N and 15N/13C labelled proteins 
 
*glucose consists of 12C for 15N labelled protein and 13C for 15N/13C labelled protein 
Salts recipe g/L
KH2PO4  13
K2HPO4 10
Na2HPO4 9
K2SO4 2.4
Trace metal recipe g/L
FeCl2.7H2O 6
CaCl2.2H2O 6
MnCl2.4H2O 1.2
COCl2.6H2O 0.8
ZnSo4.7H2O 0.7
CuCl2.2H2O 0.3
H3BO3 0.02
(NH4)6Mo7O24.4H2O 0.25
EDTA 5
Minimal media recipe /L
Salts recipe 970 mL
Trace metal recipe 10 mL
1 M MgCl2 10 mL
0.1 g/L yeast extract 50 µL
5 mg/mL thiamine 6 mL
15
NH4Cl 1 g
glucose* 3 g
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50 mL wash buffer (Table 7.6). Tagged proteins were eluted in six to eight 1 mL fractions with elution 
buffer (Table 7.6). Purity of eluted fractions was assessed by SDS-PAGE (Section 7.2.3.3). 
 
7.2.3.3 SDS-PAGE 
Protein samples were mixed with 1 X LDS (Table 7.7) and heated at 80 °C for 3 minutes prior to loading 
onto precast Bolt® 4-12% bis-tris polyacrylamide gels along with Mark12TM unstained protein 
standards in 1 X NuPAGE® MES buffer (Table 7.7) on a BoltTM Mini Gel Tank at 180 V for 20-22 
minutes. Gels were stained with Coommassie Brilliant Blue G-250 (0.1 g/L in MQW) and destained in 
ROW.  
7.2.3.4 Proteolytic cleavage 
Samples selected for pooling were identified by SDS-PAGE. 
Table 7.6 Lysis, wash and elution buffers used in protein purification  
 
Lysis buffer Wash buffer Elution buffer
BHD and HDER
50 mM Tris-Cl  50 mM Tris-Cl  50 mM Tris-Cl
500 mM NaCl 300 mM NaCl 150 mM NaCl
1% [v/v] triton X100 1 mM dithiothreitol 1 mM dithiothreitol
1 mM dithiothreitol 5% [v/v] glycerol 50 mM glutathione
2 mM PMSF pH 8 pH 8
1 mg/mL lysozyme
pH 8
BRRM
50 mM Tris-Cl  50 mM Tris-Cl  50 mM Tris-Cl 
1 M NaCl 500 mM NaCl 150 mM NaCl
1% [v/v] triton X100 1 mM dithiothreitol 1 mM dithiothreitol
1 mM dithiothreitol 10% [v/v] glycerol 50 mM glutathione
2 mM PMSF pH 8 pH 8
1 mg/mL lysozyme
pH 8
Spt4/5NGN
50 mM sodium phosphate  50 mM sodium phosphate  50 mM sodium phosphate 
2 M KCl 2 M KCl 0.3 M KCl
10% glycerol 10% glycerol 10% glycerol
20 mM imidazole 20 mM imidazole 0.2 M imidazole
1 mM dithiothreitol 1 mM dithiothreitol 1 mM dithiothreitol
1 cOmplete™ tablet pH 7.4 pH 7.4
pH 7.4
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GST-BHD and GST-HDER were dialysed into cation exchange buffer A (Table 7.7) along with HRV-
3C protease to remove the N-terminal GST tag at 4 °C overnight.  
GST-BRRM was incubated with HRV-3C protease to remove the N-terminal GST tag at 4 °C overnight.  
His6-Ubq-Spt5NGN along with Spt4 were incubated with TEV at 4 °C overnight to remove the His6-
Ubq tag. 
7.2.3.5 Cation exchange chromatography 
BHD and HDER were purified by cation exchange chromatography. Dialysed protein solutions were 
filtered and then loaded at 1 ml/min on to a UNOS1 column with cation exchange buffer A and then 
eluted with a step wise salt gradient with increasing concentration of cation exchange buffer B (Table 
7.7). Purity of fractions was assessed by SDS-PAGE (section 7.2.3.3) and relatively pure fractions were 
pooled.  
7.2.3.6 Size exclusion chromatography 
Cleavage solutions of BRRM and Spt4/5NGN were filtered and then run over a Superdex® 75 HiLoad 
16/60 column at a rate of 0.5 mL/min with the relevant size exclusion buffer (Table 7.7). Purity of 
fractions was assessed by SDS-PAGE (section 7.2.3.3) and relatively pure fractions were pooled. 
 
7.2.3.7 Protein quantification 
Protein concentration was assessed by absorbance at 280 nm (A280) using ε280nm estimated from the 
primary sequence using the ProtParam web server [332]. ε280nm that were used are listed in Table 7.8. 
 
Table 7.7. Protein purification solutions 
 
Buffer Composition
1 X LDS 
0.065 M Tris-HCl pH 6.8, 2% [w/v]  SDS, 10% [v/v]  glycerol, 5% [v/v], 
β-mercaptoethanol,  0.1% [w/v]  bromophenol  blue
1 X NuPAGE® MES buffer  50 mM  MES,  50 mM  Tris  pH  7.3,  0.1% [w/v]  SDS,  1 mM  EDTA
cation exchange buffer A 50 mM Tris-Cl, 50 mM NaCl, 1 mM dithiothreitol pH 8 
cation exchange buffer B 50 mM Tris-Cl, 1 M NaCl, 1 mM dithiothreitol pH 8 
size exclusion buffer Spt4/5NGN 50mM sodium phosphate, 150 mM KCl, 1 mM dithiothreitol pH 7.4
size exclusion buffer BRRM 50 mM Tris-Cl, 150 mM NaCl, 1 mM dithiothreitol pH 8 
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7.2.4 RNA preparation 
7.2.4.1 Working with RNA 
In order to avoid RNAse contamination, appropriate buffers and solutions for RNA work were treated 
with 0.1% [v/v] diethyl pyrocarbonate (DEPC) for 30 minutes and then autoclaved to remove residual 
DEPC. Swab solution (Table 7.10) was used to decontaminate bench surfaces and gloves, and 
equipment such as pipettes and dialysis buttons. RNAse free plasticware was used where possible. 
7.2.4.2 Nucleic acid quantification 
The concentration of unlabelled nucleic acids was assessed by absorbance at 260 nm (A260) using the 
supplier’s web server ε260nm calculator (http://sg.idtdna.com/calc/analyzer). ε260nm that were used are 
listed in Table 7.9. 
The concentration of fluorescently labelled RNAs was determined by A260 and adjusted for fluorescein 
absorbance using the following equation: 
[   ] =
    	.    
        	.    
  
    
   	.    
   	
                                       Equation 7.1 
Table 7.9. RNA extinction coefficients at 260 nm 
 
RNA ε260nm M
-1
 cm
-1
RNA ε260nm M
-1
 cm
-1
BRE(257-319) 580400 1AA 55600
BRE38nt 343600 1HAArich 124500
BRE39nt 347800 2HAArich 144400
ShapeControl 377700 TrimAArich 183900
Unst 277200 GGrich 220700
mir-308 221200 AA5 235300
mir-Fold 219500 AA4 230500
AArich 241500 AA3 219900
4AA 162000 AA2 210300
T2AA 66200 AA1 200700
Table 7.8. Protein extinction coefficients at 280 nm 
 
Protein ε280nm M
-1
 cm
-1
GST-BHD 49850
BHD 6990
HDER 6990
Spt4 13980
Spt5NGN 9970
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where     
   = 26000 M-1cm-1 and     
   = 74600 M-1cm-1. 
 
7.2.4.3 Sample preparation 
RNA oligonucleotides less than 20-nt in length were purchased either fluorescein labelled or unlabelled. 
The lyophilised RNAs were resuspended in DEPC MQW to concentrations between 0.5 and 1 mM. 
7.2.4.4 Oligonucleotide annealing 
Unlabelled RNA oligonucleotides greater than 25-nt in length and all 32P-labelled RNA were 
createdby in-vitro transcription, using annealed DNA oligonucleotides incorporating a T7 promoter. 
DNA oligonucleotides were purchased, and the lyophilised DNA oligonucleotides were resuspended 
in annealing buffer (Table 7.10) to ~200 µM. Equal concentrations of sense and antisense strands 
were heated to 90 °C for two minutes and then allowed to cool to room temperature slowly.  
7.2.4.5 In-vitro transcription 
Templates for transcription were made by PCR with primers incorporating a T7 promoter, using either 
annealed oligonucleotides or plasmid DNA. The following components were assembled at room 
temperature in the following order: 0.5X transcription buffer, 4 mM DTT, 500 µM rNTPs, DNA 
template ~0.1 µg/µL, 1 µg/mL pyrophosphatase, 0.5 U/uL RNAse inhibitor, 100 µg/mL T7 RNA 
polymerase (recombinantly produced in-house). The reaction mixture was incubated for four hours at 
37 °C. RQ1 RNAse-free DNAse (1U) was added and the reaction was incubated for a further 30 
minutes. RNA was purified by applying the reaction mixture to a Mini Quick Spin RNA column for 
four minutes at 1000 g, followed by extraction with an equal volume of phenol saturated with 0.1 M 
citrate, pH 4.3, and then centrifugation at 17000 g for two minutes. The aqueous phase was separated 
Table 7.10. Nucleic acid and EMSA preparatory solutions 
 
Solution Composition
swab solution 0.1 M NaOH and 1 mM EDTA
annealing buffer  10 mM Tris, 50 mM KCl, 1 mM EDTA, pH 7.5
transcription buffer
80 mM HEPES-KOH, 70 mM MgCl2, 1 mg/ml RNAse free BSA, pH 
7.5
T4  polynucleotide  kinase buffer 70 mM  Tris-HCl  pH 7.6, 10 mM MgCl2, 5 mM DTT
1 X RNA loading dye
0.016% [w/v]  bromophenol  blue,  0.04% [w/v] xylene cyanol, 5% 
[w/v]  Ficoll™
1 X TBE buffer 90 mM Tris, 90 mM boric acid, 2.5 mM  EDTA
1 X TB buffer 90 mM Tris, 90 mM boric acid, 5 mM MgCl2
EMSA binding buffer
10 mM  MOPS  pH 7.0,  50 mM  KCl,  5 mM  MgCl2,  10% [v/v]  
glycerol, 1 mM DTT
MST binding buffer
50  mM  Tris-HCl, 50-150 mM NaCl, 10 mM MgCl2, 0.05 % [v/v] 
Tween-20, 1 mM DTT, pH 7.5
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and vortexed with an equal volume of 24:1 chloroform:isoamyl alcohol and centrifuged again, before 
RNA precipitation with 0.1 volume of 3 M sodium acetate pH 5.4 and 2.5 volumes of 100% ethanol at 
-20 °C overnight. The RNA was then pelleted by centrifugation at 17000 g for 45 minutes, washed with 
70% [v/v] ethanol and resuspended in RNAse-free MQW and stored at -20 °C. 
7.2.5 Electrophoretic mobility shift assays  
7.2.5.1 Production of  32P-labelled DNA probes 
32P-labelled DNA probes were produced by 5′ end-labelling 10 µM ssDNA with [γ-32P] ATP 
(10 mCi/mL) with 0.25 U T4 polynucleotide kinase in the supplied buffer (Table 7.10) at 37 °C for one 
hour. The reaction mixture was then applied to a Mini Quick Spin RNA column for four minutes at 
1000 g, before ethanol precipitation. Double-stranded DNA probes were made by labelling one strand 
with 32P, and then annealing with a four-fold molar excess of the unlabelled complementary strand in 
annealing buffer (Table 7.10) at 90 °C for two minutes and cooled to room temperature slowly. 
7.2.5.2 Production of  32P-labelled RNA probes 
32P-labelled RNA probes were produced by in-vitro transcription. The same protocol was used as 
detailed in Section 7.2.4.5, with the concentration of rUTP reduced to ~50 µM with the rest replaced 
by the addition of [α-32P] UTP. After transcription, the reactions were mixed with 1X RNA loading dye 
(Table 7.10) before heating at 70 °C for two minutes. The samples were then loaded onto a pre-cast 6% 
Tris-boric acid urea gel and electrophoresed at 200 V for 20-30 minutes in 1 X TBE buffer (Table 7.10). 
Gels were exposed on a phosphor screen and imaged on a Typhoon FLA900 scanner. Bands were 
excised and the RNA was extracted by macerating the gel pieces in MQW and incubating at 37 °C 
overnight. Gel pieces were pelleted by centrifugation at 17000 g for 30 minutes, the supernatant was 
removed and 2.5 volumes of 100% ethanol was added and the RNA was precipitated overnight at -
20 °C, before being pelleted by centrifugation (17000 g, 45 minutes). The RNA was resuspended in 
RNAse-free MQW and stored at -20 °C. 
7.2.5.3 32P Native PAGE 
Polyacrylamide gels were cast in 1 X TB buffer (Table 7.10) and run at 200 V for 30 minutes in 0.5 X 
TB buffer. Protein samples were incubated with ~ 10 counts per second of 32P-labelled probes in EMSA 
binding buffer (Table 7.10) at 4 °C for 30 minutes before being loaded onto the gel. Electrophoresis 
was carried out at 30-50 mA for one to six hours at 4 °C on a Hoefer SE400 Sturdier™ vertical slab gel 
unit. Gels were exposed on a phosphor screen and imaged on a Typhoon FLA900 scanner.  
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7.2.6 Microscale thermophoresis  
7.2.6.1 Sample preparation 
Protein samples were concentrated in 1 kDa cut-off Microsep centricons. Serial dilutions of protein 
samples were done to give 12 samples. Fluorescein-labelled RNA was added to each protein dilution to 
a final concentration of ~50 nM and samples were loaded into capillaries.  
7.2.6.2 Data acquisition 
Assays were run on a Monolith NT.115 instrument with LED power at 50% (excitation 460-480 nm, 
emission 515-530 nm) and MST power at 20% (infrared laser for heating of sample, 1480 nm) and the 
relative fluorescence for each point of the titration was plotted as a function of protein concentration. 
The data were fitted using Nanotemper software to the model: 
 
                                                ( ) = 	
        (      )    
(  )
                              Equation 7.2 
 
Where x = [titrated binding partner], B = [constant binding partner], KD = dissociation constant of first 
binding phase. 
7.2.7 Nuclear magnetic resonance spectroscopy 
7.2.7.1 Sample preparation 
Protein samples were concentrated in 1 kDa cut-off Microsep centricons or 3 kDa cut-off Vivaspin 
centricons and then filtered using 0.22 µm spin columns. Deuterium oxide (5-10% [v/v]) and 2,2-
dimethyl-2-silapentane-5-sulfonic acid (DSS, 200 µM) were added to protein samples before being 
loaded into 3 or 5 mm Shigemi NMR tubes.  
7.2.7.2 Spectral acquisition 
Spectra were acquired on either a 600 or 800 MHz Bruker Avance III NMR spectrometers, fitted with 
cryogenic TCI probes, at 298 K.  
The number of scans was increased upon RNA addition to account for protein dilution according to the 
following equation: 
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	                                                       Equation 7.3 
Where NS = number of scans, i = experiment number and [P] = protein concentration. 
 
7.2.7.3 Spectral processing 
All spectra were processed with TOPSPIN3 and 2D and 3D spectra were analysed in NMRFAM-
SPARKY [333]. The 1H frequency scale was referenced using the DSS signal set to 0 ppm. 15N and 13C 
reference values were calculated from the 1H frequency using the ratios provided by the Biological 
Magnetic Resonance Data Bank (15N ratio = 0.101329118; 13C ratio = 0.251449530) [334].  
7.2.7.4 Assignment of spectra 
HSQC spectra of RNA-bound states were assigned using the nearest neighbour method [207]. In this 
method, the assignments of the bound state are used based on proximity to the nearest peak in free 
protein state, with a correction of 1/7 used for 15N resonances in order to give a roughly equal weighting 
to the 1H signals. 
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Appendices 
Appendix A.1 RNA oligonucleotide sequences 
 
Table A.1 RNA oligonucleotide sequences 
 
RNA Sequence
BRE(257-319)
GCCGUUGCACCUGGAAUAUUGCACGUUGUUAAUUUUUGUGAUUGUAUAUUCCU
GGUUUCGACACGC
BRE38nt GAAUAUUGCACGUUGUUAAUUUUUGUGAUUGUAUAUUC
BRE39nt UAUUCCUGGUUUCGACACGCGGCCGUUGCACCUGGAAUA
ShapeControl UGGUUUAUGUGGAACAAUUAAAACCACUAACAAAACCA
Unst UCGAAGCCCUCUCUCAGUUUGUCAUAUACCCU
mir-308 GAGUGUCAUAUUAGGACACUAA
mir-Fold GGACUGACCACAAAUCAGUCAA
AArich UGGCUCGCAAUAACAAAAACAAAC
4AA UCAAUAACAAAAACA
T2AA AACCAA
1AA UCAAUC
1HAArich UGGCUCGCAAUAA
2HAArich AACAAAAACAAAC
TrimAArich CUCGCAAUAACAAAAACA
AA5 CCCCUCGCAAUAACAAAAACAAAC
AA4 UGGCUCGCCCUAACAAAAACAAAC
AA3 UGGCUCGCCCUCCCAAAAACAAAC
AA2 UGGCUCGCCCUCCCCCAAACAAAC
AA1 UGGCUCGCCCUCCCCCACCCAAAC
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Appendix A.2 DNA oligonucleotides sequences 
Table A.2 DNA oligonucleotide sequences 
 
Use Oligonucleotide Sequence
BHDFwd GCGGATCCCCACGTCGCACCCGCAC
BHDRev GCGAATTCCTATCATTAGGACTGGTCCTTGTGCTGATC
HDERFwd GCGGATCCCTGCCCGACTCTCTGGTGATG
HDERRev GCGAATTCTCATTAGGACTGGTCCTTGTGCTGATC 
BRRM Fwd GCGGATCCGCCGTTGGCGAGACG
BRRMRev GCGAATTCTCATTACTAATTGAAGCAGTAGGCAAAC
Cad3UTRFwd GCGGATCCTAATACGACTCACTATAGGGAGACACGACCATTCCTGTTATGCGG 
Cad3UTRRev GCGAATTCCCGCTGAGCAATAACTAGCGAGTTGCTTTATCTATGGTGTTCATATTTTA
BRE(257-319)Fwd TAATACGACTCACTATAGGGAGAATGGAGGACTTGGCGGCCGTTG
BRE(257-319)Rev GCGCGTGTCGAAACCAGGAATATACAAT
BRE38ntFwd TAATACGACTCACTATAGGGAGAGAATATTGCACGTTGTTAATTTTTGTGATTGTATATTC
BRE38ntRev GAATATACAATCACAAAAATTAACAACGTGCAATATTCTCTCCCTATAGTGAGTCGTATTA
BRE39ntFwd TAATACGACTCACTATAGGGAGATATTCCTGGTTTCGACACGCGGCCGTTGCACCTGGAATA
BRE39ntRev TATTCCAGGTGCAACGGCCGCGTGTCGAAACCAGGAATATCTCCCTATAGTGAGTCGTATTA
ShapeControlFwd TAATACGACTCACTATAGGGAGATGGTTTATGTGGAACAATTAAAACCACTAACAAAACCA
ShapeControlRev TGGTTTTGTTAGTGGTTTTAATTGTTCCACATAAACCATCTCCCTATAGTGAGTCGTATTA
UnstFwd TAATACGACTCACTATAGGGAGATCGAAGCCCTCTCTCAGTTTGTCATATACCCT
UnstRev AGGGTATATGACAAACTGAGAGAGGGCTTCGATCTCCCTATAGTGAGTCGTATTA
Cad525Fwd GAAATTAATACGACTCACTATAGGGCTTGGACTTGGCTTAACCCTTA 
Cad525Rev GCTCGAAGAGTGCGTTACAT
Cad411Fwd GAAATTAATACGACTCACTATAGGGCGGCGACAGTAACAACTACA
Cad411Rev ACTTACTACTGCTTACGAGCTATTC
CadEndFwd GAAATTAATACGACTCACTATAGGGATGTAACGCACTCTTCGAGC
CadEndRev GAGTTGCTTTATCTATGGTGTTCATA
AArichFwd GAAATTAATACGACTCACTATAGGGTGGCTCGCAATAACAAAAACAAAC
AArichRev GTTTGTTTTTGTTATTGCGAGCCACCCTATAGTGAGTCGTATTAATTTC
AA5Fwd GAAATTAATACGACTCACTATAGGGCCCCTCGCAATAACAAAAACAAAC
AA5Rev GTTTGTTTTTGTTATTGCGAGGGGCCCTATAGTGAGTCGTATTAATTTC
AA4Fwd GAAATTAATACGACTCACTATAGGGTGGCTCGCCCTAACAAAAACAAAC
AA4Rev GTTTGTTTTTGTTAGGGCGAGCCACCCTATAGTGAGTCGTATTAATTTC
AA3Fwd GAAATTAATACGACTCACTATAGGGTGGCTCGCCCTCCCAAAAACAAAC
AA3Rev GTTTGTTTTTGGGAGGGCGAGCCACCCTATAGTGAGTCGTATTAATTTC
AA2Fwd GAAATTAATACGACTCACTATAGGGTGGCTCGCCCTCCCCCAAACAAAC
AA2Rev GTTTGTTTGGGGGAGGGCGAGCCACCCTATAGTGAGTCGTATTAATTTC
AA1Fwd GAAATTAATACGACTCACTATAGGGTGGCTCGCCCTCCCCCACCCAAAC
AA1Rev GTTTGGGTGGGGGAGGGCGAGCCACCCTATAGTGAGTCGTATTAATTTC
GGrichFwd GAAATTAATACGACTCACTATAGGGUGGCUCGCGGUGGCGGAGGCGGAC
GGrichRev GTCCGCCTCCGCCACCGCGAGCCACCCTATAGTGAGTCGTATTAATTTC
TrimAArichFwd GAAATTAATACGACTCACTATAGGGCUCGCAAUAACAAAAACA
TrimAArichRev TGTTTTTGTTATTGCGAGCCCTATAGTGAGTCGTATTAATTTC
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Appendix A.3 Properties of protein constructs 
 
Amino acid sequence of GST (HRV-3C cleavage site indicated in red): 
MSPILGYWKIKGLVQPTRLLLEYLEEKYEEHLYERDEGDKWRNKKFELGLEFPNLPYYIDGD
VKLTQSMAIIRYIADKHNMLGGCPKERAEISMLEGAVLDIRYGVSRIAYSKDFETLKVDFLSK
LPEMLKMFEDRLCHKTYLNGDHVTHPDFMLYDALDVVLYMDPMCLDAFPKLVCFKKRIEAI
PQIDKYLKSSKYIAWPLQGWQATFGGGDHPPKSDLEVLFQGPLGS 
Table A.3 Protein construct properties 
 
Construct Protein residue numbers molecular weight (Da) pI
GST-BHD GST + 97-163 36785.1 6.0
BHD 97-163 7888.9 11.5
HDER 88-163 9014.3 11.6
BRRM 378-494 13228.4 4.3
Spt4 1-101 11157.7 5.0
Spt5NGN 284-375 10484.6 10.0
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Appendix A.4 PSIPRED Secondary structure prediction of bicoid 
Figure A.1 Bicoid PSIPRED secondary structure prediction 
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Figure A.1 Continued 
 
